STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

LEONA M & HARRY B HELMSLEY CHARITABLE TRUST: Form 990PF, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
LEONA M & HARRY B HELMSLEY CHARITABLE TRUST (EIN 13-7184401)
Tax period
2024-04-01 to 2025-03-31
Filed
2026-02-05
IRS object ID
202600369349100525
Schema version
2024v5.5
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2026-02-05T16:55:13-06:00ReturnTs
Tax Period End2025-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN331374517PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1PKF O'CONNOR DAVIES ADVISORY LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1245 PARK AVENUE 12TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10167ZIPCd
FieldValueIRS element (for citing)
Return Type990PFReturnTypeCd
Tax Period Begin2024-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN137184401EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE LEONA M AND HARRY B HELMSLEYBusinessNameLine1Txt
Business Name Line2CHARITABLE TRUSTBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlLEONBusinessNameControlTxt
Phone2126793600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 PARK AVENUE 659AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10169ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonNICHOLAS J SCHIAVOPersonNm
Person TitleCFOPersonTitleTxt
Phone2126793600PhoneNum
Signature2026-02-03SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonTHOMAS BLANEYPreparerPersonNm
PTINP00234022PTIN
Phone2122862600PhoneNum
Preparation2026-02-03PreparationDt
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990-PF IRS990PF

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
FMV Assets EOY$7,108,379,897FMVAssetsEOYAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd

Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses

FieldValueIRS element (for citing)
Schedule B Not RequiredYes (X)ScheduleBNotRequiredInd
Interest On Sav Rev And Expnss$3,123,289InterestOnSavRevAndExpnssAmt
Interest On Sav Net Invst Incm$3,123,289InterestOnSavNetInvstIncmAmt
Dividends Rev And Expnss$69,499,667DividendsRevAndExpnssAmt
Dividends Net Invst Incm$141,050,038DividendsNetInvstIncmAmt
Net Gain Sale Ast Rev And Expnss$388,637,842NetGainSaleAstRevAndExpnssAmt
Gross Sales Price$669,040,022GrossSalesPriceAmt
Cap Gain Net Incm Net Invst Incm$270,254,392CapGainNetIncmNetInvstIncmAmt
Other Income Rev And Expnss$35,998,860OtherIncomeRevAndExpnssAmt
Other Income Net Invst Incm$24,476,876OtherIncomeNetInvstIncmAmt
Total Rev And Expnss$497,259,658TotalRevAndExpnssAmt
Total Net Invst Incm$438,904,595TotalNetInvstIncmAmt
Comp Ofcr Dir Trst Rev And Expnss$3,489,555CompOfcrDirTrstRevAndExpnssAmt
Comp Ofcr Dir Trst Net Invst Incm$1,116,119CompOfcrDirTrstNetInvstIncmAmt
Comp Ofcr Dir Trst Dsbrs Chrtbl$2,340,081CompOfcrDirTrstDsbrsChrtblAmt
Oth Empl Slrs Wgs Rev And Expnss$20,708,479OthEmplSlrsWgsRevAndExpnssAmt
Oth Empl Slrs Wgs Net Invst Incm$4,393,931OthEmplSlrsWgsNetInvstIncmAmt
Oth Empl Slrs Wgs Dsbrs Chrtbl$16,117,382OthEmplSlrsWgsDsbrsChrtblAmt
Pension Empl Bnft Rev And Expnss$10,117,682PensionEmplBnftRevAndExpnssAmt
Pension Empl Bnft Net Invst Incm$2,130,594PensionEmplBnftNetInvstIncmAmt
Pension Empl Bnft Dsbrs Chrtbl$8,160,451PensionEmplBnftDsbrsChrtblAmt
Legal Fees Rev And Expnss$555,243LegalFeesRevAndExpnssAmt
Legal Fees Net Invst Incm$184,836LegalFeesNetInvstIncmAmt
Legal Fees Dsbrs Chrtbl$434,251LegalFeesDsbrsChrtblAmt
Accounting Fees Rev And Expnss$303,925AccountingFeesRevAndExpnssAmt
Accounting Fees Net Invst Incm$6,023AccountingFeesNetInvstIncmAmt
Accounting Fees Chrtbl Prps$228,750AccountingFeesChrtblPrpsAmt
Other Prof Fees Rev And Expnss$17,084,502OtherProfFeesRevAndExpnssAmt
Other Prof Fees Net Invst Incm$14,847,388OtherProfFeesNetInvstIncmAmt
Other Prof Fees Dsbrs Chrtbl$2,538,508OtherProfFeesDsbrsChrtblAmt
Interest Net Invst Incm$3,396,683InterestNetInvstIncmAmt
Taxes Rev And Expnss$1,302,511TaxesRevAndExpnssAmt
Taxes Net Invst Incm$3,875,590TaxesNetInvstIncmAmt
Taxes Dsbrs Chrtbl$0TaxesDsbrsChrtblAmt
Deprec And Dpltn Rev And Expnss$883,605DeprecAndDpltnRevAndExpnssAmt
Deprec And Dpltn Net Invst Incm$96,753DeprecAndDpltnNetInvstIncmAmt
Occupancy Rev And Expnss$1,733,287OccupancyRevAndExpnssAmt
Occupancy Net Invst Incm$7,513OccupancyNetInvstIncmAmt
Occupancy Dsbrs Chrtbl$1,998,276OccupancyDsbrsChrtblAmt
Trav Conf Meeting Rev And Expnss$2,631,178TravConfMeetingRevAndExpnssAmt
Trav Conf Meeting Net Invst Incm$247,403TravConfMeetingNetInvstIncmAmt
Trav Conf Meeting Dsbrs Chrtbl$2,325,918TravConfMeetingDsbrsChrtblAmt
Other Expenses Rev And Expnss$16,592,645OtherExpensesRevAndExpnssAmt
Other Expenses Net Invst Incm$56,278,149OtherExpensesNetInvstIncmAmt
Other Expenses Dsbrs Chrtbl$2,489,275OtherExpensesDsbrsChrtblAmt
Tot Opr Expenses Rev And Expnss$75,402,612TotOprExpensesRevAndExpnssAmt
Tot Opr Expenses Net Invst Incm$86,580,982TotOprExpensesNetInvstIncmAmt
Tot Opr Expenses Dsbrs Chrtbl$36,632,892TotOprExpensesDsbrsChrtblAmt
Contri Paid Rev And Expnss$346,765,830ContriPaidRevAndExpnssAmt
Contri Paid Dsbrs Chrtbl$440,927,206ContriPaidDsbrsChrtblAmt
Total Expenses Rev And Expnss$422,168,442TotalExpensesRevAndExpnssAmt
Total Expenses Net Invst Incm$86,580,982TotalExpensesNetInvstIncmAmt
Total Expenses Dsbrs Chrtbl$477,560,098TotalExpensesDsbrsChrtblAmt
Excess Revenue Over Expenses$75,091,216ExcessRevenueOverExpensesAmt
Net Investment Income$352,323,613NetInvestmentIncomeAmt

Form990 PF Balance Sheets Form990PFBalanceSheetsGrp

FieldValueIRS element (for citing)
Cash BOY$89,496,038CashBOYAmt
Cash EOY$58,011,746CashEOYAmt
Cash EOYFMV$58,011,746CashEOYFMVAmt
Sav And Temp Cash Invst BOY$55,980,540SavAndTempCashInvstBOYAmt
Sav And Temp Cash Invst EOY$71,184,590SavAndTempCashInvstEOYAmt
Sav And Temp Cash Invst EOYFMV$71,184,590SavAndTempCashInvstEOYFMVAmt
Acct Rcvbl$285,890AcctRcvblAmt
Acct Rcvbl BOY$604,736AcctRcvblBOYAmt
Acct Rcvbl EOY$285,890AcctRcvblEOYAmt
Acct Rcvbl EOYFMV$285,890AcctRcvblEOYFMVAmt
Prepaid Expenses BOY$1,033,231PrepaidExpensesBOYAmt
Prepaid Expenses EOY$1,117,294PrepaidExpensesEOYAmt
Prepaid Expenses EOYFMV$1,117,294PrepaidExpensesEOYFMVAmt
Corporate Stock BOY$643,618,129CorporateStockBOYAmt
Corporate Stock EOY$797,048,528CorporateStockEOYAmt
Corporate Stock EOYFMV$797,048,528CorporateStockEOYFMVAmt
Other Investments BOY$6,446,813,297OtherInvestmentsBOYAmt
Other Investments EOY$6,125,814,330OtherInvestmentsEOYAmt
Other Investments EOYFMV$6,125,814,330OtherInvestmentsEOYFMVAmt
Land Bldg Equip Cost Or Other Bss$10,602,402LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$4,745,371LandBldgEquipAccumDeprecAmt
Land BOY$6,670,262LandBOYAmt
Land EOY$5,857,031LandEOYAmt
Land EOYFMV$5,857,031LandEOYFMVAmt
Other Assets BOY$55,861,389OtherAssetsBOYAmt
Other Assets EOY$49,060,488OtherAssetsEOYAmt
Other Assets EOYFMV$49,060,488OtherAssetsEOYFMVAmt
Total Assets BOY$7,300,077,622TotalAssetsBOYAmt
Total Assets EOY$7,108,379,897TotalAssetsEOYAmt
Total Assets EOYFMV$7,108,379,897TotalAssetsEOYFMVAmt
Accounts Payable BOY$11,499,434AccountsPayableBOYAmt
Accounts Payable EOY$3,968,491AccountsPayableEOYAmt
Grants Payable BOY$564,121,729GrantsPayableBOYAmt
Grants Payable EOY$469,960,352GrantsPayableEOYAmt
Other Liabilities BOY$45,857,428OtherLiabilitiesBOYAmt
Other Liabilities EOY$40,418,243OtherLiabilitiesEOYAmt
Total Liabilities BOY$621,478,591TotalLiabilitiesBOYAmt
Total Liabilities EOY$514,347,086TotalLiabilitiesEOYAmt
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind
No Donor Rstr Net Assests BOY$6,678,599,031NoDonorRstrNetAssestsBOYAmt
No Donor Rstr Net Assests EOY$6,594,032,811NoDonorRstrNetAssestsEOYAmt
Tot Net Ast Or Fund Balances BOY$6,678,599,031TotNetAstOrFundBalancesBOYAmt
Tot Net Ast Or Fund Balances EOY$6,594,032,811TotNetAstOrFundBalancesEOYAmt
Total Liabilities Net Ast BOY$7,300,077,622TotalLiabilitiesNetAstBOYAmt
Total Liabilities Net Ast EOY$7,108,379,897TotalLiabilitiesNetAstEOYAmt

Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp

FieldValueIRS element (for citing)
Tot Net Ast Or Fund Balances BOY$6,678,599,031TotNetAstOrFundBalancesBOYAmt
Excess Revenue Over Expenses$75,091,216ExcessRevenueOverExpensesAmt
Other Increases$2,181,205OtherIncreasesAmt
Subtotal$6,755,871,452SubtotalAmt
Other Decreases$161,838,641OtherDecreasesAmt
Tot Net Ast Or Fund Balances EOY$6,594,032,811TotNetAstOrFundBalancesEOYAmt

Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail

Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp (399 entries)

PropertyPropertyDescHow AcquiredHowAcquiredCdGross Sales PriceGrossSalesPriceAmtCost Or Other BasisCostOrOtherBasisAmtGain Or LossGainOrLossAmtGains Minus Excess Or LossesGainsMinusExcessOrLossesAmtSoldSoldDt
SALE OF PUBLICLY TRADED SECURITIESP$100,776,909$49,067$100,727,842$100,727,842
ACADIAN FRONTIERP$8,137$8,137$8,1372025-02-21
ACADIAN FRONTIERP$170,334$170,334$170,3342024-04-12
ACCEL GROWTH FUND IVP$60,891$60,891$60,8912024-05-28
ACCEL GROWTH FUND IVP$194,429$194,429$194,4292024-10-09
ACCEL GROWTH IIP$95,530$95,530$95,5302024-08-06
ACCEL GROWTH IIP$285,950$285,950$285,9502025-02-20
ACCEL GROWTH IIP$790,579$790,579$790,5792024-12-20
ACCEL GROWTH IIP$93,382$93,382$93,3822024-08-27
ACCEL GROWTH IIP$110,121$110,121$110,1212024-09-04
ACCEL GROWTH IIP$110,121$110,121$110,1212024-09-09
ACCEL GROWTH IIP$110,346$110,346$110,3462024-09-19
ACCEL GROWTH IIP$267,610$267,610$267,6102024-11-07
ACCEL GROWTH IIP$260,384$260,384$260,3842024-11-21
ACCEL GROWTH VP$56,579$56,579$56,5792024-11-12
ACCEL GROWTH VP$44,712$44,712$44,7122024-08-12
ACCEL LEADERS FUNDP$339,577$339,577$339,5772024-07-08
ACCEL LEADERS IIP$169,631$169,631$169,6312024-11-12
ACCEL LEADERS IIP$134,020$134,020$134,0202024-08-12
ACCEL XIIP$310,941$310,941$310,9412024-07-01
ACCEL XIIP$223,664$223,664$223,6642025-01-14
ACCEL XIIP$66,765$66,765$66,7652024-05-28
AH IVP$554,375$554,375$554,3752024-05-10
AH IVP$135,239$135,239$135,2392024-04-17
AH IVP$581,363$581,363$581,3632025-02-06
AH IVP$5,422,148$5,422,148$5,422,1482024-12-09
AH IVP$506,086$506,086$506,0862024-11-13
AH IVP$5,475,799$5,475,799$5,475,7992024-09-10
AH IVP$1,007,639$1,007,639$1,007,6392024-08-08
AH IVP$488,086$488,086$488,0862024-08-05
AH IVP$445,055$445,055$445,0552024-07-16
AH IVP$37,200$37,200$37,2002024-04-17
AH IVP$408,164$408,164$408,1642024-06-13
AH IV PARALLELP$307,142$307,142$307,1422024-04-17
AH IV PARALLELP$401,912$401,912$401,9122024-05-10
AH IV PARALLELP$727,034$727,034$727,0342024-06-13
AH IV PARALLELP$792,745$792,745$792,7452024-07-16
AH IV PARALLELP$337,469$337,469$337,4692024-08-05
AH IV PARALLELP$247,006$247,006$247,0062024-08-08
AH IV PARALLELP$433,039$433,039$433,0392024-09-10
AH IV PARALLELP$342,430$342,430$342,4302024-11-13
AH IV PARALLELP$461,124$461,124$461,1242024-12-09
AH IV PARALLELP$1,035,544$1,035,544$1,035,5442025-02-06
AH LSV IP$439,031$439,031$439,0312024-09-10
AH LSV IP$543,327$543,327$543,3272024-12-11
AH LSV IP$484,717$484,717$484,7172025-02-06
AH LSV IP$412,821$412,821$412,8212024-11-06
AH LSV IP$475,224$475,224$475,2242024-12-09
BAYVIEWP$676,375$676,375$676,3752024-08-08
BAYVIEWP$124,950$124,950$124,9502025-01-10
BAYVIEWP$50,495$50,495$50,4952024-12-31
BLACKROCK US DEBTP$20,000,000$18,609,900$1,390,100$1,390,1002024-06-04
BLACKROCK US DEBTP$15,000,000$13,391,867$1,608,133$1,608,1332024-08-27
BLACKROCK US DEBTP$14,245$13,611$634$6342024-04-24
BLACKROCK US DEBTP$15,000,000$13,384,573$1,615,427$1,615,4272024-09-03
BLACKROCK US DEBTP$12,127$10,961$1,166$1,1662024-10-22
BLACKROCK US DEBTP$13,647$12,559$1,088$1,0882024-07-22
BLACKROCK US DEBTP$10,756$9,826$930$9302025-01-24
CAMBERP$15,000,000$9,232,493$5,767,507$5,767,5072024-12-31
CHATHAMP$516-$516-$5162024-10-17
CHATHAMP$10,000,516$4,632,028$5,368,488$5,368,4882024-09-30
CHATHAMP$5,000,000$2,228,298$2,771,702$2,771,7022025-03-31
CHATHAM OFFSHOREP$5,000,000$2,261,774$2,738,226$2,738,2262025-03-31
CHATHAM OFFSHOREP$10,000,000$4,738,543$5,261,457$5,261,4572024-09-30
COLLER VIP$581,635$581,635$581,6352024-09-20
COLLER VIP$114,941$114,941$114,9412025-03-28
COLLER VIP$86,683$86,683$86,6832024-12-16
COLLER VIP$96,318$96,318$96,3182025-02-12
COLLER VIP$178,332$178,332$178,3322024-07-03
COLLER VIP$298,045$298,045$298,0452024-05-10
COLLER VIIP$2,733,736$2,733,736$2,733,7362024-09-30
COLLER VIIP$1,439,065$1,439,065$1,439,0652024-10-21
COLLER VIIP$940,500$940,500$940,5002024-07-26
COLLER VIIP$3,196,572$3,196,572$3,196,5722025-01-07
COLLER VIIP$1,182,116$1,182,116$1,182,1162024-06-27
CRESTVIEW IIIP$716,723$716,723$716,7232024-12-23
CRESTVIEW IIIP$350,515$350,515$350,5152024-06-18
CRESTVIEW IVP$217,828$217,828$217,8282024-06-18
EIG ENERGY FUND XVIP$96,495$96,495$96,4952024-04-16
EIG ENERGY FUND XVIP$345,347$345,347$345,3472024-06-28
EIG ENERGY XVP$351,294$351,294$351,2942025-03-25
EIG ENERGY XVIIP$57,950$57,950$57,9502025-03-31
EIG ENERGY XVIIP$23,663$23,663$23,6632024-06-28
EIG ENERGY XVIIP$431,455$431,455$431,4552024-08-06
EIG ENERGY XVIIP$406,437$406,437$406,4372024-10-30
EIG ENERGY XVIIP$3,056$3,056$3,0562024-12-31
EIG ENERGY XVIIP$218,737$218,737$218,7372024-04-10
EMERGENCE IIIP$5,086,839$5,086,839$5,086,8392024-12-03
EMERGENCE OPP IP$342,981$342,981$342,9812025-02-12
EMERGENCE OPP IP$223,517$223,517$223,5172024-11-12
EPIRIS ELEC CO INVP$616,412$616,412$616,4122025-01-21
EPIRIS ELEC CO INVP$505,163$505,163$505,1632024-09-26
EPIRIS IIP$55,373$55,373$55,3732024-09-26
EPIRIS IIP$58,548$58,548$58,5482024-08-28
EPIRIS IIIP$251,128$251,128$251,1282025-01-21
EPIRIS IIIP$18,351$18,351$18,3512024-08-20
EPIRIS IIIP$1,163,419$1,163,419$1,163,4192024-10-30
FORTISSIMO VP$3,256,380$3,256,380$3,256,3802024-08-14
FRAZIER IXP$68,206$68,206$68,2062025-03-14
FRAZIER IXP$90,172$90,172$90,1722024-05-14
FRAZIER IXP$422,015$422,015$422,0152025-01-07
FRAZIER OVERAGEP$416,477$416,477$416,4772025-03-20
FRAZIER PUBLIC FUNDP$544,640$544,640$544,6402025-03-20
FRAZIER PUBLIC FUNDP$3,316,055$3,316,055$3,316,0552024-05-23
FRAZIER XP$164,995$164,995$164,9952025-02-07
FRAZIER XP$91,483$91,483$91,4832024-04-19
FRAZIER XIP$415,117$415,117$415,1172025-02-07
FRAZIER XIP$153,232$153,232$153,2322025-03-26
FRAZIER XIP$134,642$134,642$134,6422024-09-18
GAVEA VP$125,558$125,558$125,5582025-02-14
GAVEA VP$28,701$28,701$28,7012024-11-21
GAVEA V PLUSP$296,683$1,820,727-$1,524,044-$1,524,0442024-08-20
GENERL ATLANTIC 2013P$262,194$262,194$262,1942024-05-23
GENERL ATLANTIC 2013P$778,044$778,044$778,0442024-12-09
GENERL ATLANTIC 2013P$687,815$687,815$687,8152024-11-15
GENERL ATLANTIC 2013P$2,448,001$2,448,001$2,448,0012024-11-01
GENERL ATLANTIC 2013P$1,203,436-$1,203,436-$1,203,4362024-09-17
GENERL ATLANTIC 2013P$251,741-$251,741-$251,7412024-06-18
GENERL ATLANTIC 2013P$318,109-$318,109-$318,1092024-06-27
GENERL ATLANTIC 2013P$214,699$214,699$214,6992024-07-29
GENERL ATLANTIC 2013P$352,356$352,356$352,3562024-08-20
GENERL ATLANTIC 2013P$300,519-$300,519-$300,5192024-09-10
GENERL ATLANTIC 2013P$602,031$602,031$602,0312024-10-22
GENERL ATLANTIC 2018P$248,139$248,139$248,1392025-01-23
GENERL ATLANTIC 2018P$62,458-$62,458-$62,4582024-12-19
GENERL ATLANTIC 2018P$7,824$7,824$7,8242024-12-09
GENERL ATLANTIC 2018P$150,412-$150,412-$150,4122024-09-23
GENERL ATLANTIC 2018P$300,340-$300,340-$300,3402024-09-10
GENERL ATLANTIC 2018P$4,965$4,965$4,9652024-08-08
GENERL ATLANTIC 2018P$253,065$253,065$253,0652024-06-21
GENERL ATLANTIC 2018P$24,276$24,276$24,2762024-04-18
GENERL ATLANTIC 2018P$20,669-$20,669-$20,6692024-08-13
HIG BRAZIL LATAM BP$1,923,570$1,923,570$1,923,5702025-01-28
HIG BRAZIL LATAM BP$1,271$1,271$1,2712024-04-09
HIG BRAZIL LATAM CP$1,923,570$1,923,570$1,923,5702025-01-28
HIG BRAZIL LATAM CP$1,271$1,271$1,2712024-04-09
HIG CAPITAL VP$2,238,351$2,238,351$2,238,3512024-10-10
HIG CAPITAL VP$108,903$108,903$108,9032024-09-27
HIG GROWTH IIP$6,589,895$6,589,895$6,589,8952024-06-18
HIG GROWTH IIP$428,825$428,825$428,8252024-10-30
HIG GROWTH IIP$2,981,167$2,981,167$2,981,1672024-07-18
HIG GROWTH IIIP$15,245$15,245$15,2452024-06-24
HIG MID MARKET IIP$4,540,155$4,540,155$4,540,1552024-10-10
HIG MID MARKET IIIP$2,730,340$2,730,340$2,730,3402025-02-28
HIG MID MARKET IIIP$80,215-$80,215-$80,2152025-01-23
HIG MID MARKET IIIP$983,432$983,432$983,4322024-11-07
HIG MID MARKET IIIP$643,259$643,259$643,2592025-01-23
HIG MID MARKET IIIP$495,998$495,998$495,9982024-11-27
HIGHCLERE INTL SCP$98,500$98,500$98,5002024-04-30
HIGHCLERE INTL SCP$101,636$101,636$101,6362024-05-31
HIGHCLERE INTL SCP$99,653$99,653$99,6532024-06-30
HIGHCLERE INTL SCP$104,842$104,842$104,8422024-07-31
HIGHCLERE INTL SCP$105,581$105,581$105,5812024-08-31
HIGHCLERE INTL SCP$108,549$108,549$108,5492024-09-30
HIGHCLERE INTL SCP$101,394$101,394$101,3942024-10-31
HIGHCLERE INTL SCP$100,737$100,737$100,7372024-11-30
HIGHCLERE INTL SCP$98,786$98,786$98,7862024-12-31
HIGHCLERE INTL SCP$100,783$100,783$100,7832025-01-31
HIGHCLERE INTL SCP$100,535$100,535$100,5352025-02-28
HIGHCLERE INTL SCP$101,235$101,235$101,2352025-03-31
HIGHCLERE INTL SMIDP$10,000,000$10,000,000$10,000,0002024-07-08
HIGHCLERE INTL SMIDP$41,808$41,808$41,8082024-07-31
HIGHCLERE INTL SMIDP$42,158$42,158$42,1582024-08-31
HIGHCLERE INTL SMIDP$43,332$43,332$43,3322024-09-30
HIGHCLERE INTL SMIDP$28,085$28,085$28,0852024-10-31
HIGHCLERE INTL SMIDP$20,000,000$20,000,000$20,000,0002024-10-07
HIGHCLERE INTL SMIDP$20,000,000$20,000,000$20,000,0002024-11-07
HIGHCLERE INTL SMIDP$13,000$13,000$13,0002024-11-30
HIGHCLERE INTL SMIDP$16,366,469$16,366,469$16,366,4692024-12-06
HIGHCLERE INTL SMIDP$40,967$40,967$40,9672024-12-06
HIGHCLERE INTL SMIDP$45,862$45,862$45,8622024-06-30
HIGHCLERE INTL SMIDP$47,403$47,403$47,4032024-05-31
HIGHCLERE INTL SMIDP$46,398$46,398$46,3982024-04-30
HONGSHAN GROWTH IIIP$2,324,829$2,324,829$2,324,8292025-01-28
HONGSHAN GROWTH IIIP$158,779$158,779$158,7792025-01-16
HONGSHAN GROWTH IVP$356,150$356,150$356,1502024-04-05
HONGSHAN GROWTH IVP$267,294$267,294$267,2942025-02-11
HONGSHAN GROWTH IVP$469,601$469,601$469,6012024-09-27
HONGSHAN GROWTH IVP$1,462,758$1,462,758$1,462,7582024-10-03
HONGSHAN GROWTH VP$886,290$886,290$886,2902024-06-06
HONGSHAN GROWTH VP$387,389$387,389$387,3892025-02-20
HONGSHAN GROWTH VP$120,258$120,258$120,2582024-10-03
HONGSHAN VTR IVP$1,724,725$1,724,725$1,724,7252025-01-07
HONGSHAN VTR VP$1,572,764$1,572,764$1,572,7642024-06-27
HONGSHAN VTR VP$976,372$976,372$976,3722024-12-06
HONGSHAN VTR VIP$272,166$272,166$272,1662025-02-04
HONGSHAN VTR VIIP$226,056$226,056$226,0562025-01-23
IDG CHINA CAP IIIP$356,085$356,085$356,0852024-06-26
IDG CHINA CAP IIIP$692,441$692,441$692,4412024-12-23
IDG CHINA VTR IVP$1,431,875$1,431,875$1,431,8752024-12-27
IDG CHINA VTR IVP$1,540,318$1,540,318$1,540,3182024-06-26
IDG CHINA VTR IVP$629,533$629,533$629,5332025-03-26
IDG-ACCEL CHINA CAPP$153,499$153,499$153,4992025-03-28
IDG-ACCEL CHINA CAPP$347,979$347,979$347,9792024-12-27
IDG-ACCEL CHINA GWTHP$342,633$342,633$342,6332024-12-27
IRON POINT IVP$98,074$98,074$98,0742024-11-26
IRON POINT IVP$116,088$116,088$116,0882025-01-31
IRON POINT IVP$589,300$589,300$589,3002024-05-31
JPM PEG SECONDRY IIIP$832,831$832,831$832,8312024-06-11
JPM PEG SECONDRY IIIP$260,094$260,094$260,0942025-02-20
LA CAPITAL GLOBALP$16,782$16,782$16,7822024-08-31
LA CAPITAL GLOBALP$16,269$16,269$16,2692024-07-31
LA CAPITAL GLOBALP$16,198$16,198$16,1982024-06-30
LA CAPITAL GLOBALP$15,942$15,942$15,9422024-05-31
LA CAPITAL GLOBALP$42,967$42,967$42,9672024-09-30
LA CAPITAL GLOBALP$85,991,115$85,991,115$85,991,1152024-09-03
LA CAPITAL GLOBALP$11,000,000$11,000,000$11,000,0002024-09-04
LA CAPITAL GLOBALP$3,420,000$3,420,000$3,420,0002024-09-10
LA CAPITAL GLOBALP$15,402$15,402$15,4022024-04-30
LACM WORLD SMALL CAPP$20,503$33,936-$13,433-$13,4332025-02-28
LACM WORLD SMALL CAPP$19,904$47,400-$27,496-$27,4962025-03-31
LACM WORLD SMALL CAPP$15,602$15,602$15,6022024-04-30
LACM WORLD SMALL CAPP$16,197$16,197$16,1972024-05-31
LACM WORLD SMALL CAPP$15,997$15,997$15,9972024-06-28
LACM WORLD SMALL CAPP$17,165$17,165$17,1652024-07-31
LACM WORLD SMALL CAPP$17,262$17,262$17,2622024-08-31
LACM WORLD SMALL CAPP$17,624$17,624$17,6242024-09-30
LACM WORLD SMALL CAPP$17,198$17,198$17,1982024-10-31
LACM WORLD SMALL CAPP$18,342$18,342$18,3422024-11-30
LACM WORLD SMALL CAPP$21,118$34,954-$13,836-$13,8362025-01-31
MARATHON GLOBALP$113,216$120,019-$6,803-$6,8032025-03-31
MARATHON GLOBALP$121,799$117,793$4,006$4,0062025-01-31
MARATHON GLOBALP$117,910$118,743-$833-$8332025-02-28
MARATHON GLOBALP$106,095$98,764$7,331$7,3312024-12-31
MARATHON GLOBALP$106,715$98,641$8,074$8,0742024-11-30
MARATHON GLOBALP$104,541$99,327$5,214$5,2142024-10-31
MARATHON GLOBALP$107,477$98,535$8,942$8,9422024-09-30
MARATHON GLOBALP$105,618$99,118$6,500$6,5002024-08-31
MARATHON GLOBALP$99,672$101,153-$1,481-$1,4812024-05-31
MARATHON GLOBALP$103,314$99,863$3,451$3,4512024-07-31
MARATHON GLOBALP$98,157$101,736-$3,579-$3,5792024-04-30
MARATHON GLOBALP$101,595$100,460$1,135$1,1352024-06-28
MHR AXIOMP$8,756,041$7,122,665$1,633,376$1,633,3762024-04-10
MHR AXIOMP$6,549,708$5,404,893$1,144,815$1,144,8152024-01-23
MHR AXIOMP$4,200,693$3,346,112$854,581$854,5812025-02-25
MHR AXIOMP$7,449,691$6,060,005$1,389,686$1,389,6862024-05-15
MHR AXIOMP$13,146,060$10,728,930$2,417,130$2,417,1302024-09-30
MHR AXIOMP$10,799,601$8,610,687$2,188,914$2,188,9142025-03-26
MHR INST PARTNERS IVP$70,584$70,584$70,5842024-09-26
NEWMARKET IIFCP$2,534,924$2,534,924$2,534,9242024-04-05
ORBIMED ASIA IIIP$981,047$981,047$981,0472024-04-08
ORBIMED ASIA IIIP$1,568,863$1,568,863$1,568,8632024-12-12
ORBIMED ASIA IVP$6,453,395$6,453,395$6,453,3952024-06-27
ORBIMED ASIA IVP$134,561-$134,561-$134,5612024-04-09
ORBIMED ISRAEL IIP$1,675,630$1,675,630$1,675,6302024-07-18
ORBIMED PI IXP$3,560,122$3,560,122$3,560,1222024-12-17
ORBIMED PI VIP$414,196$414,196$414,1962024-11-13
ORBIMED PI VIP$198,429$198,429$198,4292025-03-20
ORBIMED PI VIP$1,541,464$1,541,464$1,541,4642024-05-23
ORBIMED PI VIP$163,168-$163,168-$163,1682024-07-30
ORBIMED PI VIP$398,545$398,545$398,5452024-08-22
ORBIMED PI VIP$23,202$23,202$23,2022024-04-24
ORBIMED ROYALTY IIP$1,141,698-$1,141,698-$1,141,6982024-12-06
ORBIMED ROYALTY IIP$293$293$2932024-06-06
PEAK XV VP$192,662$192,662$192,6622024-11-04
PEAK XV VP$354,728$354,728$354,7282024-10-16
PEAK XV VP$192,266$192,266$192,2662024-06-26
PEAK XV VP$120,937$120,937$120,9372025-02-14
PEAK XV VP$200,242$200,242$200,2422024-12-30
PEAK XV VP$481,436$481,436$481,4362024-12-12
PEAK XV VP$375,158$375,158$375,1582024-09-20
PEAK XV VIP$45,646$45,646$45,6462024-05-07
PEAK XV VIP$292,130$292,130$292,1302024-09-24
PEAK XV VIP$42,054$42,054$42,0542024-12-11
PITANGO VTR VIP$2,748,514$2,748,514$2,748,5142024-10-08
RIDGEWOOD IIIP$3,738,082$3,738,082$3,738,0822024-06-21
RIDGEWOOD IIIP$2,224,439$2,224,439$2,224,4392024-12-26
RIDGEWOOD IIIP$3,696,054$3,696,054$3,696,0542024-09-25
RIDGEWOOD IVP$700,091$700,091$700,0912024-12-26
RIDGEWOOD IVP$1,383,990$1,383,990$1,383,9902024-06-21
RIDGEWOOD IVP$1,471,699$1,471,699$1,471,6992024-09-25
S CAPITALP$4,737$4,737$4,7372025-01-23
S CAPITALP$7,385,395$7,385,395$7,385,3952025-01-23
SCF LIQUID PORTFOLIOP$349,840$289,035$60,805$60,8052024-10-25
SCF LIQUID PORTFOLIOP$427,320$353,048$74,272$74,2722024-10-25
SCF LIQUID PORTFOLIOP$35,600$29,412$6,188$6,1882024-10-25
SCF LIQUID PORTFOLIOP$43,950$36,311$7,639$7,6392024-10-31
SCF LIQUID PORTFOLIOP$63,079$52,115$10,964$10,9642024-10-31
SCF LIQUID PORTFOLIOP$286,232$220,713$65,519$65,5192025-02-28
SCF LIQUID PORTFOLIOP$43,950$36,163$7,787$7,7872024-11-30
SCF LIQUID PORTFOLIOP$249,200$205,050$44,150$44,1502024-11-30
SCF LIQUID PORTFOLIOP$142,440$117,204$25,236$25,2362024-11-30
SCF LIQUID PORTFOLIOP$569,760$468,817$100,943$100,9432024-12-04
SCF LIQUID PORTFOLIOP$63,607$52,189$11,418$11,4182024-12-31
SCF LIQUID PORTFOLIOP$35,600$29,210$6,390$6,3902024-12-31
SCF LIQUID PORTFOLIOP$43,950$35,880$8,070$8,0702025-01-16
SCF LIQUID PORTFOLIOP$71,200$58,126$13,074$13,0742025-01-16
SCF LIQUID PORTFOLIOP$922,304$752,943$169,361$169,3612025-01-27
SCF LIQUID PORTFOLIOP$284,880$232,568$52,312$52,3122025-01-31
SCF LIQUID PORTFOLIOP$84,105$68,661$15,444$15,4442025-01-31
SCF LIQUID PORTFOLIOP$712,200$549,176$163,024$163,0242025-02-28
SCF LIQUID PORTFOLIOP$462,931$343,809$119,122$119,1222025-03-31
SCF LIQUID PORTFOLIOP$35,600$26,439$9,161$9,1612025-03-31
SCF LIQUID PORTFOLIOP$63,079$46,847$16,232$16,2322025-03-31
SCF LIQUID PORTFOLIOP$43,950$40,512$3,438$3,4382024-04-30
SCF LIQUID PORTFOLIOP$63,079$58,145$4,934$4,9342024-04-30
SCF LIQUID PORTFOLIOP$249,270$229,771$19,499$19,4992024-04-19
SCF LIQUID PORTFOLIOP$106,800$98,446$8,354$8,3542024-04-30
SCF LIQUID PORTFOLIOP$63,607$58,631$4,976$4,9762024-04-30
SCF LIQUID PORTFOLIOP$142,400$112,834$29,566$29,5662024-05-31
SCF LIQUID PORTFOLIOP$397,545$315,003$82,542$82,5422024-05-31
SCF LIQUID PORTFOLIOP$142,440$112,866$29,574$29,5742024-05-31
SCF LIQUID PORTFOLIOP$178,049$141,082$36,967$36,9672024-06-20
SCF LIQUID PORTFOLIOP$159,018$126,002$33,016$33,0162024-06-30
SCF LIQUID PORTFOLIOP$71,200$56,417$14,783$14,7832024-06-30
SCF LIQUID PORTFOLIOP$43,950$34,825$9,125$9,1252024-07-12
SCF LIQUID PORTFOLIOP$178,049$141,082$36,967$36,9672024-07-12
SCF LIQUID PORTFOLIOP$231,400$183,356$48,044$48,0442024-07-31
SCF LIQUID PORTFOLIOP$63,079$49,982$13,097$13,0972024-07-31
SCF LIQUID PORTFOLIOP$43,950$34,825$9,125$9,1252024-07-31
SCF LIQUID PORTFOLIOP$106,829$84,649$22,180$22,1802024-07-31
SCF LIQUID PORTFOLIOP$95,411$75,601$19,810$19,8102024-08-06
SCF LIQUID PORTFOLIOP$127,214$100,801$26,413$26,4132024-08-12
SCF LIQUID PORTFOLIOP$556,563$441,007$115,556$115,5562024-08-31
SCF LIQUID PORTFOLIOP$149,561$118,508$31,053$31,0532024-08-31
SCF LIQUID PORTFOLIOP$249,271$217,871$31,400$31,4002024-09-30
SCF LIQUID PORTFOLIOP$35,600$31,116$4,484$4,4842024-09-30
SEQUOIA GBL GRTH IIIP$225,234$225,234$225,2342024-11-22
SEQUOIA GBL GRTH IIIP$145,975$145,975$145,9752024-10-22
SEQUOIA GBL GRTH IIIP$241,753$241,753$241,7532025-02-12
SEQUOIA GBL GRTH IIIP$106,342$106,342$106,3422024-07-01
SEQUOIA GBL GRTH IIIP$16,718$16,718$16,7182024-07-01
SEQUOIA GBL GRTH IIIP$47,923$47,923$47,9232024-05-14
SEQUOIA GBL GRTH IIIP$816,743$816,743$816,7432024-12-16
SEQUOIA GBL GRTH IIIP$582,029$582,029$582,0292024-12-06
SEQUOIA GBL GRTH IIIP$548,708$548,708$548,7082024-12-04
SEQUOIA GBL GRTH IIIP$505,809$505,809$505,8092024-11-25
SEQUOIA GBL GRTH IIIP$353,024$353,024$353,0242024-10-03
SEQUOIA GBL GRTH IIIP$675,056$675,056$675,0562024-11-11
SEQUOIA GBL GRTH IIIP$299,295$299,295$299,2952024-11-18
SEQUOIA GLB GROWTHP$313,584$313,584$313,5842025-02-18
SEQUOIA GLB GROWTHP$319,901$319,901$319,9012024-07-31
SEQUOIA GLB GROWTHP$922,194$922,194$922,1942024-05-14
SEQUOIA GLB GRWTH IIP$298,310$298,310$298,3102024-10-09
SEQUOIA GLB GRWTH IIP$154,892$154,892$154,8922024-04-02
SEQUOIA GLB GRWTH IIP$121,872$121,872$121,8722024-07-31
SEQUOIA GLB GRWTH IIP$581,737$581,737$581,7372025-02-11
SEQUOIA GLB GRWTH IIP$1,027,919$1,027,919$1,027,9192024-10-03
SEQUOIA GLB GRWTH IIP$881,711$881,711$881,7112024-11-19
SEQUOIA SCOUT IIIP$58,909$58,909$58,9092024-11-29
SEQUOIA US GROWTH VP$126,528$126,528$126,5282024-11-11
SEQUOIA US GROWTH VP$55,501$55,501$55,5012024-11-18
SEQUOIA US GROWTH VP$92,839$92,839$92,8392024-11-25
SEQUOIA US GROWTH VP$100,044$100,044$100,0442024-12-04
SEQUOIA US GROWTH VP$105,609$105,609$105,6092024-12-06
SEQUOIA US GROWTH VP$147,690$147,690$147,6902024-12-16
SEQUOIA US GRWTH VIIP$102,785$102,785$102,7852024-10-31
SEQUOIA US GRWTH VIIP$261,085$261,085$261,0852024-11-19
SEQUOIA US GWTH VIP$264,174$264,174$264,1742024-08-30
SEQUOIA US GWTH VIP$88,705$88,705$88,7052024-09-05
SEQUOIA US GWTH VIP$325,459$325,459$325,4592024-08-26
SEQUOIA US GWTH VIP$590,261$590,261$590,2612024-08-09
SEQUOIA US GWTH VIP$144,996$144,996$144,9962024-05-14
SEQUOIA US VTR XIVP$1,785,910$1,785,910$1,785,9102024-08-30
SEQUOIA US VTR XIVP$1,808,952$1,808,952$1,808,9522024-08-26
SEQUOIA US VTR XIVP$849,984$849,984$849,9842024-09-05
SEQUOIA US VTR XVP$34,863$34,863$34,8632024-12-31
SEQUOIA US VTR XVP$59,055$59,055$59,0552024-07-15
SILCHESTER INTLP$76,619$59,146$17,473$17,4732024-04-30
SILCHESTER INTLP$76,804$59,052$17,752$17,7522024-06-28
SILCHESTER INTLP$10,000,000$7,613,469$2,386,531$2,386,5312024-07-05
SILCHESTER INTLP$79,271$58,654$20,617$20,6172024-05-31
SILCHESTER INTLP$75,772$55,236$20,536$20,5362024-07-31
SILCHESTER INTLP$77,190$52,756$24,434$24,4342024-08-31
SILCHESTER INTLP$74,929$52,965$21,964$21,9642025-02-28
SILCHESTER INTLP$74,532$53,061$21,471$21,4712025-01-31
SILCHESTER INTLP$75,928$52,770$23,158$23,1582025-03-31
SILCHESTER INTLP$75,014$53,060$21,954$21,9542024-10-31
SILCHESTER INTLP$73,288$53,336$19,952$19,9522024-11-30
SILCHESTER INTLP$72,652$53,425$19,227$19,2272024-12-31
SILCHESTER INTLP$78,402$52,540$25,862$25,8622024-09-30
SPDR TRUST SERIES IP$9,950,569$8,832,019$1,118,550$1,118,5502024-05-30
SQUOIA GG 3 US IN AXP$69,881$69,881$69,8812024-12-20
SQUOIA GG 3 US IN AXP$368,722$368,722$368,7222024-12-31
SQUOIA GG 3 US IN AXP$1,040,506$1,040,506$1,040,5062025-02-19
STARWOOD XIP$221,679$221,679$221,6792024-09-30
STARWOOD XIP$686,978$686,978$686,9782024-09-30
ACADIAN FRONTIERP$136$136$136
ACADIAN FRONTIERP$2,120$2,120$2,120
ACADIAN FRONTIERP$134$134$134
ACADIAN FRONTIERP$4$4$4
ACADIAN FRONTIERP$123,269-$123,269-$123,269
ACADIAN FRONTIERP$2,680-$2,680-$2,680
ACADIAN FRONTIERP$448-$448-$448
ACADIAN FRONTIERP$25-$25-$25
ACADIAN FRONTIERP$77-$77-$77
ACADIAN FRONTIERP$7-$7-$7
ACADIAN FRONTIERP$51-$51-$51
ACADIAN FRONTIERP$8,114-$8,114-$8,114
ACADIAN FRONTIERP$3-$3-$3
ACADIAN FRONTIERP$44,294-$44,294-$44,294
HIG GROWTH IIIP$210,548$210,548$210,548
SCF LIQUID PORTFOLIOP$2,040,335$2,040,335$2,040,335
SCF LIQUID PORTFOLIOP$1,783,318-$1,783,318-$1,783,318
HIGHCLERE SMIDP$192,969-$192,969-$192,969
ACADIAN FRONTIERP$245,581$343,630-$98,049-$98,049
TAURUS RESOURCESP$40,318,331$24,689,818$15,628,513$15,628,513
BITCOINP$7,282,986$4,532,554$2,750,432$2,750,432
K-1 ADJUSTMENTS, NET OF UBI AND RELATED AMOUNTS ABOVEP-$225,928,033-$225,928,033
FieldValueIRS element (for citing)
Capital Gain Net Income$270,254,392CapitalGainNetIncomeAmt

Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp

FieldValueIRS element (for citing)
Investment Income Excise Tax$4,897,298InvestmentIncomeExciseTaxAmt
Tax Under Section511$0TaxUnderSection511Amt
Subtotal$4,897,298SubtotalAmt
Subtitle A Tax$0SubtitleATaxAmt
Tax Based On Investment Income$4,897,298TaxBasedOnInvestmentIncomeAmt
Estimated Plus Ovpmt Incm Tx$7,900,234EstimatedPlusOvpmtIncmTxAmt
Exempt Frgn Org Tax Wthld At Srce$0ExemptFrgnOrgTaxWthldAtSrceAmt
Extsn Request Income Tax Paid$1,000,000ExtsnRequestIncomeTaxPaidAmt
Backup Withholding Withheld$0BackupWithholdingWithheldAmt
Total Payments And Credits$8,900,234TotalPaymentsAndCreditsAmt
Form2220 AttachedYes (X)Form2220AttachedInd
Es Penalty$0EsPenaltyAmt
Overpayment$4,002,936OverpaymentAmt
Applied To ES Tax$4,002,936AppliedToESTaxAmt
Refund$0RefundAmt

Statements Regarding Acty StatementsRegardingActyGrp

FieldValueIRS element (for citing)
Legislative Political Acty0LegislativePoliticalActyInd
More Than100 Spent0MoreThan100SpentInd
Form1120 POL Filed0Form1120POLFiledInd
Section4955 Organization Tax$0Section4955OrganizationTaxAmt
Section4955 Managers Tax$0Section4955ManagersTaxAmt
Tax Reimbursed$0TaxReimbursedAmt
Activities Not Previously Rpt0ActivitiesNotPreviouslyRptInd
Changes To Articles Or Bylaws0ChangesToArticlesOrBylawsInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Organization Dissolved Etc0OrganizationDissolvedEtcInd
Section508e Rqr SatisfiedYes (1)Section508eRqrSatisfiedInd
At Least5000 In AssetsYes (1)AtLeast5000InAssetsInd
Org Report Or Register StateNYOrgReportOrRegisterStateCd
Form990 PF Filed With Atty GenYes (1)Form990PFFiledWithAttyGenInd
Private Operating Foundation0PrivateOperatingFoundationInd
New Substantial Contributors0NewSubstantialContributorsInd
Own Controlled EntityYes (1)OwnControlledEntityInd
Donor Advised Fund0DonorAdvisedFundInd
Comply With Public Insp RqrYes (1)ComplyWithPublicInspRqrInd
Website AddressHELMSLEYTRUST.ORGWebsiteAddressTxt

Persons With Books Name PersonsWithBooksName

FieldValueIRS element (for citing)
Business Name Line1NICHOLAS J SCHIAVO CFOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2126793600PhoneNum

Location Of Books US Address LocationOfBooksUSAddress

FieldValueIRS element (for citing)
Address Line1230 PARK AVENUE SUITE 659AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10169ZIPCd
FieldValueIRS element (for citing)
Foreign Accounts QuestionYes (1)ForeignAccountsQuestionInd
Foreign CountryASForeignCountryCd
Foreign CountryAUForeignCountryCd
Foreign CountryBEForeignCountryCd
Foreign CountryCAForeignCountryCd
Foreign CountryDAForeignCountryCd
Foreign CountryFIForeignCountryCd
Foreign CountryFRForeignCountryCd
Foreign CountryGMForeignCountryCd
Foreign CountryHKForeignCountryCd
Foreign CountryIDForeignCountryCd
Foreign CountryEIForeignCountryCd
Foreign CountryISForeignCountryCd
Foreign CountryITForeignCountryCd
Foreign CountryJAForeignCountryCd
Foreign CountryNLForeignCountryCd
Foreign CountryNZForeignCountryCd
Foreign CountryNOForeignCountryCd
Foreign CountryPOForeignCountryCd
Foreign CountrySNForeignCountryCd
Foreign CountryKSForeignCountryCd
Foreign CountrySPForeignCountryCd
Foreign CountrySWForeignCountryCd
Foreign CountrySZForeignCountryCd
Foreign CountryTWForeignCountryCd
Foreign CountryUKForeignCountryCd

Statements Regarding Acty4720 StatementsRegardingActy4720Grp

FieldValueIRS element (for citing)
Sale Or Exch Disqualified PrsnYes (1)SaleOrExchDisqualifiedPrsnInd
Brrw Or Lend Disqualified Prsn0BrrwOrLendDisqualifiedPrsnInd
Furn Goods Disqualified PrsnYes (1)FurnGoodsDisqualifiedPrsnInd
Pay Comp Disqualified PrsnYes (1)PayCompDisqualifiedPrsnInd
Transfer Ast Disqualified Prsn0TransferAstDisqualifiedPrsnInd
Payment To Government Official0PaymentToGovernmentOfficialInd
Acts Fail To Qlfy As Exceptions0ActsFailToQlfyAsExceptionsInd
Uncorrected Prior Acts0UncorrectedPriorActsInd
Undistributed Income PY0UndistributedIncomePYInd
Business HoldingsYes (1)BusinessHoldingsInd
Excess Business Holdings0ExcessBusinessHoldingsInd
Jeopardy Investments0JeopardyInvestmentsInd
Uncorrected PY Jeopardy Invst0UncorrectedPYJeopardyInvstInd
Influence Legislation0InfluenceLegislationInd
Influence Election0InfluenceElectionInd
Grants To Individuals0GrantsToIndividualsInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Noncharitable Purpose0NoncharitablePurposeInd
Transactions Fail To Qlfy As Exc0TransactionsFailToQlfyAsExcInd
Maintained Expenditure RspnsYes (1)MaintainedExpenditureRspnsInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd

Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp

Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee Benefit ProgramEmployeeBenefitProgramAmtExpense Account Other AllwncExpenseAccountOtherAllwncAmt
SANDOR FRANKEL
C/O TRUST 230 PARK AVENUENEW YORKNY10169TRUSTEE25.00$150,000$0$0
DAVID PANZIRER
C/O TRUST 230 PARK AVENUENEW YORKNY10169TRUSTEE35.00$150,000$0$0
WALTER PANZIRER
C/O TRUST 230 PARK AVENUENEW YORKNY10169TRUSTEE32.00$150,000$0$0
SARAH E PAUL
C/O TRUST 230 PARK AVENUENEW YORKNY10169CHIEF EXECUTIVE OFFICER40.00$1,030,857$238,318$0
JACQUELINE F BAUSCH
C/O TRUST 230 PARK AVENUENEW YORKNY10169GENERAL COUNSEL40.00$652,750$102,800$0
JOSHUA W FENTON
C/O TRUST 230 PARK AVENUENEW YORKNY10169CHIEF INVESTMENT OFFICER40.00$1,017,577$237,966$0
NICHOLAS J SCHIAVO
C/O TRUST 230 PARK AVENUENEW YORKNY10169CHIEF FINANCIAL OFFICER40.00$486,040$123,033$0

Compensation Highest Paid Empl CompensationHighestPaidEmplGrp (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee BenefitsEmployeeBenefitsAmtExpense AccountExpenseAccountAmt
AL Y KIM
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIRECTOR OF INVESTME40.00$769,227$177,456$0
MEENAKSHI C LAKSHMAN
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIR. OF STRATEGY & R40.00$764,742$177,456$0
CHRISTOPHER J RAPCEWICZ
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIR. OF RISK MNGMT.40.00$760,560$156,747$0
BRIAN B CHUN
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIRECTOR OF INVESTME40.00$550,358$110,848$0
MAUREEN E RAYHILL
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIRECTOR OF HUMAN RE40.00$505,841$102,226$0
FieldValueIRS element (for citing)
Other Employee Paid Over50k109OtherEmployeePaidOver50kCnt

Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdService TypeServiceTypeTxtCompensationCompensationAmtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
NEWMARKET IIFC
1325 NORTH BEACH STREET SUITE 201PHILADELPHIAPA19125INVESTMENT MANAGEMENT$8,414,015
HIG GROWTH II
600 5TH AVE 24TH FLNEW YORKNY10020INVESTMENT MANAGEMENT$2,620,945
IFP GLOBAL FRANCHISE
INVESTMENT MANAGEMENT$1,828,023LEVEL 1 10 PORTMAN SQUARELONDONUKW1H 6AZ
COLLER VII
INVESTMENT MANAGEMENT$1,618,408116 PARK STREETLONDONUKW1K 6AZ
HIGHCLERE INTERNATIONAL INVESTORS
INVESTMENT MANAGEMENT$1,530,2772 MANCHESTER SQUARELONDONUK
FieldValueIRS element (for citing)
Contractor Paid Over50k38ContractorPaidOver50kCnt

Summary Of Direct Chrtbl Acty SummaryOfDirectChrtblActyGrp

FieldValueIRS element (for citing)
Description1FOR COMMUNICATIONS DESIGNED TO SUPPORT AND AMPLIFY THE CHARITABLE WORK OF OUR GRANTEES, THROUGH STRATEGIC COMMUNICATIONS PLANNING, VIDEO PRODUCTION, AND DESIGN, SPECIFICALLY IN FURTHERANCE OF THE FOUNDATION'S MISSION OF PROMOTING HEALTH AND IMPROVING PEOPLE'S LIVES.Description1Txt
Expenses1$1,390,656Expenses1Amt
Description2FOR TECHNICAL SUPPORT TO GRANTEES, INCLUDING PROVIDING RESEARCH DATA, TO HELP MEET THEIR CHARITABLE GOALS.Description2Txt
Expenses2$93,051Expenses2Amt
Description3FOR CONVENING OF GRANTEES AND RESEARCHERS, INCLUDING CONFERENCE SPONSORSHIP AND SUPPORT, TO PROMOTE SHARED LEARNING AND THE IDENTIFICATION OF NEW PROJECTS TO FURTHER THE FOUNDATION'S CHARITABLE MISSION.Description3Txt
Expenses3$312,168Expenses3Amt

Sum Of Program Related Invst SumOfProgramRelatedInvstGrp

FieldValueIRS element (for citing)
Description1THETIS PHARMACEUTICALS, LLC - DEVELOPMENT OF A NOVEL RESOLVIN E1 THERAPY FOR TREATMENT OF CROHN'S DISEASEDescription1Txt
Expenses1$4,400,000Expenses1Amt
Description2TIXIMED, INC. - DEVELOPING A DRUG TO PROTECT BETA CELLS DURING TYPE 1 DIABETES DEVELOPMENTDescription2Txt
Expenses2$2,650,000Expenses2Amt
All Other Program Rltd Invst Tot$1,520,000AllOtherProgramRltdInvstTotAmt
Total$8,570,000TotalAmt

Minimum Investment Return MinimumInvestmentReturnGrp

FieldValueIRS element (for citing)
Average Monthly FMV Of Sec$6,991,393,403AverageMonthlyFMVOfSecAmt
Average Monthly Cash Balances$160,961,317AverageMonthlyCashBalancesAmt
FMV All Other Noncharitable Ast$769,022FMVAllOtherNoncharitableAstAmt
Total FMV Of Unused Assets$7,153,123,742TotalFMVOfUnusedAssetsAmt
Reduction Claimed$0ReductionClaimedAmt
Acquisition Indebtedness$0AcquisitionIndebtednessAmt
Adjusted Total FMV Of Unused Ast$7,153,123,742AdjustedTotalFMVOfUnusedAstAmt
Cash Deemed Charitable$107,296,856CashDeemedCharitableAmt
Net Vl Noncharitable Assets$7,045,826,886NetVlNoncharitableAssetsAmt
Minimum Investment Return$352,291,344MinimumInvestmentReturnAmt

Distributable Amount DistributableAmountGrp

FieldValueIRS element (for citing)
Minimum Investment Return$352,291,344MinimumInvestmentReturnAmt
Tax Based On Investment Income$4,897,298TaxBasedOnInvestmentIncomeAmt
Income Tax$471,679IncomeTaxAmt
Total Tax$5,368,977TotalTaxAmt
Distributable Before Adj$346,922,367DistributableBeforeAdjAmt
Recoveries Qualfied Distri$7,276,276RecoveriesQualfiedDistriAmt
Distributable Before Ded$354,198,643DistributableBeforeDedAmt
Deduction From Distributable$0DeductionFromDistributableAmt
Distributable As Adjusted$354,198,643DistributableAsAdjustedAmt

PF Qualifying Distributions PFQualifyingDistributionsGrp

FieldValueIRS element (for citing)
Expenses And Contributions$477,560,098ExpensesAndContributionsAmt
Program Related Invst Total$8,570,000ProgramRelatedInvstTotalAmt
Charitable Assets Acquis Paid$70,375CharitableAssetsAcquisPaidAmt
Qualifying Distributions$486,200,473QualifyingDistributionsAmt

Undistributed Income UndistributedIncomeGrp

FieldValueIRS element (for citing)
Distributable As Adjusted$354,198,643DistributableAsAdjustedAmt
Undistributed Income PY$0UndistributedIncomePYAmt
Total For Prior Years$0TotalForPriorYearsAmt
Excess Distribution Cyov Yr1$129,248,898ExcessDistributionCyovYr1Amt
Total Excess Distribution Cyov$129,248,898TotalExcessDistributionCyovAmt
Qualifying Distributions$486,200,473QualifyingDistributionsAmt
Applied To Year1$0AppliedToYear1Amt
Applied To Prior Years$0AppliedToPriorYearsAmt
Treated As Distri From Corpus$0TreatedAsDistriFromCorpusAmt
Applied To Current Year$354,198,643AppliedToCurrentYearAmt
Remaining Distri From Corpus$132,001,830RemainingDistriFromCorpusAmt
Excess Distri Cyov App CY Corpus$0ExcessDistriCyovAppCYCorpusAmt
Excess Distribution Cyov App CY$0ExcessDistributionCyovAppCYAmt
Total Corpus$261,250,728TotalCorpusAmt
Prior Year Undistributed Incm$0PriorYearUndistributedIncmAmt
Prior Year Deficiency Or Tax$0PriorYearDeficiencyOrTaxAmt
Taxable1$0Taxable1Amt
Taxable2$0Taxable2Amt
Undistributed Income CY$0UndistributedIncomeCYAmt
Corpus Distri170b1 E Or4942g3$0CorpusDistri170b1EOr4942g3Amt
Excess Distri Cyov From Yr5$0ExcessDistriCyovFromYr5Amt
Excess Distri Cyov To Next Yr$261,250,728ExcessDistriCyovToNextYrAmt
Excess From Year1$129,248,898ExcessFromYear1Amt
Excess From Current Year$132,001,830ExcessFromCurrentYearAmt

Supplementary Information SupplementaryInformationGrp

FieldValueIRS element (for citing)
Only Contri To PreselectedYes (X)OnlyContriToPreselectedInd

Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (570 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient RelationshipRecipientRelationshipTxtRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line1RecipientForeignAddress/AddressLine1TxtCityRecipientForeignAddress/CityNmCountryRecipientForeignAddress/CountryCdAddress Line2RecipientUSAddress/AddressLine2TxtAddress Line2RecipientForeignAddress/AddressLine2Txt
A GLIMMER OF HOPE FOUNDATION
11101 LOS COMANCHEROS RDAUSTINTX78717N/APFEMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY$1,446,574
ACTION4DIABETES
N/APCPHILIPPINES T1D TASK FORCE$222,5009 PARKFIELD ROADTAUNTONUK
ACUMEN AMERICA LLC
40 WORTH STREETNEW YORKNY10013N/APCSUPPLEMENTAL SUPPORT TO ADDRESS SOCIAL DETERMINANTS OF HEALTH FOR PEOPLE WITH INSULIN REQUIRING DIABETES$50,000
ADI NEGEV-NAHALAT ERAN RA
N/APCREHABILITATION EQUIPMENT$244,998POB 331OFAKIMIS
AFRICAN MISSION HEALTHCARE FOUNDATION
101 NORTH WOODLAND BOULEVARDDELANDFL32720N/APCST. FRANCIS HOSPITAL MATERNITY CENTER$191,802
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVENUEBRONXNY104611975N/APCPROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D$173,613
ALIMENTIV INC
N/ANCDEVELOPMENT OF A NEXT GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES$259,951100 DUNDAS STREETLONDONCA
ALIMENTIV INC
N/ANCVALIDATION OF THE PRO SYMPTOMS AND IMPACTS QUESTIONNAIRE FOR CROHNS DISEASE$469,915100 DUNDAS STREETLONDONCA
ALLIANCE OF COMMUNITY HEALTH PLANS FOUNDATION INC
1825 EYE STREET NW 401WASHINGTONDC20006N/ASOICOLLABORATING WITH HEALTH PLANS TO OVERCOME BARRIERS TO COVERAGE AND UTILIZATION OF CONTINUOUS GLUCOSE MONITORING : LAYING THE FOUNDATION$500,000
ALLIANCE OF COMMUNITY HEALTH PLANS FOUNDATION INC
1825 EYE STREET NW 401WASHINGTONDC20006N/ASOICOLLABORATING WITH HEALTH PLANS TO OVERCOME BARRIERS TO COVERAGE AND UTILIZATION OF CONTINUOUS GLUCOSE MONITORING : LAYING THE FOUNDATION$539,349
ALTRU HEALTH SYSTEM
PO BOX 6002GRAND FORKSND58206N/APCALTRU HEALTH SYSTEM ULTRASOUND INITIATIVE$4,214,824
ALVIN AILEY DANCE FOUNDATION INC
405 W 55TH STNEW YORKNY10019N/APCGENERAL OPERATING SUPPORT$10,000
AMERICAN CAMPING ASSOCIATION INC
5000 STATE ROAD 67 NORTHMARTINSVILLEIN46151N/APCACA PROFESSIONAL DEVELOPMENT 2024-2027$55,330
AMERICAN COLLEGE OF DIABETOLOGY INC
PO BOX 87633FAYETTEVILLENC28304N/APCIMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS$1,200,436
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APC2025-2027 TYPE 1 DIABETES CAMP INITIATIVE$480,260
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APC2022-2024 TYPE 1 DIABETES CAMP INITIATIVE$399,368
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCTRAINING AND MENTORSHIP PROGRAMS$350,108
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCTRAINING AND MENTORSHIP PROGRAMS$455,274
AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE
4930 DEL RAY AVEBETHESDAMD20814N/APCAMPLIFYING LEARNING FROM THE CEDARS-SINAI ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM BEYOND MALNUTRITION$64,189
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCPOST-ACUTE STROKE CARE IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA$379,458
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCHEARTCORPS AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE$871,217
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCAMERICAN HEART ASSOCIATION CENTER FOR TELEHEALTH$6,966,024
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCEXPANDING THE SYSTEM OF STROKE CARE IN MINNESOTA$908,680
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCMISSION LIFELINE STROKE SOUTH DAKOTA$957,913
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCMISSION LIFELINE STROKE HAWAII$1,606,124
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCMISSION LIFELINE STROKE IOWA$2,521,277
AMERICAN PHARMACISTS ASSOCIATION FOUNDATION
2215 CONSTITUTION AVE NWWASHINGTONDC20037N/APCPROJECT IMPACT CGM EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES$1,335,393
AMERICAN PHARMACISTS ASSOCIATION FOUNDATION
2215 CONSTITUTION AVE NWWASHINGTONDC20037N/APCPROJECT IMPACT CGM EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES$167,500
AMERICAN SAMOA DEPT OF HEALTH FOR AMERICAN SAMOA COMMUNITY HEALTH CTR
ONE FAGAALU ROADPAGO PAGOAS96799N/AGOVIMAGING EQUIPMENT AT AMERICAN SAMOA COMMUNITY HEALTH CENTERS$1,335,622
AMERICAN TELEMEDICINE ASSOCIATION
601 13TH ST NWWASHINGTONDC20005N/APCGENERAL OPERATING SUPPORT$25,500
AMERICAN TELEMEDICINE ASSOCIATION
601 13TH ST NWWASHINGTONDC20005N/APCLEVEL 5 MEMBERSHIP$25,500
AMERICANS FOR BEN-GURION UNIVERSITY
1001 AVENUE OF THE AMERICAS 19THNEW YORK CITYNY10018N/APCGENERAL OPERATING SUPPORT$20,000FLOOR
AMICI DI ADWA ENTE DEL TERZO SETTORE
N/APCA HOSPITAL FOR ADWA, ETHIOPIA IN THE TIGRAY REGION$1,398,329VIA GIACOMO MATTEOTTI 8CENTOIT
AMSTERDAM UMC RESEARCH BV
N/APCA PROSPECTIVE RANDOMIZED STUDY OF TREATMENT SELECTION BASED ON EPIGENETIC MARKERS IN CROHNS DISEASE OMICROHN$1,532,103MEIBERGDREEF 9AMSTERDAMNL
AMSTERDAM UMC RESEARCH BV
N/APCIDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE$225,500MEIBERGDREEF 9AMSTERDAMNL
AMSTERDAM UMC RESEARCH BV
N/APCIDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE$306,900MEIBERGDREEF 9AMSTERDAMNL
ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO
225 EAST CHICAGO AVENUE BOX 205CHICAGOIL60611N/APCIMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D$2,325,006
ANTHOS HOME INC
238 SEELEY STBROOKLYNNY11218N/APCLAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS$500,000
ANTHOS HOME INC
238 SEELEY STBROOKLYNNY11218N/APCLAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS$1,000,000
ASHLEY MEDICAL CENTER
612 CENTER AVE NASHLEYND584130450N/APCASHLEY MEDICAL CENTER (ND) ULTRASOUND INITIATIVE$76,961
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCDANATECH DIABETES TECHNOLOGY PLATFORM EXPANSION & MAINTENANCE$1,030,062
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCEXPANSION OF THE DANATECH PLATFORM$432,057
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCEXPANSION OF THE DANATECH PLATFORM$423,489
ASSOCIATION SANTE DIABETE
N/APCSTRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS$587,2215 RUE FEDERICO GARCIA LORCAGRENOBLEFR
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD
N/APCFECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE THE MIRO (MICROBIOTA RESTORATION) STUDY.$315,42155 VICTORIA PARADEFITZROYAS
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD
N/APCFECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE THE MIRO (MICROBIOTA RESTORATION) STUDY.$209,37755 VICTORIA PARADEFITZROYAS
BALLAD RESEARCH INSTITUTE
3525 JOHN HOPKINS COURTSAN DIEGOCA92121N/APCCD127-HIGH T-CELL POPULATIONS IN AUTOANTIBODY POSITIVE CHILDREN$315,380
BAPTIST MEDICAL CENTRE
N/APCELEVATING MATERNAL AND PEDIATRIC HEALTHCARE$4,505,896BAPTIST MEDICAL CENTRE ROADNALERIGUGH
BAPTIST MEDICAL CENTRE
N/APCCT SCANNER FOR BAPTIST MEDICAL CENTRE$848,730BAPTIST MEDICAL CENTRE ROADNALERIGUGH
BAR ILAN UNIVERSITY IN ISRAEL
N/APCTHE LEONA M. AND HARRY B. HELMSLEY ENERGY PROTOTYPE LAB AT BAR-ILAN UNIVERSITY$3,348,125MAX VE-ANNA WEBB STRAMAT GANIS
BARBARA'S HOUSE
100 MELROSE AVENUEGREENWICHCT06830N/APCGENERAL OPERATING SUPPORT$45,000
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZAHOUSTONTX77030N/APCPREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE$265,400
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
1201 NINTH AVENUESEATTLEWA981012795N/APCMECHANISMS OF AUTOANTIBODY REVERSION IN AT-RISK SUBJECTS$379,135
BEN-GURION UNIVERSITY OF THE NEGEV
N/APCISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CD.$765,436BEN-GURION BLVD 1BEER SHEVAIS
BEN-GURION UNIVERSITY OF THE NEGEV
N/APCCONSTRUCTION OF THE LEONA M. AND HARRY B. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING$5,785,714BEN-GURION BLVD 1BEER SHEVAIS
BEYOND TYPE 1
400 CONCAR DRIVE OFFICE 03-155SAN MATEOCA94402N/APCCAPACITY BUILDING SUPPORT$555,000
BEYOND TYPE 1
400 CONCAR DRIVE OFFICE 03-155SAN MATEOCA94402N/APCCAPACITY BUILDING SUPPORT$600,000
BEYOND TYPE 1
400 CONCAR DRIVE OFFICE 03-155SAN MATEOCA94402N/APCCAPACITY BUILDING SUPPORT$600,000
BILLINGS CLINIC FOUNDATION
2917 TENTH AVENUE NORTHBILLINGSMT59101N/APCBILLINGS CLINIC SURGICAL INTENSIVE CARE UNIT$2,000,000
BILLINGS CLINIC FOUNDATION
2917 TENTH AVENUE NORTHBILLINGSMT59101N/APCBILLINGS CLINIC SURGICAL INTENSIVE CARE UNIT$5,000,000
BILLINGS CLINIC FOUNDATION
2917 TENTH AVENUE NORTHBILLINGSMT59101N/APCEXPANDING ECMO SERVICES AT BILLINGS CLINIC$449,629
BILLINGS CLINIC FOUNDATION
2917 TENTH AVENUE NORTHBILLINGSMT59101N/APCBILLINGS CLINIC TRANSFER CENTER$2,215,173
BIPARTISAN POLICY CENTER INC
1225 I ST NW 1000WASHINGTONDC20005N/APCSTRENGTHENING RURAL HEALTH CARE DELIVERY AND SERVICES$658,783
BLUE CIRCLE HEALTH INC
1209 ORANGE STREETWILMINGTONDE19801N/ANCDEVELOPMENT OF BLUE CIRCLE HEALTH$3,975,887
BLUE CIRCLE HEALTH INC
1209 ORANGE STREETWILMINGTONDE19801N/ANCDEVELOPMENT OF BLUE CIRCLE HEALTH$4,470,843
BLUE CIRCLE HEALTH INC
1209 ORANGE STREETWILMINGTONDE19801N/ANCDEVELOPMENT OF BLUE CIRCLE HEALTH$4,470,844
BNAI ZION MEDICAL CENTER
N/AGOVDEVELOPMENT OF THE HELMSLEY CARDIOVASCULAR CARE UNIT$2,764,48347 GOLOMB STHAIFAIS
BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION
2601 ENTERPRISE ROADRENONV89512N/APCCARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM$137,345
BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION
2601 ENTERPRISE ROADRENONV89512N/APCULTRASOUND TRAINING INITIATIVE IN NEVADA$197,208
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDEVELOPMENT OF PERSONALIZED DECISION SUPPORT TOOL USING NETIOB TO HELP MANAGE EXERCISE FOR PEOPLE WITH T1D$758,218
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDETERMINING THE THERAPEUTIC POTENTIAL OF STATINS ON STRICTURING CROHNS DISEASE$667,666
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDEVELOPMENT OF A MOLECULAR SWITCH BASED CONTINUOUS INSULIN SENSOR$1,306,247
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDIABDOCS NATIONAL K12 SUPPLEMENT$201,490
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDIABETESWISE FOR EXERCISE$835,639
BOSTON MEDICAL CENTER CORPORATION
ONE BOSTON MEDICAL CENTER PLACEBOSTONMA02118N/APCSUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D$128,527
BOSTON SYMPHONY ORCHESTRA INC
301 MASSACHUSETTS AVENUEBOSTONMA02115N/APCGENERAL OPERATING SUPPORT$12,500
BREAKING GROUND HOUSING DEVELOPMENT FUND CORPORATION
505 EIGHTH AVENUE 5TH FLOORNEW YORKNY10018N/APCPILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING$567,155
BREAKTHROUGH T1D
200 VESEY STREETNEW YORKNY10281N/APCCO-FUNDED DEVELOPMENT OF A 3-B-HYDROXYBUTYRATE BINDING PROTEIN BASED CONTINUOUS KETONE MONITORING MICROSENSOR$200,000
BREAKTHROUGH T1D
200 VESEY STREETNEW YORKNY10281N/APCCO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE$133,332
BREAKTHROUGH T1D
200 VESEY STREETNEW YORKNY10281N/APCHELMSLEY AND JDRF CO-FUNDED WORKSHOPS$93,442
BRIDGES TO PROSPERITY INC
1031 33RD STREETDENVERCO80205N/APCTRANSFORMATIVE CONNECTIVITY IN RURAL ZAMBIA$2,306,101
CANDID
32 OLD SLIP 24TH FLOORNEW YORKNY10005N/APCGENERAL OPERATING SUPPORT$28,749
CARDIFF UNIVERSITY
N/APCT1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D$211,71830-36 NEWPORT RDWALESUK
CARE-FOR-RARE FOUNDATION
N/APCVERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES MUNICH STUDIES$667,252LINDWURMSTRASSE 4MUNICHGM
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCHELPING MOTHERS AND NEWBORNS SURVIVE AND THRIVE$1,337,724
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCEXPANDING COMMUNITY RECOVERY AND RESILIENCE$1,808,630
CAVALIER COUNTY MEMORIAL HOSPITAL ASSOCIATION
909 2ND SREETLANGDONND58249N/APCNORTH DAKOTA ULTRASOUND INITIATIVE$408,100
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCVERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES CEDARS-SINAI$115,500
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCA MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY$211,815
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCA MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY$219,514
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCTHE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM BEYOND MALNUTRITION$519,768
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCTHE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM BEYOND MALNUTRITION$733,694
CENTER FOR HEALTH CARE STRATEGIES INC
300 AMERICAN METRO BOULEVARD SUITEHAMILTONNJ08619N/APCIDENTIFYING OPPORTUNITIES TO SUPPORT T1D AUTOANTIBODY SCREENING IN MEDICAID PROGRAMS AND HEALTH CARE SYSTEMS THAT SERVE MEDICAID BENEFICIARIES$149,672125
CENTER FOR HEALTH CARE STRATEGIES INC
300 AMERICAN METRO BOULEVARD SUITEHAMILTONNJ08619N/APCCGM MEDICAID ACCESS ACCELERATOR - TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN$1,002,514125
CENTER FOR HEALTH CARE STRATEGIES INC
300 AMERICAN METRO BOULEVARD SUITEHAMILTONNJ08619N/APCEXPANDING ACCESS TO AID DEVICES IN MEDICAID$141,530125
CENTER FOR URBAN COMMUNITY SERVICES INC
198 EAST 121ST STREETNEW YORKNY10035N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000
CENTRE HOSPITALIER REGIONAL DE NANCY
N/AGOVPREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE THE NEMO PROJECT$94,38629 AVENUE MAL DE LATTRE TASSIGNYNANCYFR
CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD
N/APCDEFINING THE SIGNALING CIRCUITS AND REGULONS MEDIATING CROHNS FIBROSIS.$612,471WELLINGTON SQUAREOXFORDUK
CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD
N/APCTHE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD$244,860WELLINGTON SQUAREOXFORDUK
CHI HEALTH FOUNDATION
12809 WEST DODGE ROADOMAHANE68154N/APCECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY$359,722
CHI HEALTH FOUNDATION
12809 WEST DODGE ROADOMAHANE68154N/APCECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY$458,920
CHI HEALTH FOUNDATION
12809 WEST DODGE ROADOMAHANE68154N/APCCHI HEALTH ND ULTRASOUND INITIATIVE$903,993
CHILDREN'S HOSPITAL CORPORATION
PO BOX 414413BOSTONMA022414413N/APCVERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES BOSTON STUDIES$1,470,081
CHILDREN'S HOSPITAL CORPORATION
PO BOX 414413BOSTONMA022414413N/APCADVANCING THE DEVELOPMENT OF A NOVEL IMPLANTABLE GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM$1,296,628
CHILDREN'S HOSPITAL CORPORATION
PO BOX 414413BOSTONMA022414413N/APCNOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI)$732,284
CHILDREN'S HOSPITAL LOS ANGELES
4650 SUNSET BOULEVARDLOS ANGELESCA90027N/APCBEYOND COYOT1 EXPANSION OF PATIENT-CENTERED VIRTUAL CARE$153,056
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCVALIDATION OF A PERIPHERAL BLOOD BIOMARKER SIGNATURE FOR ANTI-TNF RESPONSE IN PATIENTS WITH CROHNS DISEASE (ATPBIOS)$583,113
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE$1,093,319
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCCOMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL$963,282
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCROLE OF PPAR-ALPHA IN PROMOTING BRUSH BORDER MATURITY OF INTESTINAL ENTEROCYTES$439,601
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCDELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D$725,157
CHILDREN'S HOSPITAL OF PHILADELPHIA
2716 SOUTH STREETPHILADELPHIAPA191462305N/APCLEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D$107,168
CHRISTIAN UNITY HOSPITAL CORPORATION
164 WEST 13TH STREETGRAFTONND58237N/APCNORTH DAKOTA ULTRASOUND INITIATIVE$646,571
CITY FUTURES INC
80 8TH AVENEW YORKNY10011N/APCNYC GREENSPACE POLICY REPORTS FOCUSED ON PROMOTING RECREATION, AND IMPROVING ACCESS TO GREENSPACE$150,000
CITY PARKS FOUNDATION INC
830 FIFTH AVENUENEW YORKNY10065N/APCCATALYST SUSTAINABILITY THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN PARKS$161,100
CITY PARKS FOUNDATION INC
830 FIFTH AVENUENEW YORKNY10065N/APCSTRENGTHENING NYCS URBAN FOREST PLAN PUBLIC PARK LANDS$466,100
CITY PARKS FOUNDATION INC
830 FIFTH AVENUENEW YORKNY10065N/APCNYC GREEN FUND$750,000
CLALIT HEALTH SERVICES
N/APCISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES$463,512101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCA NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER$700,000101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCA NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER$2,658,835101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCA NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER$2,541,165101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM$1,472,591101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT$145,605101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCT LINEAR ACCELERATOR FOR RABIN CANCER CENTER$2,050,000101 ARLOZOROV STREETTEL AVIVIS
CLINTON HEALTH ACCESS INITIATIVE INC
383 DORCHESTER AVENUE SUITE 400BOSTONMA02127N/APCREACH EXPANDING ACCESS TO PRIMARY CARE FOR DIABETES AND HYPERTENSION (2024-2027)$1,652,598
CLINTON HEALTH ACCESS INITIATIVE INC
383 DORCHESTER AVENUE SUITE 400BOSTONMA02127N/APCIMPROVING MEDICAL OXYGEN PRODUCTION AND UTILIZATION$2,811,261
COMMUNITY HEALTH SERVICE INC
2310 4TH AVE NMOORHEADMN56560N/APCCOMMUNITY HEALTH SERVICE INC ULTRASOUND INITIATIVE$132,287
CONVERGENT IMPACT INC
3223 ARAPAHOE AVEBOULDERCO80303N/APCCOLLABORATIVE ON HOUSING FOR HEALTH$500,000
CORNELL UNIVERSITY FOR THE JOAN & SANFORD I WEILL MEDICAL COLLEGE
1300 YORK AVENUENEW YORKNY100654805N/APCTARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE$863,618
CORPORATION FOR SUPPORTIVE HOUSING
55 BROADWAYNEW YORK CITYNY10006N/APCHEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING$500,000
COUNCIL FOR ECONOMIC EDUCATION
122 EAST 42ND STREETNEW YORK CITYNY10168N/APCGENERAL OPERATING SUPPORT$25,000
COUNCIL ON FOUNDATIONS INC
1255 23RD ST NWWASHINGTONDC20037N/APCGENERAL OPERATING SUPPORT FOR ONE YEAR MEMBERSHIP$34,000
COUNCIL ON THE ENVIRONMENT INC
100 GOLD ST SUITE 3300NEW YORKNY10038N/APCGENERAL OPERATING SUPPORT$15,000
COZAD HOSPITAL DISTRICT NO 2
300 EAST 12TH STREETCOZADNE69130N/AGOVTELE-EMERGENCY AT COZAD COMMUNITY HEALTH SYSTEM$35,283
CRITICAL PATH INSTITUTE
1840 EAST RIVER ROADTUCSONAZ85718N/APCTRANSLATIONAL THERAPEUTICS ACCELERATOR DEVELOPING KINASE INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE TO TREAT T1D$500,000
CRITICAL PATH INSTITUTE
1840 EAST RIVER ROADTUCSONAZ85718N/APCT1D CONSORTIUM 2.0$266,741
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSPONSORSHIP FOR THE 2025 CROHNS & COLITIS CONGRESS PRESENTED BY THE CROHNS & COLITIS FOUNDATION AND THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION$235,000
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCACHIEVING REMISSION IN IBD OPTIMIZING TREAT-TO-TARGET IN CLINICAL PRACTICE$1,632,470
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCAPPLICATION OF MACHINE LEARNING TO PRECISION NUTRITION IN CROHNS DISEASE$342,493
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCINTERNATIONAL CONSORTIUM ON MEDICAL NUTRITION IN IBD$310,748
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCACCELERATING ENROLLMENT IN IBD CLINICAL TRIALS$744,245
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCIBD VENTURES ACADEMIC INCUBATOR$1,180,400
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CD PATIENTS LIVING IN CANADA$374,91260 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE$297,61260 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS UK
N/APCIMPLEMENTATION OF A LOWER GI DIAGNOSTIC PATHWAY IN PRIMARY HEALTHCARE AND DEVELOPMENT AND DISSEMINATION OF A LOWER GI PATIENT TOOLKIT$467,7261 BISHOPS SQUAREHATFIELDUK
CROHN'S COLITIS CURE
N/APCENHANCING INFLAMMATORY BOWEL DISEASE CARE CONSUMER-CENTRIC PORTAL FOR BETTER COMMUNICATION & REDUCED NAVIGATION STRESS$871,250100 HARRIS STREETPYRMONT NSWAS
DARTMOUTH- HITCHCOCK CLINIC
ONE MEDICAL CENTER DRIVELEBANONNH03756N/APCCAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM$706,219
DEUTSCHE WELTHUNGERHILFE EV
N/APCHOLISTICALLY ADDRESSING AGROBUSINESS$1,898,076FRIEDRICH-EBERT-STRABE 1BONN BAD GODESBERGGM
DIABETES AUSTRALIA
N/APCIMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES THROUGH GEOGRAPHIC EXPANSION AND COUNTRY-SPECIFIC DATA-DRIVEN INITIATIVES$1,855,50419-23 MOORE STREET GROUND FLOORTURNERAS
DUKE UNIVERSITY
2200 WEST MAIN STREET SUITE 1000DURHAMNC27705N/APCNOVEL ASSAYS FOR PROGLUCAGON PEPTIDES TO UNDERSTAND ALPHA CELL FUNCTION IN HEALTH AND DIABETES$275,861
DUNDY COUNTY HOSPITAL
1313 N CHEYENNE STBENKELMANNE69021N/AGOVTELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL$11,725
EMERGING PRACTITIONERS IN PHILANTHROPY INC
201 N UNION ST STE 110ALEXANDRIAVA22314N/APCGENERAL OPERATING SUPPORT FOR 2024 MEMBERSHIP$11,250
EMORY UNIVERSITY
1599 CLIFTON ROAD NEATLANTAGA303224250N/APCCARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION$302,430
ENGINEERING MINISTRIES INTERNATIONAL USA
7025 CAMPUS DRIVECOLORADO SPRINGSCO80920N/APCEVALUATING RURAL HEALTH CARE FACILITIES$89,417
ENGINEERING MINISTRIES INTERNATIONAL USA
7025 CAMPUS DRIVECOLORADO SPRINGSCO80920N/APCMINGA MISSION HOSPITAL DEVELOPMENT$1,433,145
ESSENTIA HEALTH
502 E 2ND STDULUTHMN55805N/ASOIII FIESSENTIA HEALTH ULTRASOUND INITIATIVE$2,065,413
FAIRVIEW HEALTH SERVICES
2450 RIVERSIDE AVEMINNEAPOLISMN55454N/APCIMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE$3,176,500
FAMILY HEALTHCARE CENTER
301 NP AVE NFARGOND58102N/APCFAMILY HEALTHCARE CENTER ULTRASOUND INITIATIVE$172,160
FEDERAL INSTITUTE OF TECHNOLOGY ZURICH ETHZ
N/APCSPATIAL BIOLOGY OF CROHNS COLITIS$421,278RAMISTRASSE 101ZURICHSZ
FJC
225 WEST 39TH STREETNEW YORKNY10018N/APCTHE WELLNESS CLASSROOM, A PROJECT OF FJC - A FOUNDATION OF PHILANTHROPIC FUNDS$1,000,000
FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY (FIRST)
200 BEDFORD STREETMANCHESTERNH03101N/APCFIRST SENIOR MENTOR PROGRAM$200,000
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND
N/APCACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT$1,118,735CHEMIN DU POMMIER 40LE GRANDSACONNEXSZ
FOUNTAIN HOUSE INC
425 WEST 47TH STREETNEW YORKNY10036N/APCGENERAL OPERATING SUPPORT$5,000
FRIENDS OF RYE TOWN PARK INC
PO BOX 345RYENY10580N/APCGENERAL OPERATING SUPPORT$7,000
FUNDACIO DE RECERCA CLINIC BARCELONA INSTITUT D'INVESTIGACIONS BIOMED
N/AGOVEARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING$576,960ROSSELLO 149BARCELONASP
GALILEE MEDICAL CENTER
N/AGOVRENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER$2,200,000BEN ZVI BLVD POB 21NAHARIYAIS
GALILEE MEDICAL CENTER
N/AGOVRENOVATION OF ONE FLOOR OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER$750,000BEN ZVI BLVD POB 21NAHARIYAIS
GATES PHILANTHROPY PARTNERS
PO BOX 60555CITY OF INDUSTRYCA91716N/APCPOLIO ERADICATION FUND SUPPORT$1,000,000
GAY AND LESBIAN COMMUNITY CENTER OF SOUTHERN NEVADA INC
401 S MARYLAND PARKWAYLAS VEGASNV89101N/APCCAPITAL SUPPORT FOR THE CENTER$2,267,929
GENETIC ALLIANCE INC
25904 WOODFIELD ROADDAMASCUSMD20872N/APCIHOPE GENETIC HEALTH$250,000
GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE
N/APCSCIBD-RESPONSE MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE$187,672WELLCOME GENOME CAMPUSCAMBRIDGEUK
GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE
N/APCSCIBD-RESPONSE MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE$402,672WELLCOME GENOME CAMPUSCAMBRIDGEUK
GEORGETOWN UNIVERSITY
37TH O STREET NWWASHINGTONDC20057N/APCADVANCING ACCESS TO HIGH QUALITY, AFFORDABLE DIABETES CARE THROUGH PRIVATE HEALTH INSURANCE REGULATION$432,998
GEORGIA TECH RESEARCH CORPORATION
505 10TH STREET NWATLANTAGA303320420N/ASOIII FILONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE$485,616
GEOSCIENCE AUSTRALIA
N/AGOVDIGITAL EARTH AFRICA - SUSTAINABLE UPTAKE AND IMPACT$1,195,336101 JERRABOMBERRA AVESYMONSTONAS
GOOD SAMARITAN HOSPITAL ASSOCIATION
800 S MAIN AVERUGBYND58368N/APCHEART OF AMERICA MEDICAL CENTER ULTRASOUND INITIATIVE$468,841
GRANTMAKERS FOR EFFECTIVE ORGANIZATIONS
1310 L STREET NWWASHINGTONDC20005N/APCGENERAL OPERATING SUPPORT$18,920
GRANTMAKERS IN HEALTH
1100 CONNECTICUT AVENUE NWWASHINGTONDC20036N/APCGENERAL OPERATING SUPPORT FOR 2024$24,640
HADASSAH MEDICAL ORGANIZATION
N/APCRECRUITMENT OF TOP MEDICAL TALENT FOR THE NEW HADASSAH-HELMSLEY MEDICAL CENTER, NETIVOT$950,450POB 12000JERUSALEMIS
HADASSAH MEDICAL ORGANIZATION
N/APCEQUIPPING THE NEW HADASSAH - HELMSLEY MEDICAL CENTER, NETIVOT$5,265,160POB 12000JERUSALEMIS
HAWAI'I HEALTH SYSTEMS CORP KAUA'I REGION FOR VETERANS MEMORIAL HOSP
4643 WAIMEA CANYON DRIVEWAIMEAHI96796N/AGOVMEDICAL SIMULATION AT KAUA'I VETERANS MEMORIAL HOSPITAL$381,278
HAZEN MEMORIAL HOSPITAL ASSOCIATION
510 8TH AVE NEHAZENND58545N/APCSAKAKAWEA MEDICAL CENTER (ND) ULTRASOUND INITIATIVE$88,179
HEALING HANDS OF JOY
4747 HEDGEMORE DRCHARLOTTENC28209N/APCELIMINATION OF OBSTETRIC FISTULA$500,000
HEALTH RESEARCH ALLIANCE INC
PO BOX 146RALEIGHNC27612N/APCGENERAL OPERATING SUPPORT$22,150
HEBREW UNIVERSITY OF JERUSALEM
N/APCMETHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS DISEASE$221,500BOYAR BUILDING 5TH FLOORJERUSALEMIS
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$1,184,939INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$1,310,183INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$1,927,629INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$1,282,899INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$794,714INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH AND AUTOIMMUNITY OUTCOMES IN CHILDREN$162,877INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$1,913,981INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY THE PRIMARY ORAL INSULIN TRIAL$800,000INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY THE PRIMARY ORAL INSULIN TRIAL$1,833,580INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCFR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT$3,157INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCFR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT$46,760INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$988,211INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$920,486INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCEUROPEAN PRE-T1D REGISTRY$158,504INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD BIOSAMPLE RFP$229,162INGOLSTDTER LANDSTRAE 1NEUHERBERGGM
HENRY J KAISER FAMILY FOUNDATION
185 BERRY STREET NO 2000SAN FRANCISCOCA94107N/APCKFF HEALTH NEWS RURAL HEALTH DESK$1,521,095
HERLEV OG GENTOFTE HOSPITAL
N/AGOVINTERACTION BETWEEN AMINO ACIDS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE IN PANCREATIC ALPHA CELLS$135,722HERLEV RINGVEJ 75 OPG115HERLEVDA
HIGH QUALITY MEDICAL EDUCATION
4117 PENFIELD CT SAFTONMN55001N/APCPOINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR NORTH DAKOTA RURAL PROVIDERS$1,384,586
HIGH QUALITY MEDICAL EDUCATION
4117 PENFIELD CT SAFTONMN55001N/APCPOINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS$2,112,639
HILLEL THE FOUNDATION FOR JEWISH CAMPUS LIFE
180 S GARNER STREETSTATE COLLEGEPA16804N/APCGENERAL OPERATING SUPPORT$10,000
HILLEL YAFFE MEDICAL CENTER
N/AGOVEYE INSTITUTE AND AMBULATORY SURGERY CENTER$3,158,400HA-SHALOM STHADERAIS
HILLEL YAFFE MEDICAL CENTER
N/AGOVCONSTRUCTION OF PET-CT INSTITUTE$3,536,258HA-SHALOM STHADERAIS
HOLON INSTITUTE OF TECHNOLOGY - HIT
N/APCMEDICAL TECHNOLOGIES BUILDING AT THE HOLON INSTITUTE OF TECHNOLOGY (HIT)$681,35052 GOLOMB STHOLONIS
HUMAN CELL ATLAS INCORPORATED
415 MAIN STCAMBRIDGEMA02142N/APC2024 HUMAN CELL ATLAS GENERAL MEETING$50,000
HUMBOLDT COUNTY MEMORIAL HOSPITAL
1000 N 15TH STHUMBOLDTIA50548N/AGOVTELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL$39,438
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCVERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES MOUNT SINAI STUDIES$220,000
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCTHE WOMEN WITH INFLAMMATORY BOWEL DISEASE AND MOTHERHOOD (WISDOM) REGISTRY A PROSPECTIVE STUDY OF FEMALE FERTILITY IN IBD$574,537
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCPROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS.$779,716
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCCOMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHNS DISEASE [CATHARSIS TRIAL]$523,716
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCSPATIAL MAPPING OF FIBROMUSCULAR CROHNS DISEASE FROM GENETIC TO SENESCENT SIGNALS$920,802
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCEARLY LIFE EXPOSOME BIOMARKERS AND CROHN'S DISEASE RISK THE EARLY-CD PROJECT$618,257
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCTHE USE OF GLP-1R AGONISTS TO PROMOTE EPITHELIAL HEALING IN CROHNS DISEASE$993,497
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCDEFINING THE PRE-DISEASE PHASE OF CROHNS DISEASE PREDICT AND PREVENT$2,303,337
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCDEVELOPMENT OF NOVEL LRRK2 INHIBITORS TO TREAT CROHNS DISEASE$583,881
IDA COUNTY IOWA COMMUNITY HOSPITAL
701 EAST SECOND STREETIDA GROVEIA51445N/APCTELE-EMERGENCY SERVICES AT HORN MEMORIAL HOSPITAL$44,685
IMPACT-SE INST FOR MONITORING PEACE & CULTURAL TOLERANCE IN SCHOOL ED
N/APCTRANSFORMING EDUCATION FOR PEACE A NATIONWIDE AWARENESS CAMPAIGN ON INCITEMENT IN PALESTINIAN/UNRWA TEXTBOOKS.$150,0002 JABOTINSKY STRAMAT GANIS
IMPROVECARENOW INC
4 CARMICHAEL ST UNIT 111ESSEX JUNCTIONVT05452N/APCIMPLEMENTING THE COMBINE TRIAL RESULTS IN THE IMPROVECARENOW (ICN) LEARNING HEALTH NETWORK$931,101
INNODIA
N/APCINNODIA NONPROFIT LAUNCH$7,905HERESTRAAT 49LEUVENBE
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVBIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL$79,7231 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$95,2131 RUE LOUIS RECHDUDELANGELU
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
N/AGOVFROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES HLA-A- VS. HLA-B-RESTRICTED CD8 T-CELL BIOMARKERS OF PROGRESSION$362,46086 RUE REGNAULTPARISFR
INSTITUTE FOR COMMUNITY LIVING INC
125 BROAD STREETNEW YORK CITYNY10004N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000
INSTITUTE FOR COMMUNITY LIVING INC
125 BROAD STREETNEW YORK CITYNY10004N/APCPILOTING A THREE-YEAR IMT/ACT STEP-DOWN PROJECT$749,790
INSULIN FOR LIFE USA INC
2555 SW 76TH STREET 130GAINESVILLEFL32608N/APCSTRENGTHENING ORGANIZATIONAL CAPACITY$60,700
INTERNATIONAL ALLIANCE FOR DIABETES ACTION INC
75 STATE STREETBOSTONMA02109N/APCSEED FUNDING SUPPORT$893,663
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCDEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION GLOBALLY (IBUS EIUS ED)$645,000HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCDEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE.$1,168,344HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCPOINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES INTRODUCTION TO INTESTINAL ULTRASONOGRAPHY$169,420HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCTHE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND)$488,553HARKORTSTR 1MUNSTERGM
INTERNATIONAL WATER MANAGEMENT INSTITUTE
N/APCDIGITAL INNOVATIONS FOR A WATER SECURE AFRICA$2,449,440127 SUNIL MAWATHABATTARAMULLACE
INT'L BANK FOR RECONSTRUCTION & DEV AND INT'L DEVELOPMENT ASSOC
1818 H STREET NWWASHINGTONDC20433N/APCHEALTH SYSTEM TRANSFORMATION AND RESILIENCE MULTI-DONOR TRUST FUND - NONCOMMUNICABLE DISEASE PARTNERSHIP GENERAL OPERATING SUPPORT$2,500,000
ISRAEL ANTIQUITIES AUTHORITY
N/AGOVREVIVAL EXHIBITION AT BEN GURION AIRPORT$350,00027 SULTAN SULEIMAN STREETJERUSALEMIS
ISRAEL CENTER ON ADDICTION RA
N/APCICA'S EMERGENCY MENTAL HEALTH SUPPORT$55,0002 HATZORAN STNETANYAIS
JACOBSON MEMORIAL HOSPITAL CARE CENTER
601 EAST ST NELGINND58533N/APCJACOBSON MEMORIAL HOSPITAL ULTRASOUND INITIATIVE$77,620
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCTECHNOSPHERE INSULIN VERSUS RAPID ACTING ANALOGUE INSULIN ON EXERCISE-INDUCED HYPOGLYCEMIA IN ADULTS WITH T1D USING AUTOMATED INSULIN DELIVERY$1,025,846
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCVIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING$194,126
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY$180,800
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY$47,712
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCCGM FOR THE EARLY DETECTION AND MANAGEMENT OF DYSGLYCEMIA IN PREGNANCY (IMAGINE)$1,337,806
JDRF AUSTRALIA
N/APCENDIA FOLLOW UP 2023-2025 SAMPLES ANALYSIS RFA$929,30980-84 CHANDOS STREETSYDNEYAS
JDRF AUSTRALIA
N/APCENDIA FOLLOW UP 2023-2025 SAMPLES ANALYSIS RFA$816,62880-84 CHANDOS STREETSYDNEYAS
JERUSALEM COLLEGE OF TECHNOLOGY
N/APCEMERGENCY SUPPORT FOR STUDENTS AT THE JERUSALEM COLLEGE OF TECHNOLOGY.$100,00021 HAVAAD HALEUMI STJERUSALEMIS
JERUSALEM FOUNDATION INC
420 LEXINGTON AVENUENEW YORKNY10170N/APCBUILDING A NEW HOME FOR TSAD KADIMA$500,000
JEWISH BOARD OF FAMILY & CHILDREN'S SERVICES INC
463 7TH AVENEW YORKNY10018N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000
JOHNS HOPKINS UNIVERSITY
733 NORTH BROADWAY MRB 117BALTIMOREMD21205N/APCDEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING$742,901
JOHNS HOPKINS UNIVERSITY
733 NORTH BROADWAY MRB 117BALTIMOREMD21205N/APCENGINEERED CYTOKINE/ANTIBODY FUSION PROTEIN TO TREAT CROHNS DISEASE$750,000
JOSLIN DIABETES CENTER INC
ONE JOSLIN PLACEBOSTONMA02215N/APCAN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES$569,990
K9S FOR WARRIORS
114 CAMP K9 ROADPONTE VEDRAFL32081N/APCGENERAL OPERATING SUPPORT/WARRIOR SERVICE DOG PAIRING PROGRAM$7,500
KAISER FOUNDATION HEALTH PLAN OF GEORGIA INC
1375 PEACHTREE STREET NEATLANTAGA30309N/APCEXPANSION OF THE T1DES PILOT TO A PUBLIC HOSPITAL$41,911
KAPIOLANI HEALTH FOUNDATION
55 MERCHANT STHONOLULUHI96813N/APCMARTHA B. SMITH CANCER & INFUSION CENTER AT KAPIOLANI MEDICAL CENTER FOR WOMEN & CHILDREN$5,000,000
KATHOLIEKE UNIVERSITEIT TE LEUVEN
N/APCTARGETING CHRONIC INFLAMMATION AND TISSUE REMODELLING IN CROHN'S DISEASE WITH ENGINEERED T CELLS$426,571WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT TE LEUVEN
N/APCEMBODY EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY$221,407WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT TE LEUVEN
N/APCFAT AS A VILLAIN IN CROHN'S DISEASE.$1,456,556WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT TE LEUVEN
N/APCIDS 2024 BRUGES$50,000WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT TE LEUVEN
N/APCEDENT1FI$1,644,973WAAISTRAAT 6 BOX 5105LEUVENBE
KING'S COLLEGE LONDON
N/APCRESOLVING HARMFUL ACCUMULATION OF INNATE LYMPHOID CELLS DURING CROHNS DISEASE.$384,292150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCCHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6) SUBJECTS$8,567150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCPRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY)$221,552150 STAMFORD STREETLONDONUK
KYLER CARES FOUNDATION
8070 CROWDER BOULEVARD SUITE BNEW ORLEANSLA70126N/APCCAPACITY BUILDING SUPPORT$339,900
KYLER CARES FOUNDATION
8070 CROWDER BOULEVARD SUITE BNEW ORLEANSLA70126N/APCCAPACITY BUILDING SUPPORT$339,900
LANDER COUNTY HOSPITAL DISTRICT
535 SOUTH HUMBOLDT STREETBATTLE MOUNTAINNV898201988N/AGOVBATTLE MOUNTAIN GENERAL HOSPITAL HOSPITAL EQUIPMENT REVITALIZATION$1,035,000
LINTON HOSPITAL
111 ELM AVE WESTLINTONND58552N/APCLINTON HOSPITAL (ND) ULTRASOUND INITIATIVE$76,961
LIVING WATER INTERNATIONAL
4001 GREENBRIAR DRIVESTAFFORDTX77477N/APCSCALING INTEGRATED WASH SERVICES$2,574,349
LUTHERAN CHARITY ASSOCIATION
2422 20TH STREET SWJAMESTOWNND58401N/APCJAMESTOWN REGIONAL MEDICAL CENTER ULTRASOUND INITIATIVE$693,723
MARY C WHEELER SCHOOL INC
216 HOPE STREETPROVIDENCERI02906N/APCGENERAL OPERATING SUPPORT$12,500
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCACCELERATING PROGRESS AND PROMOTING QUALITY T1D CARE FOR THE POOREST BILLION THROUGH THE GLOBAL PEN-PLUS PARTNERSHIP$6,753,638
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCREAL-TIME POST-OP TOUCHLESS, REMOTE MONITORING IN CROHNS DISEASE THE SAPPHIRE TRIAL$2,905,515
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCU.S. PREVENTIVE TYPE 1 DIABETES COALITION$543,037
MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCVALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE$1,352,242
MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCMICROBES, MOLECULES, AND CHEMISTRY DYSBIOSIS IN CROHNS DISEASE$1,722,621
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVENUECAMBRIDGEMA02139N/APCCOMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS$348,553
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCDEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES$151,705
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCSTENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM$157,469
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCMILITARY SCIENCES MEDICAL TRAINING 2024-2026$160,940
MCKENZIE COUNTY HEALTHCARE SYSTEMS INC
709 4TH AVE NEWATFORD CITYND58854N/APCMCKENZIE HEALTH ULTRASOUND INITIATIVE$46,052
MCKENZIE COUNTY HEALTHCARE SYSTEMS INC
709 4TH AVE NEWATFORD CITYND58854N/APCMCKENZIE HEALTH ULTRASOUND INITIATIVE$757,493
MEDICAL UNIVERSITY OF SOUTH CAROLINA
179 ASHLEY AVENUECHARLESTONSC29425N/AGOVENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES$28,108
MEDICINES FOR HUMANITY INC
800 HINGHAM STREETROCKLANDMA02370N/APCMAI MBELEKI II EXPANSION$322,909
MERCY HOSPITAL OF DEVILS LAKE
1031 7TH STREET NEDEVILS LAKEND58301N/APCCHI ST. ALEXIUS HEALTH DEVILS LAKE ULTRASOUND INITIATIVE$743,309
MERCY MEDICAL CENTER
1301 15TH AVENUE WESTWILLISTONND58801N/APCCHI ST. ALEXIUS HEALTH WILLISTON ULTRASOUND INITIATIVE$619,183
MICHIGAN STATE UNIVERSITY
426 AUDITORIUM ROAD ROOM 2EAST LANSINGMI488242601N/APCA C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH TYPE 1 DIABETES$1,215,611
MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC
PO BOX 27837WASHINGTONDC20038N/APCTHE INTERCONNECTED IRAN -RUSSIA-CHINA AXIS$300,000
MILLE LACS HEALTH SYSTEM
200 ELM STREET NORTHONAMIAMN56359N/APCTELE-PHARMACY AT MILLE LACS HEALTH SYSTEM$17,020
MINERAL COUNTY HOSPITAL DISTRICT
200 SOUTH A STREETHAWTHORNENV89415N/AGOVUSDA COMMUNITY FACILITY DIRECT LOAN PROGRAM APPLICATION$364,679
MINNESOTA RURAL HEALTH ASSOCIATION
27011 460TH AVEHENNINGMN56551N/APCSONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA$318,700
MINNESOTA STATE COLLEGES AND UNIVERSITIES
30 E 7TH STREETST PAULMN55101N/AGOVEXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA$217,428
MOUNTRAIL COUNTY MEDICAL CENTER INC
615 6TH ST SESTANLEYND58784N/APCNORTH DAKOTA ULTRASOUND INITIATIVE$238,556
NATIONAL ASSOCIATION OF SCHOOL NURSES INC
1100 WAYNE AVESILVER SPRINGMD20910N/APCPROVIDING COORDINATED CARE AND CAPTURING OUTCOMES FOR STUDENTS WITH T1D SCHOOL NURSE-LED PILOT PROJECT$763,279
NATIONAL COMMITTEE FOR QUALITY ASSURANCE
1100 13TH ST NWWASHINGTONDC20005N/APCNCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT$753,478
NATIONAL COMMITTEE FOR QUALITY ASSURANCE
1100 13TH ST NWWASHINGTONDC20005N/APCNCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT$621,487
NATIONAL MULTIPLE SCLEROSIS SOCIETY
733 THIRD AVENUENEW YORK CITYNY10017N/APCGENERAL OPERATING SUPPORT$10,000
NATURAL AREAS CONSERVANCY INC
1234 FIFTH AVENUENEW YORKNY10029N/APCACTIVATING AND SUSTAINING NYC NATURE TRAIL NETWORK (PHASE 3)$363,328
NATURAL AREAS CONSERVANCY INC
1234 FIFTH AVENUENEW YORKNY10029N/APCSTRENGTHENING NYC'S URBAN FOREST PLAN NATURAL AREAS$193,132
NCD ALLIANCE
N/APCGENERAL OPERATING SUPPORT - NCD ALLIANCE SUPPORTERS GROUP$42,50031-33 AVENUE GIUSEPPE MOTTAGENEVASZ
NELSON COUNTY HEALTH SYSTEM
200 NORTH MAIN STREETMCVILLEND58254N/APCNELSON COUNTY HEALTH SYSTEM ULTRASOUND INITIATIVE$153,546
NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES
4126 TECHNOLOGY WAYCARSON CITYNV89706N/AGOVNEVADA VIRTUAL CRISIS CARE$1,239,092
NEVADA HEALTH CENTERS INC
3325 RESEARCH WAYCARSON CITYNV89706N/APCQUALITY ULTRASOUND SERVICES AND TRAINING PROGRAM$14,249
NEVADA RURAL HOSPITAL PARTNERS FOUNDATION INC
4600 KIETZKE LANERENONV89502N/APCSONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL NEVADA HOSPITALS$27,500
NEW DESTINY HOUSING CORPORATION
12 W 37TH STREET 7TH FLOORNEW YORKNY10018N/APCPILOTING AFTERCARE INTERVENTION TO IMPROVE HOUSING AND HEALTH STABILITY FOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS$183,350
NEW VENTURE FUND
1828 L STREET NW SUITE 300-AWASHINGTONDC20036N/APCTYPE 1 DIABETES CAMPS PROJECT (2025-2028)$1,889,319
NEW VENTURE FUND
1828 L STREET NW SUITE 300-AWASHINGTONDC20036N/APCTYPE 1 DIABETES CAMPS PROJECT (2025-2028)$374,930
NEW YORK CITY BALLET INC
20 LINCOLN CENTER PLAZANEW YORKNY10023N/APCGENERAL OPERATING SUPPORT$15,000
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
50 WATER STREETNEW YORKNY10004N/APCEXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC$614,668
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
50 WATER STREETNEW YORKNY10004N/APCPROJECT ASAP BUILDING CAPACITY FOR SUPPORTIVE HOUSING FACILITATION AND BRIDGE CARE IN NYC'S PUBLIC HOSPITALS$777,607
NEW YORK JUNIOR TENNIS LEAGUE INC
36-36 33RD STREETASTORIANY11106N/APCGENERAL OPERATING SUPPORT$5,000
NEW YORK RESTORATION PROJECT
254 WEST 31ST STREETNEW YORKNY10001N/APCNYC URBAN REFORESTATION & EXPANSION$193,536
NEW YORK UNIVERSITY
665 BROADWAY SUITE 801NEW YORKNY10012N/APCTAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH$2,756,847
NORTH DAKOTA STATE UNIVERSITY
1301 12TH AVENUE NFARGOND58102N/AGOVEXPANDING RURAL SONOGRAPHY EXPERTISE IN NORTH DAKOTA$99,500
NORTHERN WESTCHESTER HOSPITAL ASSOCIATION
400 EAST MAIN STREETMOUNT KISCONY10549N/APCEMERGENCY DEPARTMENT RAPID ACCESS EXPANSION$400,000
NORTHWOOD DEACONESS HEALTH CENTER
4 N PARK STNORTHWOODND58267N/APCNORTHWOOD DEACONESS HEALTH CENTER (ND) ULTRASOUND INITIATIVE$95,182
NURU INTERNATIONAL
2020 PENNSYLVANIA AVE NWWASHINGTONCA20006N/APCEXPANSION OF AGRIBUSINESS$500,000
OAKLAND UNIVERSITY
2200 NORTH SQUIRREL ROADROCHESTERMI48309N/AGOVA COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2)$1,129,765
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK ROADPORTLANDOR972393098N/AGOVDISSEMINATION PILOT THE IMPLEMENTATION OF NOVEL INTERVENTIONS IN CHILDREN'S HEALTHCARE (NICH) IN ANOTHER HEALTHCARE SYSTEM$41,318
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK ROADPORTLANDOR972393098N/AGOVAN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT$1,795,816
P R HEALTH CORPORATION
115 VIVIAN STPARK RIVERND58270N/APCFIRST CARE HEALTH CENTER ULTRASOUND INITIATIVE$93,347
PALO ALTO VETERANS INSTITUTE FOR RESEARCH
3801 MIRANDA AVENUEPALO ALTOCA943040038N/APCCELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE$318,978
PANORAMA GLOBAL
2101 FOURTH AVENUE SUITE 2100SEATTLEWA98121N/APCT1D COMMUNITY FUND STAGE II$1,469,142
PAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT INC
905 KALANIANAOLE HWYKAILUAHI96734N/APCPAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT CAPACITY-BUILDING$256,540
PATH
437 N 34TH STREETSEATTLEWA98103N/APCTHE DIABETES CAREPAK PROJECT ENABLING HIGH-QUALITY DIABETES SELF-CARE$871,123
PEMBINA COUNTY MEMORIAL HOSPITAL ASSOCIATION
301 MOUNTAIN STREET EASTCAVALIERND58220N/APCNORTH DAKOTA ULTRASOUND INITIATIVE$312,733
PENNINGTON COUNTY HEALTH AND HUMAN SERVICES
321 KANSAS CITY STREETRAPID CITYSD57701N/AGOVPENNINGTON COUNTY CRISIS STABILIZATION UNIT$1,000,000
PETALS 4 PAWS LLC
PO BOX 112360STAMFORDCT06911N/APCGENERAL OPERATING SUPPORT$7,500
PHILANTHROPY NEW YORK INC
320 EAST 43RD STREETNEW YORKNY10017N/APCGENERAL OPERATING SUPPORT FOR 2025 MEMBERSHIP$63,750
PHILANTHROPY NEW YORK INC
320 EAST 43RD STREETNEW YORKNY10017N/APCGENERAL OPERATING SUPPORT$39,250
PHILLIPS COUNTY HOSPITAL ASSOCIATION
311 S 8TH AVENUE EASTMALTAMT59538N/APCTELE-EMERGENCY AND TELE-PHARMACY AT PHILLIPS COUNTY$25,448
PIONEER MEDICAL CENTER
301 WEST 7TH AVEBIG TIMBERMT59011N/APCTELE-PHARMACY AT PIONEER MEDICAL CENTER$9,988
PRESENTATION MEDICAL CENTER
213 2ND AVE NEROLLAND58367N/APCST. KATERI ULTRASOUND INITIATIVE$68,957
PROJECT CONCERN ZAMBIA LIMITED
N/APCEMPOWERED CHILDREN AND ADOLESCENTS PROGRAM PLUS$1,004,026PLOT 37/1PLUSAKAZA
PULITZER CENTER ON CRISIS REPORTING
1779 MASSACHUSETTS AVE NWWASHINGTONDC20036N/APCINSIGHT AND CONNECTION THROUGH JOURNALISM AND EDUCATION$393,053
RAMBAM HEALTH CORPORATION
N/APCANGIOGRAPHY SYSTEM FOR THE INTERVENTIONAL RADIOLOGY UNIT OF RAMBAM MEDICAL CENTER$1,365,000HAALIA HASNIA 8HAIFAIS
REACH LITERACY
2101 W 41ST STSIOUX FALLSSD57105N/APCGENERAL OPERATING SUPPORT FOR SIOUX FALLS VOLUNTEER DAY$15,000
REACHANOTHER FOUNDATION
1900 NE 3RD ST STE 106-307BENDOR97701N/APCEXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA$346,974
REACHANOTHER FOUNDATION
1900 NE 3RD ST STE 106-307BENDOR97701N/APCEXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA$952,406
REACHANOTHER FOUNDATION
1900 NE 3RD ST STE 106-307BENDOR97701N/APCTRANSFORMING PEDIATRIC NEUROSURGERY SERVICES$1,441,299
REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREETANN ARBORMI48109N/APCEVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE$92,033
REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREETANN ARBORMI48109N/APCEVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE$92,033
REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREETANN ARBORMI48109N/APCHEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS$226,169
REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SEMINNEAPOLISMN554552070N/AGOVCONTINUING DEVELOPMENT OF OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES$273,689
REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SEMINNEAPOLISMN554552070N/AGOVENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES (PHASE 3)$502,750
REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SEMINNEAPOLISMN554552070N/AGOVMINNESOTA FIRST RESPONDER AED PROJECT$1,296,918
REGENTS OF UNIVERSITY OF CALIFORNIA BERKELEY
190 DOEBERKELEYCA94720N/APCDEVELOPING MICROBIOME EDITING TOOLS TO ADVANCE UNDERSTANDING OF THE MICROBIAL INFLUENCE ON CROHN'S DISEASE$1,054,179
REGION HOVEDSTADEN
N/AGOVCAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES?$375,228KONGENS VAENGE 2HILLERODDA
RENOWN HEALTH FOUNDATION
1155 MILL STRENONV89502N/APCRENOWN HEALTH TO BRING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TO NORTHERN NEVADA$1,091,987
RESEARCH TRIANGLE INSTITUTE
3040 EAST CORNWALLIS ROADDURHAMNC277092194N/APCUSING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS A STATEWIDE IMPLEMENTATION STUDY$1,110,288
RIVER'S EDGE HOSPITAL AND CLINIC
1900 N SUNRISE DRIVEST PETERMN56082N/AGOVTELE-EMERGENCY SERVICES FOR RIVER'S EDGE HOSPITAL$17,567
SAFE WATER NETWORK
122 EAST 42ND STREETNEW YORKNY10168N/APCSCALING SUSTAINABLE SAFE WATER ACCESS$2,064,000
SAGE BIONETWORKS
2901 THIRD AVESEATTLEWA981213014N/APCEXTENSION OF VEOIBD DATA COORDINATION TO ACCELERATE DISCOVERY OF PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES$75,165
SAINT LOUIS UNIVERSITY
221 NORTH GRAND BOULEVARDSAINT LOUISMO63103N/APCIDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES$608,523
SANFORD RESEARCH
1305 W 18TH STSIOUX FALLSSD571040569N/APCPLEDGE PHASE 3$528,559
SANFORD WORLD CLINICS
1305 W 18TH STSIOUX FALLSSD57105N/APCPROGRAM DETEKTA DETECTING TYPE 1 DIABETES AND PREVENTING DIABETIC KETOACIDOSIS (DKA)$59,605
SAPIR ACADEMIC COLLEGE
N/APCPLANNING FOR SAPIR ACADEMIC COLLEGE LAW SCHOOL BUILDING$303,000POST HOF ASHKELON 7915600GEVIMIS
SAVE A LAB RESCUE
165 ELLERY AVEMIDDLETOWNRI02842N/APCGENERAL OPERATING SUPPORT$25,000
SEATTLE CHILDREN'S HOSPITAL
PO BOX 5731 M/S S-200SEATTLEWA981455005N/APCEXPANDING USE OF ENGINEERED TREGS IN T1D THERAPY (PHASE 4)$609,141
SHAARE ZEDEK MEDICAL CENTER
N/APCISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT$989,08312 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCDEVELOPMENT OF THE HELMSLEY COMPREHENSIVE CARDIAC CARE CENTER$2,500,00012 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCDEVELOPMENT OF THE HELMSLEY SURGICAL WING$2,500,00012 SHMUEL BAIT STREETJERUSALEMIS
SHARE TRUST INC
310 DEDHAM STDOVERMA02030N/APCBUILDING COMMUNITY DRIVEN COLLECTIVE ACTION$1,540,658
SHATTERPROOF A NONPROFIT CORP
101 MERRITT 7 CORPORATE PARK 1STNORWALKCT06851N/APCGENERAL OPERATING SUPPORT$200,000FLOOR
SIMULATION IN MOTION MONTANA INC
2021 11TH AVE SUITE 1HELENAMT59601N/APCSIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY$100,000
SIMULATION IN MOTION MONTANA INC
2021 11TH AVE SUITE 1HELENAMT59601N/APCSIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY$100,000
SNV NETHERLANDS DEVELOPMENT ORGANISATION
N/APCSCALING THE HEALTHY FUTURE FOR ALL MODEL$1,246,508PARKSTRAAT 83DEN HAAGNL
SOCIAL SCIENCE RESEARCH COUNCIL
ONE PIERREPONT PLAZA 15TH FLOORBROOKLYNNY11201N/APCDATA2GO.NYC REVAMP AND DATA CLINIC$336,025
SOCIETY FOR MUCOSAL IMMUNOLOGY INC
N83 W13410 LEON ROADMENOMONEE FALLSWI53051N/APC21ST INTERNATIONAL CONGRESS OF MUCOSAL IMMUNOLOGY (ICMI 2024)$15,000
SOCIETY FOR THE PRESERVATION OF NEW ENGLAND ANTIQUITIES
151 ESSEX STREETHAVERHILLMA01832N/APCGENERAL OPERATING SUPPORT$50,000
SOLIDARIDAD NETWORK FOUNDATION LIMITED
N/APCHOOVES FOR SUSTAINABILITY (H4S)$468,562163 KUDU ROADLUSAKAZA
SOUTH LINCOLN HOSPITAL DISTRICT
711 ONYX STKEMMERERWY83101N/AGOVTELE-EMERGENCY AT SOUTH LINCOLN MEDICAL CENTER$10,791
SOUTHCENTRAL FOUNDATION
4501 DIPLOMACY DRANCHORAGEAK99508N/APCFWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM$818,171
SOUTHWEST HEALTHCARE CORPORATION
802 SECOND STREET NWBOWMANND58623N/APCNORTH DAKOTA ULTRASOUND INITIATIVE$225,517
ST ALOISIUS HOSPITAL INC
325 BREWSTER STREET EASTHARVEYND58341N/APCSMP HEALTH - ST. ALOISIUS ULTRASOUND PROJECT$256,572
ST LUKE HEALTH CARE FOUNDATION
28W609 HICKORY LNWEST CHICAGOIL60185N/APCHOPE CENTER FOR WOMEN AND CHILDREN$3,293,350
ST LUKE'S HOSPITAL
702 1ST ST SWCROSBYND58730N/APCST. LUKE'S MEDICAL CENTER ULTRASOUND INITIATIVE$74,770
ST ALEXIUS MEDICAL CENTER
900 EAST BROADWAY AVEBISMARCKND58501N/APCCHI ST. ALEXIUS HEALTH ULTRASOUND INITIATIVE$3,799,563
ST ANDREW'S HOSPITAL
316 OHMER STREETBOTTINEAUND58318N/APCST. ANDREW'S HOSPITAL ULTRASOUND INITIATIVE$74,293
ST JOSEPHS HOSPITAL AND HEALTH CENTER
2500 FAIRWAY STDICKINSONND58601N/APCCHI ST. ALEXIUS HEALTH DICKINSON ULTRASOUND INITIATIVE$632,439
ST MARK'S HOSPITAL FOUNDATION
N/APCSUPPORT FOR THE ONGOING DEVELOPMENT OF THE TOPCLASS PERIANAL CD CONSORTIUM$254,998ACTON LANELONDONUK
ST MARK'S HOSPITAL FOUNDATION
N/APCGLOBAL PERIANAL CROHN'S DISEASE PRIORITY SETTING PARTNERSHIP$24,288ACTON LANELONDONUK
ST ROSE DOMINICAN HEALTH FOUNDATION
102 E LAKE MEAD PARKWAYHENDERSONNV89015N/ASOIDIGNITY HEALTH - ST. ROSE DOMINICAN - SIENA CAMPUS ECMO PROGRAM$124,981
ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH
N/APCWHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D?$298,2249 PRINCES STMELBOURNEAS
STATE OF NEVADA DEPARTMENT OF DIVISION OF STATE PARKS
901 S STEWART ST SUITE 5005CARSON CITYNV89701N/APCVALLEY OF FIRE VISITOR CENTER$3,500,000
STATE UNIVERSITY OF IOWA FOUNDATION
ONE WEST PARK ROADIOWA CITYIA52242N/APCSIMULATION IN MOTION-IOWA ENDOWMENT$100,000
STICHTING ACCESS TO MEDICINE FOUNDATION
N/APCEXPANDING ACCESS TO DIABETES CARE$1,000,000NARITAWEG 227 SUITE AAMSTERDAMNL
STICHTING HEALTH ACTION INTERNATIONAL
N/APCADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV$1,200,977OVERTOOM 60AMSTERDAMNL
STICHTING PHARMACCESS INTERNATIONAL
N/APCSAFECARE A BUSINESS MODEL FOR HEALTHCARE QUALITY$686,565AHTC TOWER C4 PAASHEUVELWEG 25AMSTERDAMNL
STICHTING THE OCEAN CLEANUP
N/APCDEVELOP AND SCALE TECHNOLOGIES TO RID THE OCEANS OF PLASTICS$5,000,000BATAVIERENSTRAAT 15ROTTERDAMNL
STIFTELSEN FOR UTBILDNING (IOIBD)
N/APCTHE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD$132,000LINKPING UNIVERSITY HOSPITAL FLOOROREBROSW14
SUPPORTIVE HOUSING NETWORK OF NEW YORK INC
247 W 37TH STNEW YORK CITYNY10018N/APCTRAINING ACADEMY AND COMMUNITY OF PRACTICE FOR SUPPORTIVE HOUSING PROVIDERS$450,000
SUSTAINABLE COASTLINES HAWAII
3160 WAIALAE AVEHONOLULUHI96816N/APCSCALING SUSTAINABLE COASTLINES HAWAII BUILDING LEADERSHIP FOR LONG-TERM GROWTH AND IMPACT$299,213
T1D EXCHANGE INC
101 FEDERAL STREET SUITE 440BOSTONMA02110N/APCEQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY$1,917,417
T1D EXCHANGE INC
101 FEDERAL STREET SUITE 440BOSTONMA02110N/APCEQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY$650,000
T1D EXCHANGE INC
101 FEDERAL STREET SUITE 440BOSTONMA02110N/APCEQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY$2,567,417
T1D EXCHANGE INC
101 FEDERAL STREET SUITE 440BOSTONMA02110N/APCEQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY$633,709
TAMPERE UNIVERSITY FOUNDATION SR
N/APCENTEROVIRUS-INDUCED TYPE 1 DIABETES MECHANISMS AND BIOMARKERS FOR RISK$227,066KALEVANTIE 4 33100TAMPEREFI
TECHNISCHE UNIVERSITAET MUENCHEN
N/AGOVCOST-EFFECTIVENESS OF PUBLIC HEALTH SCREENING FOR PRE-SYMPTOMATIC TYPE 1 DIABETES WITH AND WITHOUT TREATMENT FOR PREVENTION OF TYPE 1 DIABETES$151,947ARCISSTRABE 21MUNCHENGM
TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL
N/AGOVIBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS$268,340WEIZMANN ST 6TEL AVIVIS
TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL
N/AGOVCONSTRUCTION OF THE SHELTERED -5 FLOOR OF THE NORTH TOWER$4,879,510WEIZMANN ST 6TEL AVIVIS
THE ACADEMIC COLLEGE AT TEL-HAI
N/APCTHE HELMSLEY RESEARCH AND INNOVATION WING IN THE TEL-HAI COMPUTER SCIENCE BUILDING.$2,600,000TEL-HAI COLLEGEUPPER GALILEEIS
THE ACADEMIC COLLEGE AT TEL-HAI
N/APCTHE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH$1,517,781TEL-HAI COLLEGEUPPER GALILEEIS
THE ASSOCIATION FOR THE BETTERMENT OF ESHKOL REGION RESIDENTS
N/APCBE'ERI AGRICULTURAL EQUIPMENT$2,203,283ESHKOL REGIONAL COUNCILKIBBUTZ MAGENIS
THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV
N/APCRAMAT HANEGEV SENIOR CITIZEN CENTER$2,241,8032012100 HALUTZRAMAT HANEGEVIS
THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV
N/APCRAMAT HANEGEV CENTRAL AUDITORIUM$843,9882012100 HALUTZRAMAT HANEGEVIS
THE BINYAMIN FUND INC
445 CENTRAL AVENUECEDARHURSTNY11516N/APCEMERGENCY GENERATORS FOR COMMUNITIES IN THE BINYAMIN REGIONAL COUNCIL$350,000
THE BIONICS INSTITUTE OF AUSTRALIA
N/APCPATIENT-SPECIFIC ADAPTIVE, ELECTRIC THERAPY FOR CROHNS DISEASE$1,779,261384-388 ALBERT STREETEAST MELBOURNEAS
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCUNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS$971,014
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$3,497,605
THE CENTER FOR EFFECTIVE PHILANTHROPY INC
675 MASSACHUSETTS AVENUECAMBRIDGEMA02139N/APCGENERAL OPERATING SUPPORT FOR 2024$54,780
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
N/APCDOES THE WESTERN DIET TRIGGER CROHN'S DISEASE VIA OSMOTIC STRESS?$808,734TRINITY LANECAMBRIDGEUK
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
N/APCNEW INSIGHTS INTO CROHN'S DISEASE FROM STUDYING NAKED MOLE RATS$1,510,641TRINITY LANECAMBRIDGEUK
THE CITY OF HOPE
1500 E DUARTE RDDUARTECA91010N/APCTHE HELMSLEY CHARITABLE TRUST GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE$300,000
THE CITY OF HOPE
1500 E DUARTE RDDUARTECA91010N/APCCD318 MEDIATED REGULATION OF ISLET AUTOANTIGEN SPECIFIC T CELL IMMUNITY$368,500
THE CITY OF HOPE
1500 E DUARTE RDDUARTECA91010N/APCGENETIC PROTECTION BY HLA-DQ6 IN T1D$235,681
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCDEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES$1,321,210
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCTHE MILESTONE INITIATIVE EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA$236,313
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCMECHANOBIOLOGY OF THE INTESTINAL EPITHELIAL BARRIER DISRUPTION IN CROHNS DISEASE$387,615
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM$869,476
THE COMMUNICATIONS NETWORK
1717 NORTH NAPER BLVDNAPERVILLEIL60563N/APCGENERAL OPERATING SUPPORT FOR 2025-27 MEMBERSHIP$30,000
THE END FUND INC
2 PARK AVENUENEW YORKNY10016N/APCTACKLING TRACHOMA SURGERY DISPARITIES$2,117,400
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD$137,4172500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD$127,0772500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCA DRUG-WIDE SCAN TO IDENTIFY REPURPOSED MEDICATIONS FOR CROHN'S DISEASE$394,3652500 UNIVERSITY DRIVE NWCALGARYCA
THE HOLE IN THE WALL GANG FUND INC
555 LONG WHARF DRIVENEW HAVENCT06511N/APCGENERAL OPERATING SUPPORT$5,000
THE HOSPITAL FOR SICK CHILDREN
N/APCVERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES$555,480555 UNIVERSITY AVETORONTOCA
THE HOSPITAL FOR SICK CHILDREN
N/APCIMMUNE RESPONSES TO GUT MICROBES ASSOCIATED WITH T1D RISK AND PROGRESSION$248,621555 UNIVERSITY AVETORONTOCA
THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
N/APCIMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION$156,358EXHIBITION RDLONDONUK
THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
N/APCUNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE$1,032,574EXHIBITION RDLONDONUK
THE JEWISH AGENCY FOR ISRAEL
N/APCBAYIT PROJECT, COMMUNAL MULTI-FAMILY SHELTERS AT THE SHOSHANA ABSORPTION CENTER IN KIRYAT GAT$750,00048 KING GEORGE STREETJERUSALEMIS
THE JEWISH AGENCY FOR ISRAEL
N/APCTHE SECURITY FUND SECURING AND SAFEGUARDING JEWISH COMMUNITIES WORLDWIDE$1,500,00048 KING GEORGE STREETJERUSALEMIS
THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL LTD
N/APCOPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS PURSUING NURSING DEGREES$200,000YEZREEL VALLEYYEZREEL VALLEYIS
THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL LTD
N/APCNURSING SIMULATION CENTER UPGRADES$751,269YEZREEL VALLEYYEZREEL VALLEYIS
THE MILKEN INSTITUTE
1250 FOURTH STREETSANTA MONICACA90401N/APCFASTERCURES LEADERSLINK PROGRAM EXPANSION$250,000
THE NATURE CONSERVANCY
4245 NORTH FAIRFAX DRIVE SUITE 100ARLINGTONVA22203N/APCFUTURE FOREST NYC PHASE III$347,804
THE QUEENS MEDICAL CENTER
1301 PUNCHBOWL STHONOLULUHI96813N/APCTHE QUEENS MEDICAL CENTER & CLARENCE T.C. CHING ECMO PROGRAM EXCELLENCE AND VIABILITY APPRAISAL$1,635,796
THE QUEENS MEDICAL CENTER
1301 PUNCHBOWL STHONOLULUHI96813N/APCTHE QUEEN'S MEDICAL CENTER - WEST OAHU CANCER CENTER EXPANSION$5,000,000
THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA
PO BOX 400195CHARLOTTESVILLEVA229044195N/APCTYPE 1 DIABETES RISK PREDICTION INTEGRATION OF PHYSIOLOGY WITH GENETICS$115,896
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE
120 THEORY SUITE 200IRVINECA926971050N/APCDEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D$1,108,867
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
10889 WILSHIRE BLVD SUITE 700LOS ANGELESCA900951406N/APCGLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D$439,378
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
10889 WILSHIRE BLVD SUITE 700LOS ANGELESCA900951406N/APCGLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D$128,649
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVELA JOLLACA92093N/APCTHE DRUGGABLE GPCROME IN CROHNS DISEASE$1,091,471
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143N/APCPREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO)$269,368
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143N/APCPREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO)$269,368
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SANTA BARBARA
UC SANTA BARBARASANTA BARBARACA93106N/APCEXERCISE SPECIFIC AID ALGORITHM FOR TYPE 1 DIABETES$1,027,327
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCEPITHELIAL MITOCHONDRIAL DYSFUNCTION AND EXTRACELLULAR VESICLES IN CROHNS DISEASE FIBROSTENOSIS.$457,178
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCPREPARE 4 AID PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY$269,500
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCPRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE)$315,557
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCDEFINING HUMAN ISLET MYELOID CELL POPULATIONS THROUGH PROGRESSION OF TYPE 1 DIABETES$291,029
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCSEEDS PATHWAY SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY$686,820
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCSEEDS PATHWAY SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY$598,309
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCEPIGENOMIC BIOMARKERS OF THE INCOMPLETE MATERNAL PROTECTION IN TYPE 1 DIABETES$150,914
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCMAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL$300,000
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCCOMPLEMENT SYSTEM IN THE INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY$124,200
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCT AND B CELL RECEPTOR ATLAS ACROSS TISSUES AND STAGES OF TYPE 1 DIABETES$501,000
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCEXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D$200,584
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCCGM IN PRIMARY CARE - REFER OR LEARN IMPLEMENTATION AND EVALUATION$332,512
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCIMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES)$935,698
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCIMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE$513,331
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACEAURORACO800452571N/APCASK THE EXPERTS 2024$500,000
THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNINGMCGILL UNIV
N/APCDATA GOVERNANCE RESOURCE$190,336845 SHERBROOKE STREET WESTMONTREALCA
THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH
N/APCISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD)$756,6992 KATZIRRAMAT GANIS
THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH
N/APCTHE UTILITY OF HAND-HELD ULTRASOUND DEVICES TO DETECT BOWEL WALL INFLAMMATORY ACTIVITY IN CROHN'S DISEASE$118,2102 KATZIRRAMAT GANIS
THE SONIA NABETA FOUNDATION INC
4705 5TH STREET UNIT 405LONG ISLAND CITYNY11101N/APCWORLD OF WARRIORS$482,110
THE STATE UNIVERSITY COLLEGE AT ONEONTA FOUNDATION CORPORATION INC
108 RAVINE PARKWAYONEONTANY13820N/APCGENERAL OPERATING SUPPORT$25,000
THE TEL AVIV JAFFA ACADEMIC COLLEGE
N/APCNEED-BASED SCHOLARSHIPS FOR NURSING STUDENTS$266,667RABENU YERUHAM ST 2 POB 8401TEL AVIV YAFFOIS
THE TREVOR PROJECT INC
PO BOX 69232WEST HOLLYWOODCA90069N/APCLGBTQ YOUTH SUICIDE PREVENTION PROJECT$2,081,072
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
615 WEST 131ST STREETNEW YORKNY100273922N/APCADDING HEALTH QUESTIONS TO THE POVERTY TRACKER TO SURVEY THE HEALTHCARE NEEDS AND UTILIZATION PREFERENCES OF LOW-INCOME NEW YORKERS$146,689
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$413,263
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$429,646
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
615 WEST 131ST STREETNEW YORKNY100273922N/APCSUPPORT FOR T1D TRANSITION PROGRAMS$200,000
THE UNIVERSITY OF ADELAIDE
N/APCPANCREATIC EXOCRINE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES IN YOUNG CHILDREN$55,260NORTH TERRACEADELAIDEAS
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637N/APCDEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND$333,042
THE UNIVERSITY OF EDINBURGH
N/APCBUILDING A CROSS-DISCIPLINE SCIENTIFIC APPROACH TOWARDS UNDERSTANDING CROHNS DISEASE - LEVERAGING UK HELMSLEY STUDIES$47,977SOUTH BRIDGEEDINBURGHUK
THE UNIVERSITY OF EDINBURGH
N/APCMITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC)$682,311SOUTH BRIDGEEDINBURGHUK
THE UNIVERSITY OF EDINBURGH
N/APCHUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE$209,222SOUTH BRIDGEEDINBURGHUK
THE UNIVERSITY OF QUEENSLAND
N/APCGUT MICROBIAL METABOLITES DURING EARLY-LIFE DEVELOPMENT AS PREDICTORS OF ISLET AUTOIMMUNITY$69,271CUMBRAE STEWART BUILDING 72BRISBANEAS
THE UNIVERSITY OF WESTERN AUSTRALIA
N/APCCGM ASSESSMENTS OF ENDIA CHILDREN$35,86635 STIRLING HIGHWAYCRAWLEYAS
THE WEIZMANN INSTITUTE OF SCIENCE
N/APCEARLY CHILDHOOD DEVELOPMENT AND COMMUNITY CENTER AT THE WEIZMANN INSTITUTE OF SCIENCE$3,000,000234 HERZEL STREHOVOTIS
THE WEIZMANN INSTITUTE OF SCIENCE
N/APCQUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS$300,000234 HERZEL STREHOVOTIS
TIOGA MEDICAL CENTER
PO BOX 159TIOGAND58852N/APCTIOGA MEDICAL CENTER ULTRASOUND INITIATIVE$326,201
TOWNER COUNTY MEDICAL CENTER INC
7448 US 281CANDOND58324N/APCTOWNER COUNTY MEDICAL CENTER ULTRASOUND INITIATIVE$241,563
TRICKLE UP PROGRAM INC
31 WEST 34TH STREETNEW YORKNY10001N/APCGENERAL OPERATING SUPPORT$25,000
TRINITY HEALTH
407 3RD STREETMINOTND58701N/APCTRINITY HEALTH ULTRASOUND INITIATIVE$3,020,087
TRUSTEES AND FRIENDS OF AGRICULTURAL RESEARCH AT THE VOLCANI CENTER
N/APCPROTECTING FARMERS AND AGRICULTURAL WORKERS ACROSS NORTHERN ISRAEL$962,990HA MACABIM 68 PO BOX 15159RISHON LEZIONIS
TRUSTEES OF INDIANA UNIVERSITY
509 EAST 3RD STREETBLOOMINGTONID474013654N/AGOVTARGETING METABOLIC DRIVERS OF B CELL DIFFERENTIATION IN TYPE 1 DIABETES$58,372
TRUSTEES OF INDIANA UNIVERSITY
509 EAST 3RD STREETBLOOMINGTONID474013654N/AGOVTHE FINDING IMMUNE NASCENT DIABETES (FIND-T1D)$160,875
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREETPHILADELPHIAPA191046205N/APCENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS$407,000
TZAFON MEDICAL CENTER
N/AGOVSECURING TZAFON MEDICAL CENTER'S ELECTRICAL CONNECTION TO ISRAEL'S POWER GRID$895,000DOV HOZ 0TIBERIASIS
TZAFON MEDICAL CENTER
N/AGOVSHELTERED HOSPITALIZATION AREA$340,000DOV HOZ 0TIBERIASIS
UNITED JEWISH APPEAL FEDERATION OF JEWISH PHILANTHROPIES OF NY INC
130 EAST 59TH STREETNEW YORKNY10022N/APCGENERAL OPERATING SUPPORT.$18,000
UNITED JEWISH APPEAL FEDERATION OF JEWISH PHILANTHROPIES OF NY INC
130 EAST 59TH STREETNEW YORKNY10022N/APCGENERAL OPERATING SUPPORT$5,000
UNITED STATES FUND FOR UNICEF
125 MAIDEN LANENEW YORKNY10038N/APCACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS$869,232
UNIVERSITE CATHOLIQUE DE LOUVAIN
N/APCLONGITUDINAL STUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN AND ADOLESCENTS WITH NEW-ONSET TYPE 1 DIABETES$62,567PLACE DE L UNIVERSITE 1LOUVAINLANEUVEBE
UNIVERSITE DE GENEVE
N/AGOVPRECLINICAL TESTING OF S100A9 TO IMPROVE GLYCEMIC CONTROL IN TYPE 1 DIABETES$1,112,238RUE MICHEL SERVET 1GENEVESZ
UNIVERSITE LIBRE DE BRUXELLES
N/AGOVSTUDYING THE SELECTIVE B CELL SENSITIVITY TO A HOMOZYGOUS PD-L1 MUTATION IN NEONATAL DIABETES$213,278AVENUE FRANKLIN ROOSEVELT 50BRUSSELSBE
UNIVERSITE LIBRE DE BRUXELLES
N/AGOVGENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING$213,602AVENUE FRANKLIN ROOSEVELT 50BRUSSELSBE
UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C
1001 MAIN STREETBUFFALONY14203N/APCFINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS$419,662
UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C
1001 MAIN STREETBUFFALONY14203N/APCFINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS$118,038
UNIVERSITY HOSPITALS HEALTH SYSTEM INC
11100 EUCLID AVENUECLEVELANDOH44106N/APCTYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS$866,199
UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA
1800 W CHARLESTON BLVDLAS VEGASNV89102N/AGOVDEVELOPMENT OF AN EXTRACORPOREAL LIFE SUPPORT (ECLS) PROGRAM AT UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA$387,094
UNIVERSITY OF BIRMINGHAM
N/APCDEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES AN EXPERIMENTAL MEDICINE STUDY$152,801CHANCELLORS COURTBIRMINGHAMUK
UNIVERSITY OF BRISTOL
N/APCTYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY$431,779TYNDALL AVENUEBRISTOLUK
UNIVERSITY OF CINCINNATI
51 GOODMAN DRIVE SUITE 500CINCINNATIOH45221N/AGOVSTUDIES ON THE ROLE OF C-PEPTIDE TO REGULATE BLOOD GLUCOSE DURING SLEEP AND EXERCISE$416,500
UNIVERSITY OF DUNDEE
N/APCHYPO-RESOLVE - UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA$133,804NETHERGATEDUNDEEUK
UNIVERSITY OF EXETER
N/APCADVANCING B-CELL SPECIFIC THERAPY BY IDENTIFYING B-CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS$55,571NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF EXETER
N/APCEXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2 FROM OBSERVATION TO MECHANISM$206,160NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF EXETER
N/APCSTIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES$95,777NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF EXETER
N/APCB CELL SIGNATURES IN TYPE 1 DIABETES$247,813NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVUNDERSTANDING T1D AND INSULIN-REQUIRING DIABETES IN FEDERALLY QUALIFIED HEALTH CENTERS (FQHC) A NATIONAL NEEDS ASSESSMENT$548,565
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVGENERATING AUTOANTIGEN-SPECIFIC ANTIBODY-PRODUCING HYBRIDOMAS AS A RENEWABLE SOURCE OF ISLET AUTOANTIBODIES$36,272
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVGENERATING AUTOANTIGEN-SPECIFIC ANTIBODY-PRODUCING HYBRIDOMAS AS A RENEWABLE SOURCE OF ISLET AUTOANTIBODIES$27,771
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVHUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION$213,106
UNIVERSITY OF GLASGOW COURT
N/APCUNRAVELING THE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION.$367,104UNIVERSITY AVENUEGLASGOWUK
UNIVERSITY OF GLASGOW COURT
N/APCCOMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE THE BIOPIC STUDY$176,239UNIVERSITY AVENUEGLASGOWUK
UNIVERSITY OF IOWA
112 NORTH CAPITOL STREETIOWA CITYIA52442N/AGOVSUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION$199,968
UNIVERSITY OF IOWA
112 NORTH CAPITOL STREETIOWA CITYIA52442N/AGOVSIMULATION IN MOTION IOWA (SIM-IA)$714,411
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655N/AGOVDIETA ANTI-INFLAMATORIA A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS$473,409
UNIVERSITY OF MELBOURNE
N/APCUSE OF WHEY PROTEIN TO REDUCE RISK OF HYPOGLYCEMIA DURING EXERCISE FOR PEOPLE WITH T1D$371,201161 BARRY STREETCARLTONAS
UNIVERSITY OF MIAMI
1320 SOUTH DIXIE HIGHWAY SUITE 650CORAL GABLESFL33146N/APCDEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES$247,023
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/AGOVGENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES$149,7961350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/AGOVPILOTING INTEGRATION OF PORTABLE ULTRASOUNDS$1,038,6541350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/AGOVDEVELOPMENT OF A CONTINUOUS INSULIN SENSOR$837,8461350
UNIVERSITY OF NORTH DAKOTA
1301 N COLUMBIA RD SUITE E105GRAND FORKSND58202N/AGOVSIMULATION IN MOTION (SIM) CONSORTIUM$46,976
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEID465565708N/APCDEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM$705,510
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEID465565708N/APCGLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES$483,726
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEID465565708N/APCGLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES$188,155
UNIVERSITY OF OULU
N/APCMATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING$274,391PO BOX 8000OULUFI
UNIVERSITY OF PITTSBURGH
3420 FORBES AVENUEPITTSBURGHPA152603203N/APCSINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE$237,102
UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN
2304 WHITIS AVEAUSTINTX787121111N/AGOVINCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN$200,927
UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN
2304 WHITIS AVEAUSTINTX787121111N/AGOVINCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN$198,646
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLESALT LAKE CITYUT84112N/APCINDUCTION OF PERIPHERAL TOLERANCE TO BETA CELL ANTIGENS BY SPECIFIC TARGETING OF LANGERIN DENDRITIC CELLS$290,806
UNIVERSITY OF VIRGINIA LAW SCHOOL FOUNDATION
580 MASSIE ROADCHARLOTTESVILLEVA22903N/APCGENERAL OPERATING SUPPORT FOR THE CATHERINE MURPHY KEATING '87 RESTRICTED FUND$75,000
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NESEATTLEWA981959472N/AGOVPATHOGENIC ACTION OF AUTOANTIBODIES ON ISLET FUNCTION AND VIABILITY IN TYPE 1 DIABETES$385,000
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NESEATTLEWA981959472N/AGOVDESIGN OF ISLET TARGETED AGONISTS OF PD1 AND CTLA4$387,576
UPPSALA UNIVERSITY HOSPITAL
N/APCIMMUNE-EVASIVE ISLETS FOR TRANSPLANTATION$1,139,284AKADEMISKA SJUKHUSETUPPSALASW
URBAN PATHWAYS INC
575 EIGHTH AVENEW YORKNY10018N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000
VANDERBILT UNIVERSITY MEDICAL CENTER
3319 WEST END AVENUE SUITE 970NASHVILLETN37203N/APCEXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY$364,886
VANDERBILT UNIVERSITY MEDICAL CENTER
3319 WEST END AVENUE SUITE 970NASHVILLETN37203N/APCDEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA$275,000
VANDERBILT UNIVERSITY MEDICAL CENTER
3319 WEST END AVENUE SUITE 970NASHVILLETN37203N/APCSCREENING HUMAN ISLETS TO IDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA$330,000
VANDERBILT UNIVERSITY MEDICAL CENTER
3319 WEST END AVENUE SUITE 970NASHVILLETN37203N/APCADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES$121,999
VANDERBILT UNIVERSITY MEDICAL CENTER
3319 WEST END AVENUE SUITE 970NASHVILLETN37203N/APCISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES$163,405
VANDERBILT UNIVERSITY
110 21ST AVENUE SOUTHNASHVILLETN372032417N/APCNORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING$275,000
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES$1,913,552
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES$1,260,384
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES$1,865,381
VILLAGES OF HOPE AFRICA SOCIETY
N/APCINFRASTRUCTURE IMPROVEMENTS AND EXPANSION$151,1522450 MILLTOWER COURTMISSISSAUGACA
VIVLI INC
101 MIDDLESEX TURNPIKE SUITE 6BURLINGTONMA018034914N/APCDATA SHARING PLATFORM FOR T1-DEXI DATASETS$74,348
WARREN MEMORIAL HOSPITAL
905 2ND STFRIENDNE68359N/AGOVTELE-EMERGENCY SERVICES AT FRIEND COMMUNITY HEALTHCARE SYSTEM$11,027
WASHINGTON UNIVERSITY
1 BROOKINGS DRIVESAINT LOUISMO63130N/APCRESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING$330,000
WASHINGTON UNIVERSITY
1 BROOKINGS DRIVESAINT LOUISMO63130N/APCPRECLINICAL DEVELOPMENT TO ADVANCE A T1D ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D$1,271,885
WASHINGTON UNIVERSITY
1 BROOKINGS DRIVESAINT LOUISMO63130N/APCCELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE$488,300
WATER4 INC
2405 NW 10TH STREETOKLAHOMA CITYOK73107N/APCSCALING NUMA IN NORTHERN GHANA$1,478,953
WEST RIVER HEALTH SERVICES FOUNDATION
1000 HIGHWAY 12HETTINGERND58639N/ASOIII FINORTH DAKOTA US REVITALIZATION PROJECT$68,591
WILCOX HEALTH FOUNDATION
3-3420 KUHIO HIGHWAYLIHUEHI96766N/APCWILCOX MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT$3,944,163
WILDLIFE CONSERVATION SOCIETY
2300 SOUTHERN BOULEVARDBRONXNY10460N/APCGENERAL OPERATING SUPPORT FOR ELEPHANTS$10,000
WISHEK HOSPITAL CLINIC ASSOCIATION
1007 4TH AVE SOUTHWISHEKND58495N/APCSOUTH CENTRAL HEALTH ULTRASOUND INITIATIVE$83,657
WNET FOR THE WLIW-21 PUBLIC BROADCASTING
825 EIGHTH AVENUENEW YORKNY100197435N/APCGENERAL OPERATING SUPPORT$5,000
WORLD HEALTH ORGANIZATION
N/APCSTRENGTHENING INTEGRATED PREVENTION AND CONTROL OF CHRONIC AND SEVERE NCDS IN THE WHO AFRICAN REGION, USING T1D, SCD, ARF, AND RHD AS ENTRY POINTS$3,126,083AVENUE APPIA 20GENEVASZ
WORLD HEALTH ORGANIZATION
N/APCSTRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT$3,129,504AVENUE APPIA 20GENEVASZ
WYOMING ASSOCIATION OF SHERIFFS AND CHIEFS OF POLICE
PO BOX 481DOUGLASWY82633N/APCWYOMING VIRTUAL CRISIS CARE PILOT PROGRAM$798,469
YALE UNIVERSITY
PO BOX 208327NEW HAVENCT065208327N/APCTARGETING NEWLY DISCOVERED HOST-MICROBIOTA INTERACTION NODES TO TREAT OR PREVENT CROHNS DISEASE$599,035
YALE UNIVERSITY
PO BOX 208327NEW HAVENCT065208327N/APCEXPOSOMICS FOR EARLY LIFE CROHNS DISEASE$413,016
YITZHAK SHAMIR MEDICAL CENTER
N/AGOVEXPANSION AND RENOVATION OF THE CANCER INSTITUTE AT SHAMIR MEDICAL CENTER$1,978,286BEER YAAKOVTZRIFINIS
YOUNG MEN'S CHRISTIAN ASSOCIATION OF RYE NY
21 LOCUST AVERYENY10580N/APCGENERAL OPERATING SUPPORT$10,000
YOUNG MEN'S CHRISTIAN ASSOCIATION RETIREMENT FUND
120 BROADWAYNEW YORKNY10271N/ASOIGENERAL OPERATING SUPPORT$10,000
YOUTH DEVELOPMENT ORGANIZATION INC
15 UNION STREET 563LAWRENCEMA01840N/APCCAPACITY BUILDING PROJECT SUPPORT 2024-2026$200,000
ZAKA - SEARCH AND RESCUE
N/APCEMERGENCY AND DISASTER PREPAREDNESS IN ISRAEL$350,000234 JAFFA STREETJERUSALEMIS
ZIV MEDICAL CENTER ZEFAT
N/AGOVNEW NEUROSURGERY DEPARTMENT$2,100,000DERECH HARAMBAM 1ZEFATIS
ZIV MEDICAL CENTER ZEFAT
N/AGOVNEW THORACIC SURGERY UNIT$1,325,000DERECH HARAMBAM 1ZEFATIS
FieldValueIRS element (for citing)
Total Grant Or Contri Pd Dur Yr$440,927,206TotalGrantOrContriPdDurYrAmt

Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (485 entries)

Address Line1RecipientForeignAddress/AddressLine1TxtCityRecipientForeignAddress/CityNmCountryRecipientForeignAddress/CountryCdRecipient RelationshipRecipientRelationshipTxtRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdAddress Line2RecipientUSAddress/AddressLine2TxtAddress Line2RecipientForeignAddress/AddressLine2Txt
ACADEMISCH ZIEKENHUIS LEIDEN
2 ALBINUSDREEFLEIDENNLN/AGOVSAFETY AND EFFICACY OF IMMUNE INTERVENTION WITH TOLEROGENIC DENDRITIC CELLS IN PATIENTS WITH EARLY T1D (D-SENSE II)$238,910
ACADEMISCH ZIEKENHUIS LEIDEN
2 ALBINUSDREEFLEIDENNLN/AGOVSAFETY AND EFFICACY OF IMMUNE INTERVENTION WITH TOLEROGENIC DENDRITIC CELLS IN PATIENTS WITH EARLY T1D (D-SENSE II)$93,238
ACTION4DIABETES
9 PARKFIELD ROADTAUNTONUKN/APCPHILIPPINES T1D TASK FORCE$284,390
ALBERT EINSTEIN COLLEGE OF MEDICINE
N/APCENHANCING THE COMMUNITY HEALTH WORKER (CHW) MODEL TO PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D$171,1501300 MORRIS PARK AVENUEBRONXNY104611975
ALIMENTIV INC
100 DUNDAS STREETLONDONCAN/ANCVALIDATION OF THE PRO SYMPTOMS AND IMPACTS QUESTIONNAIRE FOR CROHNS DISEASE$749,412
ALIMENTIV INC
100 DUNDAS STREETLONDONCAN/ANCVALIDATION OF THE PRO SYMPTOMS AND IMPACTS QUESTIONNAIRE FOR CROHNS DISEASE$55,930
AMERICAN CAMPING ASSOCIATION INC
N/APCACA PROFESSIONAL DEVELOPMENT 2024-2027$60,2215000 STATE ROAD 67 NORTHMARTINSVILLEIN46151
AMERICAN CAMPING ASSOCIATION INC
N/APCACA PROFESSIONAL DEVELOPMENT 2024-2027$65,2585000 STATE ROAD 67 NORTHMARTINSVILLEIN46151
AMERICAN DIABETES ASSOCIATION INC
N/APC2025-2027 TYPE 1 DIABETES CAMP INITIATIVE$480,2602451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202
AMERICAN DIABETES ASSOCIATION INC
N/APC2025-2027 TYPE 1 DIABETES CAMP INITIATIVE$480,2602451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202
AMERICAN DIABETES ASSOCIATION INC
N/APCTRAINING AND MENTORSHIP PROGRAMS$805,3822451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202
AMERICAN HEART ASSOCIATION INC
N/APCHEARTCORPS AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE$850,0987272 GREENVILLE AVENUEDALLASTX75231
AMERICAN HEART ASSOCIATION INC
N/APCEXPANDING THE SYSTEM OF STROKE CARE IN MINNESOTA$1,563,5757272 GREENVILLE AVENUEDALLASTX75231
AMERICAN HEART ASSOCIATION INC
N/APCAMERICAN HEART ASSOCIATION CENTER FOR TELEHEALTH$4,816,5537272 GREENVILLE AVENUEDALLASTX75231
AMERICAN HEART ASSOCIATION INC
N/APCEXPANDING THE SYSTEM OF STROKE CARE IN MINNESOTA$1,546,1237272 GREENVILLE AVENUEDALLASTX75231
AMERICAN HEART ASSOCIATION INC
N/APCMISSION LIFELINE STROKE SOUTH DAKOTA$1,592,1907272 GREENVILLE AVENUEDALLASTX75231
AMERICAN HEART ASSOCIATION INC
N/APCMISSION LIFELINE STROKE SOUTH DAKOTA$1,836,3547272 GREENVILLE AVENUEDALLASTX75231
AMERICAN HEART ASSOCIATION INC
N/APCMISSION LIFELINE STROKE HAWAII$2,220,8997272 GREENVILLE AVENUEDALLASTX75231
AMERICAN HEART ASSOCIATION INC
N/APCMISSION LIFELINE STROKE HAWAII$1,988,0207272 GREENVILLE AVENUEDALLASTX75231
AMSTERDAM UMC RESEARCH BV
MEIBERGDREEF 9AMSTERDAMNLN/APCA PROSPECTIVE RANDOMIZED STUDY OF TREATMENT SELECTION BASED ON EPIGENETIC MARKERS IN CROHNS DISEASE OMICROHN$1,476,985
ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO
N/APCIMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D$1,542,882225 EAST CHICAGO AVENUE BOX 205CHICAGOIL60611
ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO
N/APCIMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D$1,245,216225 EAST CHICAGO AVENUE BOX 205CHICAGOIL60611
ANTHOS HOME INC
N/APCLAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS$2,750,000238 SEELEY STBROOKLYNNY11218
ANTHOS HOME INC
N/APCLAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS$750,000238 SEELEY STBROOKLYNNY11218
APHP ST ANTOINE HOSPITAL
184 RUE DU FAUBOURG SAINT-ANTOINEPARISFRN/AGOVFECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE)$421,681
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
N/ANCDANATECH DIABETES TECHNOLOGY PLATFORM EXPANSION & MAINTENANCE$928,645125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
N/ANCDANATECH DIABETES TECHNOLOGY PLATFORM EXPANSION & MAINTENANCE$640,509125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606
ASSOCIATION SANTE DIABETE
5 RUE FEDERICO GARCIA LORCAGRENOBLEFRN/APCSTRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS$587,221
ASSOCIATION SANTE DIABETE
5 RUE FEDERICO GARCIA LORCAGRENOBLEFRN/APCSTRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS$325,558
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD
55 VICTORIA PARADEFITZROYASN/APCFECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE THE MIRO (MICROBIOTA RESTORATION) STUDY.$315,421
BALLAD RESEARCH INSTITUTE
N/APCCD127-HIGH T-CELL POPULATIONS IN AUTOANTIBODY POSITIVE CHILDREN$243,3903525 JOHN HOPKINS COURTSAN DIEGOCA92121
BAYLOR COLLEGE OF MEDICINE
N/APCPREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE$282,140ONE BAYLOR PLAZAHOUSTONTX77030
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
N/APCLINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D$288,2001201 NINTH AVENUESEATTLEWA981012795
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
N/APCMECHANISMS OF AUTOANTIBODY REVERSION IN AT-RISK SUBJECTS$350,1941201 NINTH AVENUESEATTLEWA981012795
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
N/APCMECHANISMS OF AUTOANTIBODY REVERSION IN AT-RISK SUBJECTS$348,8741201 NINTH AVENUESEATTLEWA981012795
BEN-GURION UNIVERSITY OF THE NEGEV
BEN-GURION BLVD 1BEER SHEVAISN/APCCONSTRUCTION OF THE LEONA M. AND HARRY B. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING$10,542,857
BETH ISRAEL DEACONESS MEDICAL CENTER INC
N/APCPROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE THE OPTIMIZE TRIAL$797,851330 BROOKLINE AVENUEBOSTONMA022155491
BEYOND TYPE 1
N/APCCAPACITY BUILDING SUPPORT$645,000400 CONCAR DRIVE OFFICE 03-155SAN MATEOCA94402
BILLINGS CLINIC FOUNDATION
N/APCEXPANDING ECMO SERVICES AT BILLINGS CLINIC$485,8262917 TENTH AVENUE NORTHBILLINGSMT59101
BILLINGS CLINIC FOUNDATION
N/APCBILLINGS CLINIC TRANSFER CENTER$880,2332917 TENTH AVENUE NORTHBILLINGSMT59101
BILLINGS CLINIC FOUNDATION
N/APCBILLINGS CLINIC TRANSFER CENTER$348,7982917 TENTH AVENUE NORTHBILLINGSMT59101
BIPARTISAN POLICY CENTER INC
N/APCSTRENGTHENING RURAL HEALTH CARE DELIVERY AND SERVICES$584,9231225 I ST NW 1000WASHINGTONDC20005
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
N/APCDEVELOPMENT OF PERSONALIZED DECISION SUPPORT TOOL USING NETIOB TO HELP MANAGE EXERCISE FOR PEOPLE WITH T1D$1,069,498443 VIA ORTEGASTANFORDCA94305
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
N/APCDETERMINING THE THERAPEUTIC POTENTIAL OF STATINS ON STRICTURING CROHNS DISEASE$775,549443 VIA ORTEGASTANFORDCA94305
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
N/APCDETERMINING THE THERAPEUTIC POTENTIAL OF STATINS ON STRICTURING CROHNS DISEASE$591,775443 VIA ORTEGASTANFORDCA94305
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
N/APCDEVELOPMENT OF A MOLECULAR SWITCH BASED CONTINUOUS INSULIN SENSOR$1,333,066443 VIA ORTEGASTANFORDCA94305
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
N/APCDEVELOPMENT OF A MOLECULAR SWITCH BASED CONTINUOUS INSULIN SENSOR$1,360,687443 VIA ORTEGASTANFORDCA94305
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
N/APCMICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE$1,006,687443 VIA ORTEGASTANFORDCA94305
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
N/APCDIABDOCS NATIONAL K12 SUPPLEMENT$395,280443 VIA ORTEGASTANFORDCA94305
BOSTON MEDICAL CENTER CORPORATION
N/APCSUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D$257,191ONE BOSTON MEDICAL PLACEBOSTONMA02118
BOSTON MEDICAL CENTER CORPORATION
N/APCSUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D$257,191ONE BOSTON MEDICAL PLACEBOSTONMA02118
BOSTON MEDICAL CENTER CORPORATION
N/APCSUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D$257,191ONE BOSTON MEDICAL PLACEBOSTONMA02118
BREAKING GROUND HOUSING DEVELOPMENT FUND CORPORATION
N/APCPILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING$585,924505 EIGHTH AVENUE 5TH FLOORNEW YORKNY10018
BREAKTHROUGH T1D
N/APCCO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE$133,334200 VESEY STREETNEW YORKNY10281
BREAKTHROUGH T1D
N/APCJOINING FORCES BUILDING A SHARED 'GRAND ACCESS STRATEGY' FOR SAVING T1D LIVES$500,000200 VESEY STREETNEW YORKNY10281
BREAKTHROUGH T1D
N/APCHELMSLEY AND JDRF CO-FUNDED WORKSHOPS$157,366200 VESEY STREETNEW YORKNY10281
BRIDGES TO PROSPERITY INC
N/APCTRANSFORMATIVE CONNECTIVITY IN RURAL ZAMBIA$2,359,6361031 33RD STREETDENVERCO80205
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
HILLS ROADCAMBRIDGEUKN/AGOVTHE UK IBD BIORESOURCE TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE$657,605
CARDIFF UNIVERSITY
30-36 NEWPORT RDWALESUKN/APCT1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D$525,638
CARDIFF UNIVERSITY
30-36 NEWPORT RDWALESUKN/APCT1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D$525,638
CARDIFF UNIVERSITY
30-36 NEWPORT RDWALESUKN/APCT1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D$262,543
CATHOLIC RELIEF SERVICES-USCCB
N/APCHELPING MOTHERS AND NEWBORNS SURVIVE AND THRIVE$1,273,764228 W LEXINGTON STBALTIMOREMD21201
CATHOLIC RELIEF SERVICES-USCCB
N/APCEXPANDING COMMUNITY RECOVERY AND RESILIENCE$1,073,759228 W LEXINGTON STBALTIMOREMD21201
CENTER FOR HEALTH CARE STRATEGIES INC
N/APCCGM MEDICAID ACCESS ACCELERATOR - TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN$626,707300 AMERICAN METRO BOULEVARD SUITEHAMILTONNJ08619125
CENTER FOR URBAN COMMUNITY SERVICES INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000198 EAST 121ST STREETNEW YORKNY10035
CENTER FOR URBAN COMMUNITY SERVICES INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000198 EAST 121ST STREETNEW YORKNY10035
CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD
WELLINGTON SQUAREOXFORDUKN/APCINTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE$93,443
CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD
WELLINGTON SQUAREOXFORDUKN/APCALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA$515,981
CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD
WELLINGTON SQUAREOXFORDUKN/APCALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA$202,677
CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD
WELLINGTON SQUAREOXFORDUKN/APCDEFINING THE SIGNALING CIRCUITS AND REGULONS MEDIATING CROHNS FIBROSIS.$607,072
CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD
WELLINGTON SQUAREOXFORDUKN/APCDEFINING THE SIGNALING CIRCUITS AND REGULONS MEDIATING CROHNS FIBROSIS.$625,660
CHI HEALTH FOUNDATION
N/APCECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY$229,46012809 WEST DODGE ROADOMAHANE68154
CHILDREN'S HOSPITAL CORPORATION
N/APCADVANCING THE DEVELOPMENT OF A NOVEL IMPLANTABLE GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM$1,332,312PO BOX 414413BOSTONMA022414413
CHILDREN'S HOSPITAL CORPORATION
N/APCADVANCING THE DEVELOPMENT OF A NOVEL IMPLANTABLE GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM$1,378,160PO BOX 414413BOSTONMA022414413
CHILDREN'S HOSPITAL LOS ANGELES
N/APCBEYOND COYOT1 EXPANSION OF PATIENT-CENTERED VIRTUAL CARE$531,6304650 SUNSET BOULEVARDLOS ANGELESCA90027
CHILDREN'S HOSPITAL MEDICAL CENTER
N/APCVALIDATION OF A PERIPHERAL BLOOD BIOMARKER SIGNATURE FOR ANTI-TNF RESPONSE IN PATIENTS WITH CROHNS DISEASE (ATPBIOS)$560,2423333 BURNET AVENUECINCINNATIOH45229
CHILDREN'S HOSPITAL MEDICAL CENTER
N/APCVALIDATION OF A PERIPHERAL BLOOD BIOMARKER SIGNATURE FOR ANTI-TNF RESPONSE IN PATIENTS WITH CROHNS DISEASE (ATPBIOS)$733,1213333 BURNET AVENUECINCINNATIOH45229
CHILDREN'S HOSPITAL MEDICAL CENTER
N/APCCOMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL$1,016,5953333 BURNET AVENUECINCINNATIOH45229
CHILDREN'S HOSPITAL MEDICAL CENTER
N/APCCOMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL$407,9323333 BURNET AVENUECINCINNATIOH45229
CHILDREN'S HOSPITAL OF PHILADELPHIA
N/APCLEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D$121,2072716 SOUTH STREETPHILADELPHIAPA191462305
CITY FUTURES INC
N/APCNYC GREENSPACE POLICY REPORTS FOCUSED ON PROMOTING RECREATION, AND IMPROVING ACCESS TO GREENSPACE$75,00080 8TH AVENEW YORKNY10011
CITY FUTURES INC
N/APCNYC GREENSPACE POLICY REPORTS FOCUSED ON PROMOTING RECREATION, AND IMPROVING ACCESS TO GREENSPACE$75,00080 8TH AVENEW YORKNY10011
CITY PARKS FOUNDATION INC
N/APCCATALYST SUSTAINABILITY THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN PARKS$139,790830 FIFTH AVENUENEW YORKNY10065
CITY PARKS FOUNDATION INC
N/APCSTRENGTHENING NYCS URBAN FOREST PLAN PUBLIC PARK LANDS$188,595830 FIFTH AVENUENEW YORKNY10065
CITY PARKS FOUNDATION INC
N/APCNYC GREEN FUND$500,000830 FIFTH AVENUENEW YORKNY10065
CLINTON HEALTH ACCESS INITIATIVE INC
N/APCREACH EXPANDING ACCESS TO PRIMARY CARE FOR DIABETES AND HYPERTENSION (2024-2027)$2,901,095383 DORCHESTER AVENUE SUITE 400BOSTONMA02127
CLINTON HEALTH ACCESS INITIATIVE INC
N/APCREACH EXPANDING ACCESS TO PRIMARY CARE FOR DIABETES AND HYPERTENSION (2024-2027)$3,215,685383 DORCHESTER AVENUE SUITE 400BOSTONMA02127
CLINTON HEALTH ACCESS INITIATIVE INC
N/APCIMPROVING MEDICAL OXYGEN PRODUCTION AND UTILIZATION$1,166,919383 DORCHESTER AVENUE SUITE 400BOSTONMA02127
CONVERGENT IMPACT INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH$492,3003223 ARAPAHOE AVEBOULDERCO80303
CONVERGENT IMPACT INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH$1,212,3003223 ARAPAHOE AVEBOULDERCO80303
COREWELL HEALTH
N/APCEXPANDING ACCESS TO ROBOTIC PCI AND ESTABLISHING A MULTI-STATE NETWORK TO STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS$5,885,473100 MICHIGAN ST NEGRAND RAPIDSMI49503
CORK UNIVERSITY FOUNDATION
WESTERN ROADCORKEIN/APCENDOSCOPIC MULTIMODAL ASSESSMENT USING ADVANCED IMAGING INTEGRATED AI TO PREDICT RECURRENCE IN POST-OPERATIVE CROHNS DISEASE - PROSPERS$663,503
CORK UNIVERSITY FOUNDATION
WESTERN ROADCORKEIN/APCENDOSCOPIC MULTIMODAL ASSESSMENT USING ADVANCED IMAGING INTEGRATED AI TO PREDICT RECURRENCE IN POST-OPERATIVE CROHNS DISEASE - PROSPERS$941,943
CORNELL UNIVERSITY FOR THE JOAN & SANFORD I WEILL MEDICAL COLLEGE
N/APCTARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE$202,6201300 YORK AVENUENEW YORKNY100654805
CORPORATION FOR SUPPORTIVE HOUSING
N/APCHEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING$800,00055 BROADWAYNEW YORK CITYNY10006
CORPORATION FOR SUPPORTIVE HOUSING
N/APCHEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING$500,00055 BROADWAYNEW YORK CITYNY10006
COUNCIL ON FOUNDATIONS INC
N/APCGENERAL OPERATING SUPPORT$34,0001255 23RD ST NWWASHINGTONDC20037
COZAD HOSPITAL DISTRICT NO 2
N/AGOVTELE-EMERGENCY AT COZAD COMMUNITY HEALTH SYSTEM$17,570300 EAST 12TH STREETCOZADNE69130
CROHN'S & COLITIS FOUNDATION INC
N/APCACHIEVING REMISSION IN IBD OPTIMIZING TREAT-TO-TARGET IN CLINICAL PRACTICE$1,622,595733 THIRD AVENUE SUITE 510NEW YORKNY10017
CROHN'S & COLITIS FOUNDATION INC
N/APCACHIEVING REMISSION IN IBD OPTIMIZING TREAT-TO-TARGET IN CLINICAL PRACTICE$739,745733 THIRD AVENUE SUITE 510NEW YORKNY10017
CROHN'S & COLITIS FOUNDATION INC
N/APCAPPLICATION OF MACHINE LEARNING TO PRECISION NUTRITION IN CROHNS DISEASE$626,728733 THIRD AVENUE SUITE 510NEW YORKNY10017
CROHN'S & COLITIS FOUNDATION INC
N/APCACCELERATING ENROLLMENT IN IBD CLINICAL TRIALS$375,484733 THIRD AVENUE SUITE 510NEW YORKNY10017
CROHN'S AND COLITIS UK
1 BISHOPS SQUAREHATFIELDUKN/APCIMPLEMENTATION OF A LOWER GI DIAGNOSTIC PATHWAY IN PRIMARY HEALTHCARE AND DEVELOPMENT AND DISSEMINATION OF A LOWER GI PATIENT TOOLKIT$170,782
CROHN'S COLITIS CURE
100 HARRIS STREETPYRMONT NSWASN/APCENHANCING INFLAMMATORY BOWEL DISEASE CARE CONSUMER-CENTRIC PORTAL FOR BETTER COMMUNICATION & REDUCED NAVIGATION STRESS$991,768
DARTMOUTH- HITCHCOCK CLINIC
N/APCCAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM$268,958ONE MEDICAL CENTER DRIVELEBANONNH03756
DEUTSCHE WELTHUNGERHILFE EV
FRIEDRICH-EBERT-STRABE 1BONN BAD GODESBERGGMN/APCHOLISTICALLY ADDRESSING AGROBUSINESS$892,391
DEUTSCHE WELTHUNGERHILFE EV
FRIEDRICH-EBERT-STRAE 1BONN BAD GODESBERGGMN/APCHOLISTICALLY ADDRESSING AGROBUSINESS$1,079,659
DIABETES AUSTRALIA
19-23 MOORE STREET GROUND FLOORTURNERASN/APCIMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES, THROUGH GEOGRAPHIC EXPANSION AND COUNTRY DATA-DRIVEN INITIATIVES.$2,443,661
DUKE UNIVERSITY
N/APCNOVEL ASSAYS FOR PROGLUCAGON PEPTIDES TO UNDERSTAND ALPHA CELL FUNCTION IN HEALTH AND DIABETES$275,0962200 WEST MAIN STREET SUITE 1000DURHAMNC27705
EMORY UNIVERSITY
N/APCCARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION$283,0991599 CLIFTON ROAD NEATLANTAGA303224250
ENGINEERING MINISTRIES INTERNATIONAL USA
N/APCMINGA MISSION HOSPITAL DEVELOPMENT$2,112,7457025 CAMPUS DRIVECOLORADO SPRINGSCO80920
ENGINEERING MINISTRIES INTERNATIONAL USA
N/APCMINGA MISSION HOSPITAL DEVELOPMENT$1,089,5427025 CAMPUS DRIVECOLORADO SPRINGSCO80920
FJC
N/APCTHE WELLNESS CLASSROOM, A PROJECT OF FJC - A FOUNDATION OF PHILANTHROPIC FUNDS$1,000,000225 WEST 39TH STREETNEW YORKNY10018
FJC
N/APCNYC FUND TO END YOUTH & FAMILY HOMELESSNESS, A PROJECT OF FJC.$300,000225 WEST 39TH STREETNEW YORKNY10018
FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY (FIRST)
N/APCFIRST SENIOR MENTOR PROGRAM$200,000200 BEDFORD STREETMANCHESTERNH03101
GALILEE MEDICAL CENTER
BEN ZVI BLVD POB 21NAHARIYAISN/AGOVRENOVATION OF ONE FLOOR OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER$750,000
GATES PHILANTHROPY PARTNERS
N/APCPOLIO ERADICATION FUND SUPPORT$1,000,000PO BOX 60555CITY OF INDUSTRYCA91716
GENETIC ALLIANCE INC
N/APCIHOPE GENETIC HEALTH$250,00025904 WOODFIELD ROADDAMASCUSMD20872
GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE
WELLCOME GENOME CAMPUSCAMBRIDGEUKN/APCSCIBD-RESPONSE MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE$143,892
GEOSCIENCE AUSTRALIA
101 JERRABOMBERRA AVESYMONSTONASN/AGOVDIGITAL EARTH AFRICA - SUSTAINABLE UPTAKE AND IMPACT$2,737,545
GRANTMAKERS FOR EFFECTIVE ORGANIZATIONS
N/APCGENERAL OPERATING SUPPORT$18,9201310 L STREET NWWASHINGTONDC20005
HAWAI'I HEALTH SYSTEMS CORP KAUA'I REGION FOR VETERANS MEMORIAL HOSP
N/AGOVMEDICAL SIMULATION AT KAUA'I VETERANS MEMORIAL HOSPITAL$250,0004643 WAIMEA CANYON DRIVEWAIMEAHI96796
HEALING HANDS OF JOY
N/APCELIMINATION OF OBSTETRIC FISTULA$335,0004747 HEDGEMORE DRCHARLOTTENC28209
HEALING HANDS OF JOY
N/APCELIMINATION OF OBSTETRIC FISTULA$165,0004747 HEDGEMORE DRCHARLOTTENC28209
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCCONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$2,482,836
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCCONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$3,716,830
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCCONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$3,716,830
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCCONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$5,172,033
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCCONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS$5,172,032
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$1,550,379
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$1,550,379
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$1,353,865
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$1,353,865
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$1,821,858
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$1,821,858
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)$526,471
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$4,829,040
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$4,829,040
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$5,755,302
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$5,755,301
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$5,917,762
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$5,917,761
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$4,393,010
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$4,393,009
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$3,565,907
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$3,465,906
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$1,665,293
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A)$1,665,293
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCTHE GPPAD-03 STUDY THE PRIMARY ORAL INSULIN TRIAL$4,328,576
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCGPPAD COORDINATION CENTER CONTINUATION 2025-2029$1,299,716
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCGPPAD COORDINATION CENTER CONTINUATION 2025-2029$1,382,183
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCGPPAD COORDINATION CENTER CONTINUATION 2025-2029$912,527
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCGPPAD COORDINATION CENTER CONTINUATION 2025-2029$1,272,469
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCGPPAD COORDINATION CENTER CONTINUATION$1,176,451
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCEUROPEAN PRE-T1D REGISTRY$37,585
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
INGOLSTDTER LANDSTRAE 1NEUHERBERGGMN/APCGPPAD BIOSAMPLE RFP$912,618
HENRY J KAISER FAMILY FOUNDATION
N/APCKFF HEALTH NEWS RURAL HEALTH DESK$1,566,728185 BERRY STREET NO 2000SAN FRANCISCOCA94107
HENRY J KAISER FAMILY FOUNDATION
N/APCKFF HEALTH NEWS RURAL HEALTH DESK$1,612,177185 BERRY STREET NO 2000SAN FRANCISCOCA94107
HERLEV OG GENTOFTE HOSPITAL
HERLEV RINGVEJ 75 OPG115HERLEVDAN/AGOVTARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D$140,000
HIGH QUALITY MEDICAL EDUCATION
N/APCPOINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR NORTH DAKOTA RURAL PROVIDERS$1,183,4894117 PENFIELD CT SAFTONMN55001
HIGH QUALITY MEDICAL EDUCATION
N/APCPOINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR NORTH DAKOTA RURAL PROVIDERS$1,213,3184117 PENFIELD CT SAFTONMN55001
HIGH QUALITY MEDICAL EDUCATION
N/APCPOINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS$1,705,2254117 PENFIELD CT SAFTONMN55001
HILLEL THE FOUNDATION FOR JEWISH CAMPUS LIFE
N/APCGENERAL OPERATING SUPPORT$10,000180 S GARNER STREETSTATE COLLEGEPA16804
HOLON INSTITUTE OF TECHNOLOGY - HIT (RA)
52 GOLOMB STHOLONISN/APCMEDICAL TECHNOLOGIES BUILDING AT THE HOLON INSTITUTE OF TECHNOLOGY (HIT)$2,725,000
HOLON INSTITUTE OF TECHNOLOGY - HIT
52 GOLOMB STHOLONISN/APCMEDICAL TECHNOLOGIES BUILDING AT THE HOLON INSTITUTE OF TECHNOLOGY (HIT)$2,043,650
HUMBOLDT COUNTY MEMORIAL HOSPITAL
N/AGOVTELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL$15,7751000 N 15TH STHUMBOLDTIA50548
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCTHE WOMEN WITH INFLAMMATORY BOWEL DISEASE AND MOTHERHOOD (WISDOM) REGISTRY A PROSPECTIVE STUDY OF FEMALE FERTILITY IN IBD$580,3061 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCTHE WOMEN WITH INFLAMMATORY BOWEL DISEASE AND MOTHERHOOD (WISDOM) REGISTRY A PROSPECTIVE STUDY OF FEMALE FERTILITY IN IBD$597,2441 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCCOMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHNS DISEASE [CATHARSIS TRIAL]$531,9661 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCCOMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHNS DISEASE [CATHARSIS TRIAL]$520,1411 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCTHE REFLECTION STUDY PREDICTING OUTCOMES FOLLOWING ILEOCECAL RESECTION IN CROHNS DISEASE.$535,4121 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCTHE REFLECTION STUDY PREDICTING OUTCOMES FOLLOWING ILEOCECAL RESECTION IN CROHNS DISEASE.$1,367,1901 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCEARLY LIFE EXPOSOME BIOMARKERS AND CROHN'S DISEASE RISK THE EARLY-CD PROJECT$663,6101 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCTHE USE OF GLP-1R AGONISTS TO PROMOTE EPITHELIAL HEALING IN CROHNS DISEASE$1,232,1701 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCTHE USE OF GLP-1R AGONISTS TO PROMOTE EPITHELIAL HEALING IN CROHNS DISEASE$809,8991 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCDEFINING THE PRE-DISEASE PHASE OF CROHNS DISEASE PREDICT AND PREVENT$587,1521 GUSTAVE L LEVY PLNEW YORK CITYNY10029
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
N/APCDEVELOPMENT OF NOVEL LRRK2 INHIBITORS TO TREAT CROHNS DISEASE$583,8801 GUSTAVE L LEVY PLNEW YORK CITYNY10029
IDA COUNTY IOWA COMMUNITY HOSPITAL
N/APCTELE-EMERGENCY SERVICES AT HORN MEMORIAL HOSPITAL$17,875701 EAST SECOND STREETIDA GROVEIA51445
IMPROVECARENOW INC
N/APCIMPLEMENTING THE COMBINE TRIAL RESULTS IN THE IMPROVECARENOW (ICN) LEARNING HEALTH NETWORK$872,4064 CARMICHAEL ST UNIT 111ESSEX JUNCTIONVT05452
IMPROVECARENOW INC
N/APCIMPLEMENTING THE COMBINE TRIAL RESULTS IN THE IMPROVECARENOW (ICN) LEARNING HEALTH NETWORK$771,9484 CARMICHAEL ST UNIT 111ESSEX JUNCTIONVT05452
INNODIA
HERESTRAAT 49LEUVENBEN/APCINNODIA NONPROFIT LAUNCH$426,278
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
1 RUE LOUIS RECHDUDELANGELUN/AGOVBIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL$85,150
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
1 RUE LOUIS RECHDUDELANGELUN/AGOVGPPAD BIOBANK - SINT1A$108,058
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
1 RUE LOUIS RECHDUDELANGELUN/AGOVGPPAD BIOBANK - SINT1A$77,919
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
1 RUE LOUIS RECHDUDELANGELUN/AGOVGPPAD BIOBANK - SINT1A$116,852
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
1 RUE LOUIS RECHDUDELANGELUN/AGOVGPPAD BIOBANK - SINT1A$160,613
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
86 RUE REGNAULTPARISFRN/AGOVFROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES HLA-A- VS. HLA-B-RESTRICTED CD8 T-CELL BIOMARKERS OF PROGRESSION$278,787
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
86 RUE REGNAULTPARISFRN/AGOVFROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES HLA-A- VS. HLA-B-RESTRICTED CD8 T-CELL BIOMARKERS OF PROGRESSION$186,090
INSTITUTE FOR COMMUNITY LIVING INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000125 BROAD STREETNEW YORK CITYNY10004
INSTITUTE FOR COMMUNITY LIVING INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000125 BROAD STREETNEW YORK CITYNY10004
INSTITUTE FOR COMMUNITY LIVING INC
N/APCPILOTING A THREE-YEAR IMT/ACT STEP-DOWN PROJECT$749,790125 BROAD STREETNEW YORK CITYNY10004
INSULIN FOR LIFE USA INC
N/APCSTRENGTHENING ORGANIZATIONAL CAPACITY II$215,7002555 SW 76TH STREET 130GAINESVILLEFL32608
INSULIN FOR LIFE USA INC
N/APCSTRENGTHENING ORGANIZATIONAL CAPACITY II$50,0002555 SW 76TH STREET 130GAINESVILLEFL32608
INSULIN FOR LIFE USA INC
N/APCSTRENGTHENING ORGANIZATIONAL CAPACITY II$100,0002555 SW 76TH STREET 130GAINESVILLEFL32608
INSULIN FOR LIFE USA INC
N/APCSTRENGTHENING ORGANIZATIONAL CAPACITY II$165,7002555 SW 76TH STREET 130GAINESVILLEFL32608
INSULIN FOR LIFE USA INC
N/APCSTRENGTHENING ORGANIZATIONAL CAPACITY II$265,7002555 SW 76TH STREET 130GAINESVILLEFL32608
INTERNATIONAL ALLIANCE FOR DIABETES ACTION INC
N/APCSEED FUNDING SUPPORT$971,68475 STATE STREETBOSTONMA02109
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
HARKORTSTR 1MUNSTERGMN/ANCDEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION GLOBALLY (IBUS EIUS ED)$296,500
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
HARKORTSTR 1MUNSTERGMN/ANCTHE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND)$688,466
INTERNATIONAL WATER MANAGEMENT INSTITUTE
127 SUNIL MAWATHABATTARAMULLACEN/APCDIGITAL INNOVATIONS FOR A WATER SECURE AFRICA$1,550,680
INT'L BANK FOR RECONSTRUCTION & DEV AND INT'L DEVELOPMENT ASSOC
N/APCHEALTH SYSTEM TRANSFORMATION AND RESILIENCE MULTI-DONOR TRUST FUND - NONCOMMUNICABLE DISEASE PARTNERSHIP GENERAL OPERATING SUPPORT$2,500,0001818 H STREET NWWASHINGTONDC20433
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCTRIAL EVALUATING THE EFFECT OF INHALED TECHNOSPHERE INSULIN VERSUS RAPID ACTING ANALOGUE INSULIN ON EXERCISE-INDUCED HYPOGLYCEMIA IN ADULTS WITH T1D$191,81615310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCVIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING$273,88215310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY$309,89515310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY$299,92115310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY$531,92115310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCPREGNANCY DATA REPOSITORY TO ASSESS MANAGEMENT OF TYPE 1 DIABETES WITH DIABETES TECHNOLOGY (PRAM-T1D)$1,256,04415310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCPREGNANCY DATA REPOSITORY TO ASSESS MANAGEMENT OF TYPE 1 DIABETES WITH DIABETES TECHNOLOGY (PRAM-T1D)$1,223,06615310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCCGM FOR THE EARLY DETECTION AND MANAGEMENT OF DYSGLYCEMIA IN PREGNANCY (IMAGINE)$1,108,48215310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCCGM FOR THE EARLY DETECTION AND MANAGEMENT OF DYSGLYCEMIA IN PREGNANCY (IMAGINE)$1,131,14015310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCEDUCATIONAL INTERVENTION TO SUPPORT DIABETES GUIDANCE FOR EXERCISE (EDGE)$805,38515310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
N/APCEXERCISE IN DIABETES INITIATIVE LARGE ADULT STUDY$159,83815310 AMBERLY DRIVE SUITE 350TAMPAFL33647
JDRF AUSTRALIA
80-84 CHANDOS STREETSYDNEYASN/APCENDIA FOLLOW UP 2023-2025 SAMPLES ANALYSIS RFA$448,818
JERUSALEM FOUNDATION INC
N/APCBUILDING A NEW HOME FOR TSAD KADIMA$500,000420 LEXINGTON AVENUENEW YORKNY10170
JEWISH BOARD OF FAMILY & CHILDREN'S SERVICES INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000463 7TH AVENEW YORKNY10018
JEWISH BOARD OF FAMILY & CHILDREN'S SERVICES INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000463 7TH AVENEW YORKNY10018
JOHNS HOPKINS UNIVERSITY
N/APCTARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS$571,287733 NORTH BROADWAY MRB 117BALTIMOREMD21205
JOSLIN DIABETES CENTER INC
N/APCAN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES$287,280ONE JOSLIN PLACEBOSTONMA02215
KAISER FOUNDATION HEALTH PLAN OF GEORGIA INC
N/APCEXPANSION OF THE T1DES PILOT TO A PUBLIC HOSPITAL$213,7761375 PEACHTREE STREET NEATLANTAGA30309
KATHOLIEKE UNIVERSITEIT TE LEUVEN
WAAISTRAAT 6 BOX 5105LEUVENBEN/APCTARGETING CHRONIC INFLAMMATION AND TISSUE REMODELLING IN CROHN'S DISEASE WITH ENGINEERED T CELLS$389,044
KATHOLIEKE UNIVERSITEIT TE LEUVEN
WAAISTRAAT 6 BOX 5105LEUVENBEN/APCCOMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE THE OATS STUDY$490,041
KATHOLIEKE UNIVERSITEIT TE LEUVEN
WAAISTRAAT 6 BOX 5105LEUVENBEN/APCEMBODY EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY$199,460
KATHOLIEKE UNIVERSITEIT TE LEUVEN
WAAISTRAAT 6 BOX 5105LEUVENBEN/APCEMBODY EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY$205,983
KATHOLIEKE UNIVERSITEIT TE LEUVEN
WAAISTRAAT 6 BOX 5105LEUVENBEN/APCFAT AS A VILLAIN IN CROHN'S DISEASE.$1,344,948
KATHOLIEKE UNIVERSITEIT TE LEUVEN
WAAISTRAAT 6 BOX 5105LEUVENBEN/APCEDENT1FI$1,555,353
KATHOLIEKE UNIVERSITEIT TE LEUVEN
WAAISTRAAT 6 BOX 5105LEUVENBEN/APCEDENT1FI$944,656
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCT CELL RECEPTOR SEQUENCING IN TYPE 1 DIABETES - BIOMARKER DISCOVERY AND TECHNOLOGY DEVELOPMENT$115,097
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCHYPO - RESOLVE - EVALUATION OF BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA$307,779
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCRESOLVING HARMFUL ACCUMULATION OF INNATE LYMPHOID CELLS DURING CROHNS DISEASE.$325,389
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCCHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6) SUBJECTS$260,566
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCCHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6) SUBJECTS$218,298
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCPRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY)$805,337
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCPRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY)$579,408
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III$1,069,889
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III$1,079,926
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III$1,147,254
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III$1,296,483
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III$1,325,562
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III$369,984
KING'S COLLEGE LONDON
150 STAMFORD STREETLONDONUKN/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III$778,535
KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN
FEODOR-LYNEN-STRAE 17MUNCHENGMN/AGOVFECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE$949,869
KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITT MNCHEN
FEODOR-LYNEN-STRABE 17MUNCHENGMN/AGOVFECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE$907,027
KYLER CARES FOUNDATION
N/APCCAPACITY BUILDING SUPPORT$495,0008070 CROWDER BOULEVARD SUITE BNEW ORLEANSLA70126
KYLER CARES FOUNDATION
N/APCCAPACITY BUILDING SUPPORT$251,7008070 CROWDER BOULEVARD SUITE BNEW ORLEANSLA70126
LIVING WATER INTERNATIONAL
N/APCSCALING INTEGRATED WASH SERVICES$2,432,3374001 GREENBRIAR DRIVESTAFFORDTX77477
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
N/APCACCELERATING PROGRESS AND PROMOTING QUALITY T1D CARE FOR THE POOREST BILLION THROUGH THE GLOBAL PEN-PLUS PARTNERSHIP$8,560,47775 FRANCIS STREETBOSTONMA02115
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
N/APCACCELERATING PROGRESS AND PROMOTING QUALITY T1D CARE FOR THE POOREST BILLION THROUGH THE GLOBAL PEN-PLUS PARTNERSHIP$9,684,66175 FRANCIS STREETBOSTONMA02115
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
N/APCREAL-TIME POST-OP TOUCHLESS, REMOTE MONITORING IN CROHNS DISEASE THE SAPPHIRE TRIAL$1,445,27275 FRANCIS STREETBOSTONMA02115
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
N/APCREAL-TIME POST-OP TOUCHLESS, REMOTE MONITORING IN CROHNS DISEASE THE SAPPHIRE TRIAL$767,14175 FRANCIS STREETBOSTONMA02115
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
N/APCU.S. PREVENTIVE TYPE 1 DIABETES COALITION$469,40675 FRANCIS STREETBOSTONMA02115
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
N/APCU.S. PREVENTIVE TYPE 1 DIABETES COALITION$429,47575 FRANCIS STREETBOSTONMA02115
MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL
N/APCU.S. PREVENTIVE TYPE 1 DIABETES COALITION$320,34175 FRANCIS STREETBOSTONMA02115
MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL
N/APCVALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE$123,92255 FRUIT STREETBOSTONMA021142696
MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL
N/APCVALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE$65,21855 FRUIT STREETBOSTONMA021142696
MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL
N/APCVALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE$781,61355 FRUIT STREETBOSTONMA021142696
MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL
N/APCVALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE$734,20255 FRUIT STREETBOSTONMA021142696
MAYO CLINIC
N/APCMILITARY SCIENCES MEDICAL TRAINING 2024-2026$249,920200 FIRST STREET SWROCHESTERMN55905
MEDICAL UNIVERSITY OF SOUTH CAROLINA
N/AGOVENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES$384,392179 ASHLEY AVENUECHARLESTONSD29425
MICHIGAN STATE UNIVERSITY
N/APCA C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH TYPE 1 DIABETES$896,270426 AUDITORIUM ROAD ROOM 2EAST LANSINGMI488242601
MILLE LACS HEALTH SYSTEM
N/APCTELE-PHARMACY AT MILLE LACS HEALTH SYSTEM$6,809200 ELM STREET NORTHONAMIAMN56359
MINNESOTA RURAL HEALTH ASSOCIATION
N/APCSONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA$378,70027011 460TH AVEHENNINGMN56551
MINNESOTA STATE COLLEGES AND UNIVERSITIES
N/AGOVEXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA$205,28530 E 7TH STREETST PAULMN55101
MONTANA PEDIATRICS
N/ANCCREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D$536,186259 W FRONT STREETMISSOULAMT59802
NATIONAL ACADEMY OF SCIENCES
N/APCSTRENGTHENING MINORITY SERVING INSTITUTIONS$150,000500 5TH STREET NWWASHINGTONDC20001
NATIONAL ASSOCIATION OF SCHOOL NURSES INC
N/APCPROVIDING COORDINATED CARE AND CAPTURING OUTCOMES FOR STUDENTS WITH T1D SCHOOL NURSE-LED PILOT PROJECT$1,110,7871100 WAYNE AVESILVER SPRINGMD20910
NATURAL AREAS CONSERVANCY INC
N/APCSTRENGTHENING NYC'S URBAN FOREST PLAN NATURAL AREAS$206,8681234 FIFTH AVENUENEW YORKNY10029
NCD ALLIANCE
31-33 AVENUE GIUSEPPE MOTTAGENEVASZN/APC2023-2025 PARTNERSHIP$1,759,350
NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES
N/AGOVNEVADA FIRST RESPONDER AED PROJECT$60,6704126 TECHNOLOGY WAYCARSON CITYNV89706
NEW VENTURE FUND
N/APCTYPE 1 DIABETES CAMPS PROJECT (2025-2028)$1,894,0371828 L STREET NW SUITE 300-AWASHINGTONDC20036
NEW VENTURE FUND
N/APCTYPE 1 DIABETES CAMPS PROJECT (2025-2028)$1,842,8981828 L STREET NW SUITE 300-AWASHINGTONDC20036
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
N/APCPROJECT ASAP BUILDING CAPACITY FOR SUPPORTIVE HOUSING FACILITATION AND BRIDGE CARE IN NYC'S PUBLIC HOSPITALS$800,00050 WATER STREETNEW YORKNY10004
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
N/APCPROJECT ASAP BUILDING CAPACITY FOR SUPPORTIVE HOUSING FACILITATION AND BRIDGE CARE IN NYC'S PUBLIC HOSPITALS$800,00050 WATER STREETNEW YORKNY10004
NEW YORK RESTORATION PROJECT
N/APCNYC URBAN REFORESTATION & EXPANSION$306,464254 WEST 31ST STREETNEW YORKNY10001
NEW YORK RESTORATION PROJECT
N/APCNYC URBAN REFORESTATION & EXPANSION$250,000254 WEST 31ST STREETNEW YORKNY10001
NEW YORK UNIVERSITY
N/APCANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS$100,307665 BROADWAY SUITE 801NEW YORKNY10012
NEW YORK UNIVERSITY
N/APCANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS$40,419665 BROADWAY SUITE 801NEW YORKNY10012
NEW YORK UNIVERSITY
N/APCANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS$55,372665 BROADWAY SUITE 801NEW YORKNY10012
NEW YORK UNIVERSITY
N/APCTAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH$1,360,453665 BROADWAY SUITE 801NEW YORKNY10012
NORTH DAKOTA STATE UNIVERSITY
N/AGOVEXPANDING RURAL SONOGRAPHY EXPERTISE IN NORTH DAKOTA$1,295,7111301 12TH AVENUE NFARGOND58102
NORTH DAKOTA STATE UNIVERSITY
N/AGOVEXPANDING RURAL SONOGRAPHY EXPERTISE IN NORTH DAKOTA$494,1551301 12TH AVENUE NFARGOND58102
OAKLAND UNIVERSITY
N/AGOVA COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2)$1,139,6292200 NORTH SQUIRREL ROADROCHESTERMI48309
OAKLAND UNIVERSITY
N/AGOVA COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2)$1,019,1812200 NORTH SQUIRREL ROADROCHESTERMI48309
OREGON HEALTH & SCIENCE UNIVERSITY
N/AGOVAN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT$1,783,3163181 SW SAM JACKSON PARK ROADPORTLANDOR972393098
PANORAMA GLOBAL
N/APCT1D COMMUNITY FUND STAGE II$1,535,9712101 FOURTH AVENUE SUITE 2100SEATTLEWA98121
PANORAMA GLOBAL
N/APCT1D COMMUNITY FUND STAGE II$1,444,8872101 FOURTH AVENUE SUITE 2100SEATTLEWA98121
PAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT INC
N/APCPAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT CAPACITY-BUILDING$268,067905 KALANIANAOLE HWYKAILUAHI96734
PAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT INC
N/APCPAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT CAPACITY-BUILDING$225,393905 KALANIANAOLE HWYKAILUAHI96734
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
N/APCUNDERSTANDING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES.$358,1401 LETTERMAN DRIVESAN FRANCISCOCA94129
PERKINS COUNTY HOSPITAL DISTRICT
N/AGOVTELE-EMERGENCY SERVICES FOR PERKINS COUNTY HEALTH SERVICES$14,706900 LINCOLN AVEGRANTNE69140
PROJECT CONCERN ZAMBIA LIMITED
PLOT 37/1PLUSAKAZAN/APCEMPOWERED CHILDREN AND ADOLESCENTS PROGRAM PLUS$1,590,680
PULITZER CENTER ON CRISIS REPORTING
N/APCINSIGHT AND CONNECTION THROUGH JOURNALISM AND EDUCATION$400,3711779 MASSACHUSETTS AVE NWWASHINGTONDC20036
PULITZER CENTER ON CRISIS REPORTING
N/APCINSIGHT AND CONNECTION THROUGH JOURNALISM AND EDUCATION$34,0971779 MASSACHUSETTS AVE NWWASHINGTONDC20036
RAMBAM HEALTH CORPORATION
HAALIA HASNIA 8HAIFAISN/APCISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CD.$746,990
REACHANOTHER FOUNDATION
N/APCEXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA$190,1861900 NE 3RD ST STE 106-307BENDOR97701
REACHANOTHER FOUNDATION
N/APCTRANSFORMING PEDIATRIC NEUROSURGERY SERVICES$1,119,9291900 NE 3RD ST STE 106-307BENDOR97701
REACHANOTHER FOUNDATION
N/APCTRANSFORMING PEDIATRIC NEUROSURGERY SERVICES$122,9781900 NE 3RD ST STE 106-307BENDOR97701
REGENTS OF THE UNIVERSITY OF MICHIGAN
N/APCHEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS$232,6623003 SOUTH STATE STREETANN ARBORMI48109
REGENTS OF THE UNIVERSITY OF MINNESOTA
N/AGOVCONTINUING DEVELOPMENT OF OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES$269,189200 OAK STREET SEMINNEAPOLISMN554552070
REGENTS OF THE UNIVERSITY OF MINNESOTA
N/AGOVENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES (PHASE 3)$502,750200 OAK STREET SEMINNEAPOLISMN554552070
REGENTS OF THE UNIVERSITY OF MINNESOTA
N/AGOVSTANDARDIZED MICROBIOTA TRANSPLANT THERAPY IN CROHNS DISEASE. PILOT TRIAL.$1,454,586200 OAK STREET SEMINNEAPOLISMN554552070
REGENTS OF THE UNIVERSITY OF MINNESOTA
N/AGOVSTANDARDIZED MICROBIOTA TRANSPLANT THERAPY IN CROHNS DISEASE. PILOT TRIAL.$585,172200 OAK STREET SEMINNEAPOLISMN554552070
REGENTS OF THE UNIVERSITY OF MINNESOTA
N/AGOVTHERAPEUTIC USE OF PEPTIDEMHC MABS FOR T1D$220,565200 OAK STREET SEMINNEAPOLISMN554552070
REGENTS OF THE UNIVERSITY OF MINNESOTA
N/AGOVTHERAPEUTIC USE OF PEPTIDEMHC MABS FOR T1D$166,880200 OAK STREET SEMINNEAPOLISMN554552070
REGION HOVEDSTADEN
KONGENS VAENGE 2HILLERODDAN/AGOVCAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES?$113,358
RENOWN HEALTH FOUNDATION
N/APCRENOWN HEALTH TO BRING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TO NORTHERN NEVADA$243,0191155 MILL STRENONV89502
RESEARCH TRIANGLE INSTITUTE
N/APCUSING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS A STATEWIDE IMPLEMENTATION STUDY$826,3763040 EAST CORNWALLIS ROADDURHAMNC277092194
SAFE WATER NETWORK
N/APCSCALING SUSTAINABLE SAFE WATER ACCESS$1,932,000122 EAST 42ND STREETNEW YORKNY10168
SAFE WATER NETWORK
N/APCSCALING SUSTAINABLE SAFE WATER ACCESS$998,000122 EAST 42ND STREETNEW YORKNY10168
SANFORD RESEARCH
N/APCPLEDGE PHASE 3$583,3631305 W 18TH STSIOUX FALLSSD571040569
SANFORD RESEARCH
N/APCPLEDGE PHASE 3$1,093,1431305 W 18TH STSIOUX FALLSSD571040569
SANFORD WORLD CLINICS
N/APCPROGRAM DETEKTA DETECTING TYPE 1 DIABETES AND PREVENTING DIABETIC KETOACIDOSIS (DKA)$112,5231305 W 18TH STSIOUX FALLSSD57105
SANFORD WORLD CLINICS
N/APCPROGRAM DETEKTA DETECTING TYPE 1 DIABETES AND PREVENTING DIABETIC KETOACIDOSIS (DKA)$145,7521305 W 18TH STSIOUX FALLSSD57105
SEATTLE CHILDREN'S HOSPITAL
N/APCEXPANDING USE OF ENGINEERED TREGS IN T1D THERAPY (PHASE 4)$616,923PO BOX 5731 M/S S-200SEATTLEWA981455005
SHAARE ZEDEK MEDICAL CENTER
12 SHMUEL BAIT STREETJERUSALEMISN/APCDEVELOPMENT OF THE HELMSLEY COMPREHENSIVE CARDIAC CARE CENTER$1,500,000
SHAARE ZEDEK MEDICAL CENTER
12 SHMUEL BAIT STREETJERUSALEMISN/APCDEVELOPMENT OF THE HELMSLEY COMPREHENSIVE CARDIAC CARE CENTER$2,000,000
SHAARE ZEDEK MEDICAL CENTER
12 SHMUEL BAIT STREETJERUSALEMISN/APCDEVELOPMENT OF THE HELMSLEY SURGICAL WING$2,500,000
SHAARE ZEDEK MEDICAL CENTER
12 SHMUEL BAIT STREETJERUSALEMISN/APCDEVELOPMENT OF THE HELMSLEY SURGICAL WING$3,500,000
SHARE TRUST INC
N/APCBUILDING COMMUNITY DRIVEN COLLECTIVE ACTION$1,540,658310 DEDHAM STDOVERMA02030
SHATTERPROOF A NONPROFIT CORP
N/APCGENERAL OPERATING SUPPORT$170,000101 MERRITT 7 CORPORATE PARK 1STNORWALKCT06851FLOOR
SIMULATION IN MOTION MONTANA INC
N/APCSIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY$100,0002021 11TH AVE SUITE 1HELENAMT59601
SNV NETHERLANDS DEVELOPMENT ORGANISATION
PARKSTRAAT 83DEN HAAGNLN/APCSCALING THE HEALTHY FUTURE FOR ALL MODEL$1,144,205
SNV NETHERLANDS DEVELOPMENT ORGANISATION
PARKSTRAAT 83DEN HAAGNLN/APCSCALING THE HEALTHY FUTURE FOR ALL MODEL$626,684
SOLIDARIDAD NETWORK FOUNDATION LIMITED
163 KUDU ROADLUSAKAZAN/APCHOOVES FOR SUSTAINABILITY (H4S)$273,384
ST LUKE HEALTH CARE FOUNDATION
N/APCHOPE CENTER FOR WOMEN AND CHILDREN$4,790,31628W609 HICKORY LNWEST CHICAGOIL60185
ST LUKE HEALTH CARE FOUNDATION
N/APCHOPE CENTER FOR WOMEN AND CHILDREN$1,908,52428W609 HICKORY LNWEST CHICAGOIL60185
ST MARK'S HOSPITAL FOUNDATION
ACTON LANELONDONUKN/APCPERIANAL CROHNS DISEASE (PCD) EDUCATIONAL MEETING AND TOPCLASS CONSORTIUM MEMBER CONFERENCE$164,712
ST ROSE DOMINICAN HEALTH FOUNDATION
N/ASOIDIGNITY HEALTH-ST. ROSE DOMINICAN - SIENA CAMPUS CATH LAB REVITALIZATION PROJECT$172,840102 E LAKE MEAD PARKWAYHENDERSONNV89015
ST ROSE DOMINICAN HEALTH FOUNDATION
N/ASOIDIGNITY HEALTH-ST. ROSE DOMINICAN - SIENA CAMPUS CATH LAB REVITALIZATION PROJECT$87,671102 E LAKE MEAD PARKWAYHENDERSONNV89015
ST ROSE DOMINICAN HEALTH FOUNDATION
N/ASOIDIGNITY HEALTH - ST. ROSE DOMINICAN - SIENA CAMPUS ECMO PROGRAM$101,195102 E LAKE MEAD PARKWAYHENDERSONNV89015
ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH
9 PRINCES STMELBOURNEASN/APCWHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D?$255,857
STATE UNIVERSITY OF IOWA FOUNDATION
N/APCSIMULATION IN MOTION-IOWA ENDOWMENT$135,000ONE WEST PARK ROADIOWA CITYIA52242
STATE UNIVERSITY OF IOWA FOUNDATION
N/APCSIMULATION IN MOTION-IOWA ENDOWMENT$135,000ONE WEST PARK ROADIOWA CITYIA52242
STATE UNIVERSITY OF IOWA FOUNDATION
N/APCSIMULATION IN MOTION-IOWA ENDOWMENT$130,000ONE WEST PARK ROADIOWA CITYIA52242
STICHTING ACCESS TO MEDICINE FOUNDATION
NARITAWEG 227 SUITE AAMSTERDAMNLN/APCEXPANDING ACCESS TO DIABETES CARE$1,000,000
STICHTING ACCESS TO MEDICINE FOUNDATION
NARITAWEG 227 SUITE AAMSTERDAMNLN/APCEXPANDING ACCESS TO DIABETES CARE$1,000,000
STICHTING HEALTH ACTION INTERNATIONAL
OVERTOOM 60/IIAMSTERDAMNLN/APCADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV$1,300,026
STICHTING HEALTH ACTION INTERNATIONAL
OVERTOOM 60/IIAMSTERDAMNLN/APCADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV$998,988
STICHTING PHARMACCESS INTERNATIONAL
AHTC TOWER C4 PAASHEUVELWEG 25AMSTERDAMNLN/APCSAFECARE A BUSINESS MODEL FOR HEALTHCARE QUALITY$538,692
STICHTING THE OCEAN CLEANUP
BATAVIERENSTRAAT 15ROTTERDAMNLN/APCDEVELOP AND SCALE TECHNOLOGIES TO RID THE OCEANS OF PLASTICS$5,000,000
STIFTELSEN FOR UTBILDNING (IOIBD)
LINKPING UNIVERSITY HOSPITAL FLOOROREBROSWN/APCTHE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD$132,00014
SUPPORTIVE HOUSING NETWORK OF NEW YORK INC
N/APCTRAINING ACADEMY AND COMMUNITY OF PRACTICE FOR SUPPORTIVE HOUSING PROVIDERS$251,200247 W 37TH STNEW YORK CITYNY10018
SUSTAINABLE COASTLINES HAWAII
N/APCSCALING SUSTAINABLE COASTLINES HAWAII BUILDING LEADERSHIP FOR LONG-TERM GROWTH AND IMPACT$274,7873160 WAIALAE AVEHONOLULUHI96816
SUSTAINABLE COASTLINES HAWAII
N/APCSCALING SUSTAINABLE COASTLINES HAWAII BUILDING LEADERSHIP FOR LONG-TERM GROWTH AND IMPACT$176,0003160 WAIALAE AVEHONOLULUHI96816
TAMPERE UNIVERSITY FOUNDATION SR
KALEVANTIE 4 33100TAMPEREFIN/APCENTEROVIRUS-INDUCED TYPE 1 DIABETES MECHANISMS AND BIOMARKERS FOR RISK$419,684
TAMPERE UNIVERSITY FOUNDATION SR
KALEVANTIE 4 33100TAMPEREFIN/APCENTEROVIRUS-INDUCED TYPE 1 DIABETES MECHANISMS AND BIOMARKERS FOR RISK$283,718
TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL
WEIZMANN ST 6TEL AVIVISN/AGOVCONSTRUCTION OF THE SHELTERED -5 FLOOR OF THE NORTH TOWER$5,120,490
TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL
WEIZMANN ST 6TEL AVIVISN/AGOVGENETICS INSTITUTE AND GENOMICS CENTER$2,538,786
TEL-AVIV UNIVERSITY
PO 39040TEL AVIVISN/APCHELMSLEY MEDICAL SIMULATION CENTER$6,828,500
TEL-AVIV UNIVERSITY
PO 39040TEL AVIVISN/APCHELMSLEY MEDICAL SIMULATION CENTER$1,524,350
TEL-AVIV UNIVERSITY
PO 39040TEL AVIVISN/APCHELMSLEY MEDICAL SIMULATION CENTER$1,324,350
THE ACADEMIC COLLEGE AT TEL-HAI
MOBILE POST 12210UPPER GALILEEISN/APCTHE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH$3,225,321
THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV
2012100 HALUTZRAMAT HANEGEVISN/APCRAMAT HANEGEV SENIOR CITIZEN CENTER$699,190
THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV
2012100 HALUTZRAMAT HANEGEVISN/APCRAMAT HANEGEV CENTRAL AUDITORIUM$1,109,829
THE BIONICS INSTITUTE OF AUSTRALIA
384-388 ALBERT STREETEAST MELBOURNEASN/APCPATIENT-SPECIFIC ADAPTIVE, ELECTRIC THERAPY FOR CROHNS DISEASE$932,181
THE BIONICS INSTITUTE OF AUSTRALIA
384-388 ALBERT STREETEAST MELBOURNEASN/APCPATIENT-SPECIFIC ADAPTIVE, ELECTRIC THERAPY FOR CROHNS DISEASE$477,568
THE BROAD INSTITUTE INC
N/APCUNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS$1,129,976415 MAIN STREETCAMBRIDGEMA02142
THE BROAD INSTITUTE INC
N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$3,499,051415 MAIN STREETCAMBRIDGEMA02142
THE BROAD INSTITUTE INC
N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$3,477,159415 MAIN STREETCAMBRIDGEMA02142
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
TRINITY LANECAMBRIDGEUKN/APCEPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE$718,215
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
TRINITY LANECAMBRIDGEUKN/APCCLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2)$353,223
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
TRINITY LANECAMBRIDGEUKN/APCDOES THE WESTERN DIET TRIGGER CROHN'S DISEASE VIA OSMOTIC STRESS?$726,752
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
TRINITY LANECAMBRIDGEUKN/APCNEW INSIGHTS INTO CROHN'S DISEASE FROM STUDYING NAKED MOLE RATS$347,219
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
TRINITY LANECAMBRIDGEUKN/APCDOES BIOCHEMISTRY AT THE CENTRE OF LIFE DRIVE CROHN'S DISEASE?$851,645
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
TRINITY LANECAMBRIDGEUKN/APCDOES BIOCHEMISTRY AT THE CENTRE OF LIFE DRIVE CROHN'S DISEASE?$820,911
THE CITY OF HOPE
N/APCCD318 MEDIATED REGULATION OF ISLET AUTOANTIGEN SPECIFIC T CELL IMMUNITY$371,8001500 E DUARTE RDDUARTECA91010
THE CLEVELAND CLINIC FOUNDATION
N/APCMECHANOBIOLOGY OF THE INTESTINAL EPITHELIAL BARRIER DISRUPTION IN CROHNS DISEASE$342,9559500 EUCLID AVENUECLEVELANDOH44195
THE CLEVELAND CLINIC FOUNDATION
N/APCENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM$719,0519500 EUCLID AVENUECLEVELANDOH44195
THE END FUND INC
N/APCTACKLING TRACHOMA SURGERY DISPARITIES$2,124,8802 PARK AVENUENEW YORKNY10016
THE END FUND INC
N/APCTACKLING TRACHOMA SURGERY DISPARITIES$2,132,3602 PARK AVENUENEW YORKNY10016
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
2500 UNIVERSITY DRIVE NWCALGARYCAN/APCA DRUG-WIDE SCAN TO IDENTIFY REPURPOSED MEDICATIONS FOR CROHN'S DISEASE$430,190
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
2500 UNIVERSITY DRIVE NWCALGARYCAN/APCA DRUG-WIDE SCAN TO IDENTIFY REPURPOSED MEDICATIONS FOR CROHN'S DISEASE$424,253
THE HOSPITAL FOR SICK CHILDREN
555 UNIVERSITY AVETORONTOCAN/APCIMMUNE RESPONSES TO GUT MICROBES ASSOCIATED WITH T1D RISK AND PROGRESSION$250,415
THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
EXHIBITION RDLONDONUKN/APCIMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION$340,788
THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
EXHIBITION RDLONDONUKN/APCIMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION$234,854
THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
EXHIBITION RDLONDONUKN/APCUNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE$1,081,289
THE LANIADO KIRIAT SANZ HOSPITAL
DIVREI KHAYIM ST 16NATANIYAISN/APCNEW MATERNITY FLOOR C$1,350,000
THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL LTD (CC)
YEZREEL VALLEYYEZREEL VALLEYISN/APCOPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS PURSUING NURSING DEGREES$200,000
THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL LTD (CC)
YEZREEL VALLEYYEZREEL VALLEYISN/APCOPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS PURSUING NURSING DEGREES$200,000
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE
N/APCDEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D$620,649120 THEORY SUITE 200IRVINECA926971050
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
N/APCMECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN$471,1319500 GILMAN DRIVELA JOLLACA92093
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
N/APCTHE DRUGGABLE GPCROME IN CROHNS DISEASE$1,092,7339500 GILMAN DRIVELA JOLLACA92093
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
N/APCIDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF A DATA COMMONS$458,242490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
N/APCIDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF A DATA COMMONS$217,916490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SANTA BARBARA
N/APCEXERCISE SPECIFIC AID ALGORITHM FOR TYPE 1 DIABETES$1,116,996552 UNIVERSITY ROADSANTA BARBARACA93106
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCEPITHELIAL MITOCHONDRIAL DYSFUNCTION AND EXTRACELLULAR VESICLES IN CROHNS DISEASE FIBROSTENOSIS.$431,48213001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCPREPARE 4 AID PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY$1,840,78613001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCPREPARE 4 AID PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY$996,48613001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCPRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE)$807,98913001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCPRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE)$706,93913001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCDEFINING HUMAN ISLET MYELOID CELL POPULATIONS THROUGH PROGRESSION OF TYPE 1 DIABETES$226,22913001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCDEFINING HUMAN ISLET MYELOID CELL POPULATIONS THROUGH PROGRESSION OF TYPE 1 DIABETES$239,81913001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCEPIGENOMIC BIOMARKERS OF THE INCOMPLETE MATERNAL PROTECTION IN TYPE 1 DIABETES$459,40113001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCEPIGENOMIC BIOMARKERS OF THE INCOMPLETE MATERNAL PROTECTION IN TYPE 1 DIABETES$329,69513001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCT AND B CELL RECEPTOR ATLAS ACROSS TISSUES AND STAGES OF TYPE 1 DIABETES$501,00013001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCIMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES)$1,036,51313001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCIMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES)$552,43313001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCIMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE$1,215,80313001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCIMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE$319,93713001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCASK THE EXPERTS 2024$499,99813001 E 17TH PLACEAURORACO800452571
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
N/APCASK THE EXPERTS 2024$499,99513001 E 17TH PLACEAURORACO800452571
THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNINGMCGILL UNIV
845 SHERBROOKE STREET WESTMONTREALCAN/APCDATA GOVERNANCE RESOURCE$185,694
THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNINGMCGILL UNIV
845 SHERBROOKE STREET WESTMONTREALCAN/APCDATA GOVERNANCE RESOURCE$182,394
THE SCRIPPS RESEARCH INSTITUTE
N/APCGUT-RETAINED NRF2/ARE ACTIVATORS FOR IBD$1,836,02210550 NORTH TORREY PINES ROADLA JOLLACA92037
THE SDEROT DEVELOPMENT FOUNDATION
6 BAR LEV STREETSDEROTISN/APCSDEROT MEDICAL CENTER$993,626
THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA)
2 KATZIRRAMAT GANISN/APCISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD)$188,118
THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA)
2 KATZIRRAMAT GANISN/APCTHE UTILITY OF HAND-HELD ULTRASOUND DEVICES TO DETECT BOWEL WALL INFLAMMATORY ACTIVITY IN CROHN'S DISEASE$84,659
THE SONIA NABETA FOUNDATION INC
N/APCWORLD OF WARRIORS$514,2104705 5TH STREET UNIT 405LONG ISLAND CITYNY11101
THE SONIA NABETA FOUNDATION INC
N/APCWORLD OF WARRIORS$578,4704705 5TH STREET UNIT 405LONG ISLAND CITYNY11101
THE TEL AVIV JAFFA ACADEMIC COLLEGE
RABENU YERUHAM ST 2 POB 8401TEL AVIV YAFFOISN/APCNEED-BASED SCHOLARSHIPS FOR NURSING STUDENTS$266,666
THE TREVOR PROJECT INC
N/APCLGBTQ YOUTH SUICIDE PREVENTION PROJECT$1,536,740PO BOX 69232WEST HOLLYWOODCA90069
THE TREVOR PROJECT INC
N/APCLGBTQ YOUTH SUICIDE PREVENTION PROJECT$1,282,735PO BOX 69232WEST HOLLYWOODCA90069
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
N/APCSUPPORT FOR T1D TRANSITION PROGRAMS$150,000615 WEST 131ST STREETNEW YORKNY100273922
THE UNIVERSITY OF ADELAIDE
NORTH TERRACEADELAIDEASN/APCPANCREATIC EXOCRINE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES IN YOUNG CHILDREN$43,631
THE UNIVERSITY OF EDINBURGH
SOUTH BRIDGEEDINBURGHUKN/APCREPURPOSING POSITIVE ALLOSTERIC MODULATORS OF GLUTAMATE RECEPTORS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES A PILOT CLINICAL STUDY$646,292
THE UNIVERSITY OF EDINBURGH
SOUTH BRIDGEEDINBURGHUKN/APCREPURPOSING POSITIVE ALLOSTERIC MODULATORS OF GLUTAMATE RECEPTORS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES A PILOT CLINICAL STUDY$426,524
THE UNIVERSITY OF MANCHESTER
OXFORD RDMANCHESTERUKN/APCA MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION$692,839
THE WEIZMANN INSTITUTE OF SCIENCE
234 HERZEL STREHOVOTISN/APCEARLY CHILDHOOD DEVELOPMENT AND COMMUNITY CENTER AT THE WEIZMANN INSTITUTE OF SCIENCE$3,000,000
THE WEIZMANN INSTITUTE OF SCIENCE
234 HERZEL STREHOVOTISN/APCQUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS$1,302,462
TRUSTEES OF INDIANA UNIVERSITY
N/AGOVTHE FINDING IMMUNE NASCENT DIABETES (FIND-T1D)$452,575509 EAST 3RD STREETBLOOMINGTONID474013654
TRUSTEES OF INDIANA UNIVERSITY
N/AGOVTHE FINDING IMMUNE NASCENT DIABETES (FIND-T1D)$475,212509 EAST 3RD STREETBLOOMINGTONID474013654
UNIVERSIT DEGLI STUDI DI MILANO
VIA FESTA DEL PERDONO 7MILANITN/AGOVUNRAVELING THE ROLE OF CD45RACCR7 CD4 T CELLS IN THE PATHOGENESIS OF TYPE 1 DIABETES$321,749
UNIVERSITA DEGLI STUDI DI MILANO
VIA FESTA DEL PERDONO 7MILANITN/AGOVUNRAVELING THE ROLE OF CD45RACCR7 CD4 T CELLS IN THE PATHOGENESIS OF TYPE 1 DIABETES$213,050
UNIVERSITE CATHOLIQUE DE LOUVAIN
PLACE DE LUNIVERSITE 1LOUVAINLANEUVEBEN/APCSEARCH FOR MECHANISMS RESPONSIBLE FOR THE IMPAIRED GLUCAGON SECRETION IN T1D AND FOR STRATEGIES TO CORRECT THEM$304,033
UNIVERSITE CATHOLIQUE DE LOUVAIN
PLACE DE LUNIVERSITE 1LOUVAINLANEUVEBEN/APCSEARCH FOR MECHANISMS RESPONSIBLE FOR THE IMPAIRED GLUCAGON SECRETION IN T1D AND FOR STRATEGIES TO CORRECT THEM$152,546
UNIVERSITE LIBRE DE BRUXELLES
AVENUE FRANKLIN ROOSEVELT 50BRUSSELSBEN/AGOVSTUDYING THE SELECTIVEB CELL SENSITIVITY TO A HOMOZYGOUS PD-L1 MUTATION IN NEONATAL DIABETES$217,239
UNIVERSITY HOSPITALS HEALTH SYSTEM INC
N/APCTYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS$677,70011100 EUCLID AVENUECLEVELANDOH44106
UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA
N/AGOVDEVELOPMENT OF AN EXTRACORPOREAL LIFE SUPPORT (ECLS) PROGRAM AT UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA$84,7831800 W CHARLESTON BLVDLAS VEGASNV89102
UNIVERSITY OF BIRMINGHAM
CHANCELLORS COURTBIRMINGHAMUKN/APCCREATING AN OPTIMISED ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES$479,888
UNIVERSITY OF BRISTOL
TYNDALL AVENUEBRISTOLUKN/APCTYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY$358,900
UNIVERSITY OF CINCINNATI
N/AGOVSTUDIES ON THE ROLE OF C-PEPTIDE TO REGULATE BLOOD GLUCOSE DURING SLEEP AND EXERCISE$429,70051 GOODMAN DRIVE SUITE 500CINCINNATIOH45221
UNIVERSITY OF EXETER
NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUKN/APCADVANCINGB-CELL SPECIFIC THERAPY BY IDENTIFYINGB-CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS$70,533
UNIVERSITY OF EXETER
NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUKN/APCEXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2 FROM OBSERVATION TO MECHANISM$465,868
UNIVERSITY OF EXETER
NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUKN/APCUNCOVERING NEW GENETIC MECHANISMS UNDERLYING EXTREME EARLY-ONSET TYPE 1 DIABETES$692,073
UNIVERSITY OF EXETER
NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUKN/APCUNCOVERING NEW GENETIC MECHANISMS UNDERLYING EXTREME EARLY-ONSET TYPE 1 DIABETES$189,671
UNIVERSITY OF EXETER
NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUKN/APCB CELL SIGNATURES IN TYPE 1 DIABETES$260,351
UNIVERSITY OF EXETER
NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUKN/APCB CELL SIGNATURES IN TYPE 1 DIABETES$40,825
UNIVERSITY OF FLORIDA
N/AGOVUNDERSTANDING T1D AND INSULIN-REQUIRING DIABETES IN FEDERALLY QUALIFIED HEALTH CENTERS (FQHC) A NATIONAL NEEDS ASSESSMENT$208,595219 GRINTER HALLGAINESVILLEFL326115500
UNIVERSITY OF FLORIDA
N/AGOVHUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION$586,219219 GRINTER HALLGAINESVILLEFL326115500
UNIVERSITY OF FLORIDA
N/AGOVHUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION$435,671219 GRINTER HALLGAINESVILLEFL326115500
UNIVERSITY OF GLASGOW COURT
UNIVERSITY AVENUEGLASGOWUKN/APCTHE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN SURGICAL ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION.$425,075
UNIVERSITY OF GLASGOW COURT
UNIVERSITY AVENUEGLASGOWUKN/APCTHE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN SURGICAL ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION.$1,968,566
UNIVERSITY OF GLASGOW COURT
UNIVERSITY AVENUEGLASGOWUKN/APCTHE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN SURGICAL ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION.$426,282
UNIVERSITY OF HAWAII
N/AGOVIMPROVING HEALTH ACROSS RURAL HAWAII THROUGH RESEARCH AND POLICY$193,4102444 DOLE STREETHONOLULUHI96822
UNIVERSITY OF HAWAII
N/AGOVIMPROVING HEALTH ACROSS RURAL HAWAII THROUGH RESEARCH AND POLICY$190,4342444 DOLE STREETHONOLULUHI96822
UNIVERSITY OF IOWA
N/AGOVSUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION$204,566112 NORTH CAPITOL STREETIOWA CITYIA52442
UNIVERSITY OF MELBOURNE
161 BARRY STREETVICTORIAASN/APCUSE OF WHEY PROTEIN TO REDUCE RISK OF HYPOGLYCEMIA DURING EXERCISE FOR PEOPLE WITH T1D$524,787
UNIVERSITY OF MIAMI
N/APCDEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES$282,0001320 SOUTH DIXIE HIGHWAY SUITE 650CORAL GABLESFL33146
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
N/AGOVFREQUENCY AND TITER OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AUTO-ANTIBODIES IN PATIENTS WITH CD-LIKE DISEASE OF THE POUCH$336,550104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC2759913501350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
N/AGOVFREQUENCY AND TITER OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AUTO-ANTIBODIES IN PATIENTS WITH CD-LIKE DISEASE OF THE POUCH$71,233104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC2759913501350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
N/AGOVPILOTING INTEGRATION OF PORTABLE ULTRASOUNDS$1,058,738104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC2759913501350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
N/AGOVDEVELOPMENT OF A CONTINUOUS INSULIN SENSOR$1,306,168104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC2759913501350
UNIVERSITY OF NORTH DAKOTA
N/AGOVSIMULATION IN MOTION (SIM) CONSORTIUM$54,6731301 N COLUMBIA RD SUITE E105GRAND FORKSND58202
UNIVERSITY OF OULU
PO BOX 8000OULUFIN/APCMATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING$135,549
UNIVERSITY OF PITTSBURGH
N/APCANALOGUE VS HUMAN INSULIN FOR YOUTH WITH TYPE 1 DIABETES IN LOW-RESOURCE SETTINGS A RANDOMIZED CONTROLLED TRIAL (ANHUT1D TRIAL)$307,8913420 FORBES AVENUEPITTSBURGHPA152603203
UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN
N/AGOVINCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN$200,9272304 WHITIS AVEAUSTINTX787121111
UNIVERSITY OF WASHINGTON
N/AGOVPATHOGENIC ACTION OF AUTOANTIBODIES ON ISLET FUNCTION AND VIABILITY IN TYPE 1 DIABETES$385,0004333 BROOKLYN AVENUE NESEATTLEWA981959472
UNIVERSITY OF WESTERN ONTARIO
339 WINDERMERE RDLONDONCAN/APCENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM$756,873
UNIVERSITY OF WESTERN ONTARIO
339 WINDERMERE RDLONDONCAN/APCENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM$606,448
UNIVERSITY OF WYOMING FOUNDATION
N/APCULTRASOUND TRAINING INITIATIVE IN WYOMING$458,857222 S 22ND STLARAMIEWY82070
UNIVERSITY OF WYOMING FOUNDATION
N/APCULTRASOUND TRAINING INITIATIVE IN WYOMING$458,857222 S 22ND STLARAMIEWY82070
UPPSALA UNIVERSITY HOSPITAL
AKADEMISKA SJUKHUSETUPPSALASWN/APCIMMUNE-EVASIVE ISLETS FOR TRANSPLANTATION$360,374
URBAN PATHWAYS INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000575 EIGHTH AVENEW YORKNY10018
URBAN PATHWAYS INC
N/APCCOLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE$100,000575 EIGHTH AVENEW YORKNY10018
VANDERBILT UNIVERSITY MEDICAL CENTER
N/APCEXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY$149,0503319 WEST END AVENUE SUITE 970NASHVILLETN37203
VANDERBILT UNIVERSITY MEDICAL CENTER
N/APCDEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA$104,5993319 WEST END AVENUE SUITE 970NASHVILLETN37203
VANDERBILT UNIVERSITY MEDICAL CENTER
N/APCADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES$232,5253319 WEST END AVENUE SUITE 970NASHVILLETN37203
VANDERBILT UNIVERSITY MEDICAL CENTER
N/APCADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES$182,1683319 WEST END AVENUE SUITE 970NASHVILLETN37203
VAYU HEALTH
N/APCPILOT TO DESIGN A VALUE BASED PAYMENT ECOSYSTEM TO IMPROVE HEALTH AND EQUITY FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES$318,00019 ALISO WAYPORTOLA VALLEYCA94028
VAYU HEALTH
N/APCVAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES$1,242,77719 ALISO WAYPORTOLA VALLEYCA94028
VAYU HEALTH
N/APCVAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES$2,000,00019 ALISO WAYPORTOLA VALLEYCA94028
VAYU HEALTH
N/APCVAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES$4,275,63219 ALISO WAYPORTOLA VALLEYCA94028
WASHINGTON UNIVERSITY
N/APCPRECLINICAL DEVELOPMENT TO ADVANCE A T1D ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D$1,319,3731 BROOKINGS DRIVESAINT LOUISMO63130
WATER4 INC
N/APCSCALING NUMA IN NORTHERN GHANA$2,294,4792405 NW 10TH STREETOKLAHOMA CITYOK73107
WATER4 INC
N/APCSCALING NUMA IN NORTHERN GHANA$2,647,4482405 NW 10TH STREETOKLAHOMA CITYOK73107
WEIZMANN INSTITUTE OF SCIENCE
POB 26REHOVOTISN/APCQUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS$1,397,538
WESTCHESTER JEWISH CENTER
N/APCGENERAL OPERATING SUPPORT$7,500175 ROCKLAND AVEMAMARONECKNY10543
WILCOX HEALTH FOUNDATION
N/APCWILCOX MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT$6,273,0003-3420 KUHIO HIGHWAYLIHUEHI96766
WILCOX HEALTH FOUNDATION
N/APCWILCOX MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT$409,0003-3420 KUHIO HIGHWAYLIHUEHI96766
WORLD HEALTH ORGANIZATION
AVENUE APPIA 20GENEVASZN/APCSTRENGTHENING INTEGRATED PREVENTION AND CONTROL OF CHRONIC AND SEVERE NCDS IN THE WHO AFRICAN REGION, USING T1D, SCD, ARF, AND RHD AS ENTRY POINTS$3,010,445
WORLD HEALTH ORGANIZATION
AVENUE APPIA 20GENEVASZN/APCSTRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT$3,130,872
WYOMING ASSOCIATION OF SHERIFFS AND CHIEFS OF POLICE
N/APCWYOMING VIRTUAL CRISIS CARE PILOT PROGRAM$851,113PO BOX 481DOUGLASWY82633
WYOMING ASSOCIATION OF SHERIFFS AND CHIEFS OF POLICE
N/APCWYOMING VIRTUAL CRISIS CARE PILOT PROGRAM$746,408PO BOX 481DOUGLASWY82633
YALE UNIVERSITY
N/APCTARGETING NEWLY DISCOVERED HOST-MICROBIOTA INTERACTION NODES TO TREAT OR PREVENT CROHNS DISEASE$605,522PO BOX 208327NEW HAVENCT065208327
YEHUDA ABARBANEL GOVERNMENT HOSPITAL
15 KEREN KAYEMET STBAT YAMISN/AGOVMODERNIZATION OF ABARBANELS INFORMATION TECHNOLOGY AND SECURITY SYSTEMS$454,960
YOUTH DEVELOPMENT ORGANIZATION INC
N/APCCAPACITY BUILDING PROJECT SUPPORT 2024-2026$200,00015 UNION STREET 563LAWRENCEMA01840
FieldValueIRS element (for citing)
Total Grant Or Contri Apprv Fut$482,120,897TotalGrantOrContriApprvFutAmt

Analysis Income Producing Acty AnalysisIncomeProducingActyGrp

Int On Sav And Temp Cash Invst IntOnSavAndTempCashInvstGrp

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$3,123,289ExclusionAmt

Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl

FieldValueIRS element (for citing)
Business901101BusinessCd
Unrelated Business Taxbl Incm$3,051,525UnrelatedBusinessTaxblIncmAmt
Exclusion14ExclusionCd
Exclusion$66,448,142ExclusionAmt

Other Investment Income OtherInvestmentIncomeGrp

FieldValueIRS element (for citing)
Business901101BusinessCd
Unrelated Business Taxbl Incm$14,231,233UnrelatedBusinessTaxblIncmAmt
Exclusion14ExclusionCd
Exclusion$11,117,546ExclusionAmt

Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp

FieldValueIRS element (for citing)
Business901101BusinessCd
Unrelated Business Taxbl Incm$3,193,622UnrelatedBusinessTaxblIncmAmt
Exclusion18ExclusionCd
Exclusion$385,444,220ExclusionAmt

Other Revenue Described OtherRevenueDescribedGrp (4 entries)

DescDescExclusionExclusionCdExclusionExclusionAmt
GRANT RECOVERIES01$7,276,276
OTHER NON-TAXABLE INCOME01$27,454
FEDERAL EXCISE TAX BENEFIT01$3,842,567
FX TRANSACTION NET LOSS - BOOK14-$496,216

Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp

FieldValueIRS element (for citing)
Unrelated Business Taxbl Incm$20,476,380UnrelatedBusinessTaxblIncmAmt
Exclusion$476,783,278ExclusionAmt
Related Or Exempt Function Incm$0RelatedOrExemptFunctionIncmAmt
FieldValueIRS element (for citing)
Total Income Producing Acty$497,259,658TotalIncomeProducingActyAmt

Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp

FieldValueIRS element (for citing)
Trnsfr Of Cash To Nonchrtbl EOYes (1)TrnsfrOfCashToNonchrtblEOInd
Trnsfr Other Asset Nonchrtbl EO0TrnsfrOtherAssetNonchrtblEOInd
Sales Or Exchanges Of Assets0SalesOrExchangesOfAssetsInd
Purchase Of Assets Nonchrtbl EO0PurchaseOfAssetsNonchrtblEOInd
Rental Of Facilities Oth Assets0RentalOfFacilitiesOthAssetsInd
Reimbursement Arrangements0ReimbursementArrangementsInd
Loans Or Loan Guarantees0LoansOrLoanGuaranteesInd
Performance Of Services Etc0PerformanceOfServicesEtcInd
Sharing Of Facilities Etc0SharingOfFacilitiesEtcInd

Transfer Schedule Detail TransferScheduleDetail

FieldValueIRS element (for citing)
Line Number1a(1)LineNumberTxt
Involved$1,885,608InvolvedAmt

Noncharitable Exempt Org Name NoncharitableExemptOrgName

FieldValueIRS element (for citing)
Business Name Line1ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTSBusinessNameLine1Txt
FieldValueIRS element (for citing)
Transfers Trans And Shr ArrngmGRANT IN SUPPORT OF EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARETransfersTransAndShrArrngmDesc
FieldValueIRS element (for citing)
Relationships Nonchrtbl EO0RelationshipsNonchrtblEOInd

Accounting Fees Schedule AccountingFeesSchedule

Accounting Fees Detail AccountingFeesDetail (3 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
AUDIT AND TAX PREPARATION$224,069$0$151,031
BOOKKEEPING$33,406$6,023$31,269
OTHER ACCOUNTING SERVICES$46,450$0$46,450

All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch

All Other Program Related Invst AllOtherProgramRelatedInvstGrp (2 entries)

DescDescAmtAmt
ABVANCE THERAPEUTICS, INC. - DEVELOPMENT OF ABV100, A FIXED-RATIO COFORMULATION OF INSULIN AND GLUCAGON$1,170,000
IMMUNOMOLECULAR THERAPEUTICS, INC. - TARGETED IMMUNOTHERAPY TO TREAT TYPE 1 DIABETES$350,000

Expenditure Responsibility Stmt ExpenditureResponsibilityStmt

Expenditure Responsibility ExpenditureResponsibilityGrp (27 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdGrantGrantDtGrantGrantAmtPurpose Of GrantPurposeOfGrantTxtExpended By GranteeExpendedByGranteeAmtAny Diversion By GranteeAnyDiversionByGranteeTxtDates Of Reports By GranteeDatesOfReportsByGranteeTxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmProvince Or StateForeignAddress/ProvinceOrStateNmCountryForeignAddress/CountryCdAddress Line2ForeignAddress/AddressLine2Txt
A GLIMMER OF HOPE FOUNDATION
PO BOX 579CEDAR PARKTX786302018-02-20$5,000,000INTEGRATED COMMUNITY DEVELOPMENT IN AMHARA, ETHIOPIA$5,000,000NONEPRIOR+ 1/2020, 2/2021, 1/2022, 1/2023, 1/2024, 2/2025
A GLIMMER OF HOPE FOUNDATION
PO BOX 579CEDAR PARKTX786302022-12-20$4,800,000EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY$2,799,822NONE1/2024, 1/2025
ABVANCE THERAPEUTICS INC
38 BENNINGTON COURTRENONV895112024-06-18$3,920,820DEVELOPMENT OF ABV100, A FIXED-RATIO COFORMULATION OF INSULIN AND GLUCAGON$1,203,212NONE10/2024, 3/2025, 4/2025, 7/2025
AKSTON BIOSCIENCES CORPORATION
100 CUMMINGS CENTER SUITE 454CBEVERLYMA019152017-03-01$6,194,000PRECLINICAL TRIAL OF INSULIN-FUSION TO END AUTOIMMUNITY & IMPROVE QUALITY OF LIFE FOR PEOPLE LIVING WITH T1D$6,194,000NONEPRIOR+ 3/2024, 6/2024, 9/2024, 10/2024, 3/2025, 5/2025
ALIMENTIV INC (FKA ROBARTS)
2024-11-05$1,275,257VALIDATION OF THE PRO SYMPTOMS AND IMPACTS QUESTIONNAIRE FOR CROHNS DISEASE$24,517NONE1/2025100 DUNDAS STREETLONDONONCA
ALIMENTIV INC (FKA ROBARTS)
2018-11-20$3,390,428STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM TO IMPROVE CARE OF CD PATIENTS$2,751,742NONEPRIOR+ 6/2022, 2/2023, 7/2023, 11/2023, 3/2024, 3/2025100 DUNDAS STREETLONDONONTARIOCA
ALIMENTIV INC (FKA ROBARTS)
2022-02-10$894,043DEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD AND IMPROVE HEALTH OUTCOMES FOR PATIENTS$411,228NONE2/2023, 6/2023, 3/2024, 1/2025, 4/2025100 DUNDAS STREETLONDONONTARIOCA
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 S WACKER DRIVE SUITE 600CHICAGOIL606062025-01-22$2,599,216DANATECH DIABETES TECHNOLOGY PLATFORM EXPANSION & MAINTENANCE$0NONEPENDING
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 S WACKER DRIVE SUITE 600CHICAGOIL606062021-11-20$2,500,000EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE$2,500,000NONEPRIOR+ 1/2023, 12/2023, 1/2024, 12/2024, 1/2025, 4/2025
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD
2020-07-23$3,560,371FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES$3,560,371NONEPRIOR+ 2/2023, 8/2023, 3/2024, 8/2024, 2/2025, 8/202555 VICTORIA PARADE LEVEL 2FITZROYAS
BIORASIS INC
1392 STORRS RD U4213 ATL ROOM 106STORRSCT062692018-02-06$3,016,000EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD IN CARE FOR T1D$2,676,000NONEPRIOR+ 6/2024, 7/2024, 10/2024, 2/2025, 5/2025, 6/2025
CAPILLARY BIOMEDICAL INC
2 WRIGLEYIRVINECA926172020-09-02$1,500,000ADVANCED EXTENDED INFUSION SET TO IMPROVE CARE OF T1D$1,428,325NONEPRIOR+ 1/2022, 5/2022, 6/2022, 3/2023, 8/2023, 8/2024
DIABETOMICS INC
2345 NE OVERLOOK DRIVE SUITE 140HILLSBOROOR970062018-01-11$4,031,900POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION$4,031,900NONEPRIOR+ 10/2023, 7/2024, 10/2024, 1/2025, 4/2025, 8/2025
DREAMED DIABETES LTD
2023-02-23$2,850,000INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES$2,683,341NONE5/2023, 10/202414 KAPLAN STPETAH TIKVATEL AVIVIS
IMMUNOMOLECULAR THERAPEUTICS INC
299 WASHINGTON STREETWOBURNMA018012024-09-24$5,450,000TARGETED IMMUNOTHERAPY TO TREAT TYPE 1 DIABETES$108,524NONE12/2024, 1/2025, 2/2025, 6/2025, 8/2025
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
2023-11-08$1,614,000DEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION.$464,198NONE1/2025HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
2020-10-22$4,752,086DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE.$2,141,708NONEPRIOR+ 11/2022, 12/2022, 8/2023, 2/2024, 1/2025, 5/2025HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
2022-03-23$342,387POINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES: INTRODUCTION TO INTESTINAL ULTRASONOGRAPHY FOR CD PATIENTS$342,384NONE3/2023, 1/2025HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
2023-06-22$1,556,119THE EXTENT STUDY TO IMPROVE THE CARE OF CROHN'S DISEASE.$637,199NONE5/2024, 8/2024, 1/2025, 8/2025HARKORTSTR 1MUNSTERGM
NUDGE BG INC
725 OLD FARM ROADTHOUSAND OAKSCA913602025-04-08$1,000,000AUTOMATED INSULIN DELIVERY INTEROPERABILITY FRAMEWORK (AIDIF)$0NONEPENDING
PERCUSENSE INC
25134 RYE CANYON LOOPVALENCIACA913552020-09-02$2,700,000DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER TO IMPROVE CARE OF T1D$1,850,000NONEPRIOR+ 8/2023, 10/2023, 6/2024, 9/2024, 3/2025, 8/2025
PHENOTAP INC
106 WEST 32ND STREET 2ND FLOORNEW YORKNY100012025-03-05$3,000,000DEVELOPMENT OF A BHBOX ENZYME TO ENABLE CONTINUOUS KETONE SENSING$0NONE7/2025
STARTUP HEALTH T1D PRI LP
2000 BROADWAY 18TH FLOORNEW YORKNY100232023-01-30$5,000,000CATALYZING SEED AND EARLY-STAGE COMPANIES DEVELOPING INNOVATIVE T1D CARE SOLUTIONS$3,151,963NONEPRIOR+ 11/2023, 6/2024, 9/2024, 12/2024, 2/2025, 5/2025
THE UNIVERSITY OF QUEENSLAND
2021-09-08$2,493,864LIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET TYPE 1 DIABETES$2,493,864NONE1/2023, 3/2024, 2/2025CUMBRAE STEWART BUILDING 72 THEBRISBANEQUEENSLANDASUNIVERSITY OF QUEENSLAND
THE UNIVERSITY OF QUEENSLAND
2023-05-22$226,017GUT MICROBIAL METABOLITES DURING EARLY-LIFE DEVELOPMENT AS PREDICTORS OF ISLET AUTOIMMUNITY$189,690NONE3/2024, 9/2024, 5/2025CUMBRAE STEWART BUILDING 72 THEBRISBANEQUEENSLANDASUNIVERSITY OF QUEENSLAND
THETIS PHARMACEUTICALS LLC
54 DANBURY ROAD SUITE 285RIDGEFIELDNJ068772022-02-24$14,044,660DEVELOPMENT OF A NOVEL RESOLVIN E1 THERAPY FOR TREATMENT OF CROHNS DISEASE$5,912,106NONEPRIOR+ 4/2024, 6/2024, 7/2024, 12/2024, 4/2025, 6/2025
TIXIMED INC
1927 FIRST AVENUE NORTHBIRMINGHAMAL352032024-12-03$2,650,000DEVELOPING A DRUG TO PROTECT BETA CELLS DURING TYPE 1 DIABETES DEVELOPMENT$1,734,080NONE5/2025, 7/2025

General Explanation Attachment GeneralExplanationAttachment

General Explanation GeneralExplanationGrp (2 entries)

IdentifierIdentifierTxtForm And Line ReferenceFormAndLineReferenceDescMedium ExplanationMediumExplanationTxt
CONTROLLED ENTITIESFORM 990-PF, PART VI-A, LINE 11:THE FOLLOWING CONTROLLED ENTITIES ARE NOT EXCESS BUSINESS HOLDINGS:ESTATE OF LEONA M. HELMSLEY230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 20-7535047HELMSLEY ENTERPRISES, INC.230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 13-2665914LACM WORLD SMALL CAP EQUITY FUND, L.P.11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025EIN# 83-2888004MARATHON-LONDON GLOBAL SELECTORION HOUSE, 5 UPPER ST. MARTIN'S LANELONDON, UK WC2H 9EAEIN# 61-1915057MHR LONGEVITY PARTNERS40 WEST 57TH STREET, FLOOR 24NEW YORK, NY 10019EIN# 98-1471155NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER, L.P.1325 NORTH BEACH STREET, SUITE 201PHILADELPHIA, PA 19125EIN# 98-1142649PITANGO SPVBEIT ACKERSHTEIN - BLDG. B, 11 HAMENOFIM ST. 11TH FL.HERZLIYA, ISRAELEIN# 98-1492234STARTUP HEALTH T1D PRI LP2000 BROADWAY, 18TH FLOORNEW YORK, NY 10023EIN# 93-2618051
FORM 990-PF, PART VII, LINE 1 AND 2, COLUMN (C), COMPENSATION:ALL REPORTED COMPENSATION AMOUNTS INCLUDE "SALARY, FEES, BONUSES AND SEVERANCE PAYMENTS RECEIVED BY EACH PERSON LISTED," AS WELL AS CURRENT YEAR PAYMENTS OF AMOUNTS REPORTED OR REPORTABLE AS DEFERRED COMPENSATION IN CURRENT OR PRIOR YEARS.

Investments Corp Stock Schedule InvestmentsCorpStockSchedule

Investments Corporate Stock InvestmentsCorporateStockGrp (335 entries)

StockStockNmEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
WASTE CONNECTIONS INC, 31,189 SHRS$6,087,781$6,087,781
ASML HOLDING NV, 6,798 SHRS$4,504,559$4,504,559
ALPHABET INC, 49,324 SHRS$7,705,889$7,705,889
AMAZON.COM INC, 56,745 SHRS$10,796,304$10,796,304
ANSYS INC, 17,725 SHRS$5,611,026$5,611,026
ATLASSIAN CORP, 10,030 SHRS$2,128,466$2,128,466
BIO-TECHNE CORP, 77,353 SHRS$4,535,206$4,535,206
BOOZ ALLEN HAMILTON HOLDING CO, 24,977 SHRS$2,612,095$2,612,095
CBRE GROUP INC, 41,905 SHRS$5,480,336$5,480,336
CADENCE DESIGN SYSTEMS INC, 19,189 SHRS$4,880,338$4,880,338
COPART INC, 51,249 SHRS$2,900,181$2,900,181
COSTAR GROUP INC, 56,648 SHRS$4,488,221$4,488,221
DANAHER CORP, 28,442 SHRS$5,830,610$5,830,610
ECOLAB INC, 15,801 SHRS$4,005,870$4,005,870
FASTENAL CO, 26,379 SHRS$2,045,691$2,045,691
GUIDEWIRE SOFTWARE INC, 21,690 SHRS$4,063,838$4,063,838
HEICO CORP, 39,020 SHRS$8,232,049$8,232,049
INTUIT INC, 7,419 SHRS$4,555,192$4,555,192
INTUITIVE SURGICAL INC, 8,518 SHRS$4,218,710$4,218,710
KINSALE CAPITAL GROUP INC, 7,556 SHRS$3,677,581$3,677,581
MANHATTAN ASSOCIATES INC, 18,581 SHRS$3,215,256$3,215,256
MASTERCARD INC, 18,961 SHRS$10,392,903$10,392,903
MICROSOFT CORP, 20,472 SHRS$7,684,984$7,684,984
MONOLITHIC POWER SYSTEMS INC, 7,694 SHRS$4,462,366$4,462,366
MOODY'S CORP, 12,092 SHRS$5,631,123$5,631,123
MOTOROLA SOLUTIONS INC, 5,167 SHRS$2,262,164$2,262,164
OLD DOMINION FREIGHT LINE INC, 34,487 SHRS$5,705,874$5,705,874
S&P GLOBAL INC, 12,553 SHRS$6,378,179$6,378,179
SERVICENOW INC, 4,067 SHRS$3,237,901$3,237,901
SHERWIN-WILLIAMS CO/THE, 15,113 SHRS$5,277,308$5,277,308
THERMO FISHER SCIENTIFIC INC, 10,030 SHRS$4,990,928$4,990,928
TRANSDIGM GROUP INC, 5,495 SHRS$7,601,179$7,601,179
TYLER TECHNOLOGIES INC, 3,847 SHRS$2,236,607$2,236,607
UBER TECHNOLOGIES INC, 82,728 SHRS$6,027,562$6,027,562
VEEVA SYSTEMS INC, 26,243 SHRS$6,078,666$6,078,666
VERALTO CORP, 56,194 SHRS$5,476,105$5,476,105
VISA INC, 32,563 SHRS$11,412,029$11,412,029
VULCAN MATERIALS CO, 24,319 SHRS$5,673,623$5,673,623
WEST PHARMACEUTICAL SERVICES I, 18,135 SHRS$4,060,064$4,060,064
ZOETIS INC, 29,428 SHRS$4,845,320$4,845,320
SCHLUMBERGER LTD, 74,480 SHRS$3,113,264$3,113,264
FRESENIUS MEDICAL CARE AG, 141,319 SHRS$3,518,843$3,518,843
ALLEGION PLC, 20,244 SHRS$2,641,032$2,641,032
SONY GROUP CORP, 230,530 SHRS$5,853,157$5,853,157
KONINKLIJKE PHILIPS NV, 176,944 SHRS$4,494,378$4,494,378
SMITH & NEPHEW PLC, 89,859 SHRS$2,549,300$2,549,300
UNILEVER PLC, 81,279 SHRS$4,840,164$4,840,164
ALPHABET INC, 31,362 SHRS$4,849,820$4,849,820
ARAMARK, 175,247 SHRS$6,049,526$6,049,526
AVERY DENNISON CORP, 29,869 SHRS$5,315,786$5,315,786
BERKSHIRE HATHAWAY INC, 15,142 SHRS$8,064,326$8,064,326
BLACKROCK INC, 2,036 SHRS$1,927,033$1,927,033
BOOKING HOLDINGS INC, 1,484 SHRS$6,836,654$6,836,654
CDW CORP/DE, 16,609 SHRS$2,661,758$2,661,758
CSX CORP, 147,478 SHRS$4,340,278$4,340,278
CARLISLE COS INC, 6,663 SHRS$2,268,752$2,268,752
CARMAX INC, 62,091 SHRS$4,838,131$4,838,131
CARRIER GLOBAL CORP, 86,144 SHRS$5,461,530$5,461,530
DOLLAR TREE INC, 31,754 SHRS$2,383,773$2,383,773
FERGUSON ENTERPRISES INC, 36,995 SHRS$5,927,709$5,927,709
MASCO CORP, 72,819 SHRS$5,063,833$5,063,833
MICROCHIP TECHNOLOGY INC, 61,499 SHRS$2,977,167$2,977,167
O'REILLY AUTOMOTIVE INC, 2,722 SHRS$3,899,483$3,899,483
PROGRESSIVE CORP/THE, 19,411 SHRS$5,493,507$5,493,507
QUEST DIAGNOSTICS INC, 29,141 SHRS$4,930,657$4,930,657
CHARLES SCHWAB CORP/THE, 106,941 SHRS$8,371,341$8,371,341
SYSCO CORP, 57,302 SHRS$4,299,942$4,299,942
UNITEDHEALTH GROUP INC, 11,037 SHRS$5,780,629$5,780,629
RB GLOBAL INC, 72,772 SHRS$7,299,032$7,299,032
VIVENDI SE, 890,005 SHRS$2,650,534$2,650,534
AON PLC, 18,887 SHRS$7,537,613$7,537,613
NINTENDO CO LTD, 168,200 SHRS$11,371,553$11,371,553
SHISEIDO CO LTD, 416,100 SHRS$7,846,743$7,846,743
NOVARTIS AG, 125,364 SHRS$13,863,367$13,863,367
NESTLE SA, 32,891 SHRS$3,321,257$3,321,257
CIE FINANCIERE RICHEMONT SA, 47,477 SHRS$8,207,524$8,207,524
UNILEVER PLC, 214,237 SHRS$12,737,291$12,737,291
RENTOKIL INITIAL PLC, 1865,670 SHRS$8,370,603$8,370,603
RECKITT BENCKISER GROUP PLC, 177,062 SHRS$11,952,787$11,952,787
INFORMA PLC, 1003,213 SHRS$9,962,939$9,962,939
HALEON PLC, 2295,109 SHRS$11,591,918$11,591,918
GSK PLC, 744,353 SHRS$14,046,511$14,046,511
RENTOKIL INITIAL PLC, 7,123 SHRS$163,117$163,117
BRISTOL-MYERS SQUIBB CO, 233,005 SHRS$14,210,975$14,210,975
CORTEVA INC, 215,129 SHRS$13,538,068$13,538,068
EBAY INC, 150,383 SHRS$10,185,441$10,185,441
ELECTRONIC ARTS INC, 56,582 SHRS$8,177,231$8,177,231
FOX CORP, 152,390 SHRS$8,625,274$8,625,274
FOX CORP, 68,592 SHRS$3,615,484$3,615,484
INTERCONTINENTAL EXCHANGE INC, 81,240 SHRS$14,013,900$14,013,900
JOHNSON & JOHNSON, 73,505 SHRS$12,190,069$12,190,069
ESTEE LAUDER COS INC/THE, 102,083 SHRS$6,737,478$6,737,478
LIVE NATION ENTERTAINMENT INC, 73,216 SHRS$9,560,545$9,560,545
NEWS CORP, 347,717 SHRS$9,464,857$9,464,857
NEWS CORP, 124,376 SHRS$3,777,299$3,777,299
ORACLE CORP, 55,200 SHRS$7,717,512$7,717,512
SOLVENTUM CORP, 61,649 SHRS$4,687,790$4,687,790
TKO GROUP HOLDINGS INC, 39,558 SHRS$6,044,858$6,044,858
TRANSUNION, 27,518 SHRS$2,283,719$2,283,719
WARNER MUSIC GROUP CORP, 110,454 SHRS$3,462,733$3,462,733
ZILLOW GROUP INC, 26,341 SHRS$1,761,159$1,761,159
ZILLOW GROUP INC, 135,353 SHRS$9,279,802$9,279,802
QANTAS AIRWAYS LTD, 39,302 SHRS$221,644$221,644
NORTHERN STAR RESOURCES LTD, 58,974 SHRS$673,254$673,254
ERSTE GROUP BANK AG, 422 SHRS$29,046$29,046
AGNICO EAGLE MINES LIMITED, 7,865 SHRS$851,994$851,994
BARRICK GOLD CORP, 68,600 SHRS$1,331,724$1,331,724
ENBRIDGE INC, 500 SHRS$22,126$22,126
LOBLAW COMPANIES LTD, 600 SHRS$84,069$84,069
PAN AMERICAN SILVER CORP, 18,700 SHRS$482,945$482,945
WESTON (GEORGE) LTD, 400 SHRS$68,183$68,183
KINROSS GOLD CORP, 62,545 SHRS$787,869$787,869
TMX GROUP LTD, 800 SHRS$29,204$29,204
WHEATON PRECIOUS METALS CORP, 2,600 SHRS$201,731$201,731
WSP GLOBAL INC, 3,200 SHRS$542,972$542,972
IA FINANCIAL CORP INC, 4,800 SHRS$455,771$455,771
SHOPIFY INC, 8,200 SHRS$779,976$779,976
SEA LTD, 8,755 SHRS$1,142,440$1,142,440
GRAB HOLDINGS LTD, 6,774 SHRS$30,686$30,686
YANGZIJIANG SHIPBUILDING HOLDI, 131,300 SHRS$231,516$231,516
NOVO NORDISK A/S, 22,888 SHRS$1,556,863$1,556,863
WARTSILA OYJ ABP, 25,517 SHRS$451,903$451,903
NOKIA OYJ, 141,686 SHRS$740,758$740,758
ORION OYJ, 5,521 SHRS$327,173$327,173
THALES SA, 179 SHRS$47,488$47,488
HANNOVER RUECK SE, 1,465 SHRS$434,711$434,711
RHEINMETALL AG, 1,704 SHRS$2,427,832$2,427,832
DEUTSCHE TELEKOM AG, 77,111 SHRS$2,850,365$2,850,365
RATIONAL AG, 259 SHRS$214,025$214,025
MTU AERO ENGINES AG, 744 SHRS$257,415$257,415
TALANX AG, 3,275 SHRS$342,091$342,091
COMMERZBANK AG, 1,955 SHRS$44,284$44,284
LEG IMMOBILIEN SE, 892 SHRS$63,073$63,073
VONOVIA SE, 1,865 SHRS$50,284$50,284
SIEMENS ENERGY AG, 849 SHRS$49,376$49,376
DAIMLER TRUCK HOLDING AG, 16,684 SHRS$668,979$668,979
BOC HONG KONG HOLDINGS LTD, 187,500 SHRS$756,719$756,719
AIA GROUP LTD, 137,200 SHRS$1,033,369$1,033,369
CRH PLC, 1,524 SHRS$134,066$134,066
EATON CORP PLC, 4,142 SHRS$1,125,920$1,125,920
FLUTTER ENTERTAINMENT PLC, 741 SHRS$164,169$164,169
SEAGATE TECHNOLOGY HOLDINGS PL, 10,692 SHRS$908,285$908,285
TRANE TECHNOLOGIES PLC, 1,808 SHRS$609,151$609,151
BANK HAPOALIM BM, 40,669 SHRS$546,480$546,480
BANK LEUMI LE-ISRAEL BM, 39,827 SHRS$532,387$532,387
ISRAEL DISCOUNT BANK LTD, 24,965 SHRS$172,286$172,286
MIZRAHI TEFAHOT BANK LTD, 7,869 SHRS$351,544$351,544
WIX.COM LTD, 212 SHRS$34,637$34,637
FERRARI NV, 1,278 SHRS$541,430$541,430
FINECOBANK BANCA FINECO SPA, 27,842 SHRS$547,213$547,213
BANCO BPM SPA, 59,401 SHRS$599,686$599,686
UNICREDIT SPA, 38,704 SHRS$2,154,369$2,154,369
ANA HOLDINGS INC, 8,100 SHRS$149,471$149,471
ASAHI KASEI CORP, 4,800 SHRS$33,607$33,607
ASICS CORP, 5,600 SHRS$117,775$117,775
TREND MICRO INC/JAPAN, 4,900 SHRS$328,163$328,163
DAIFUKU CO LTD, 16,500 SHRS$401,852$401,852
DAITO TRUST CONSTRUCTION CO LT, 2,900 SHRS$297,001$297,001
OTSUKA CORP, 11,200 SHRS$242,365$242,365
HITACHI LTD, 12,800 SHRS$295,990$295,990
SUMITOMO MITSUI TRUST GROUP IN, 19,800 SHRS$492,550$492,550
KOMATSU LTD, 18,500 SHRS$532,707$532,707
KONAMI GROUP CORP, 5,100 SHRS$599,559$599,559
LASERTEC CORP, 200 SHRS$16,959$16,959
TOKIO MARINE HOLDINGS INC, 23,900 SHRS$916,747$916,747
SUMITOMO MITSUI FINANCIAL GROU, 12,100 SHRS$307,072$307,072
NOMURA HOLDINGS INC, 12,700 SHRS$77,131$77,131
NIPPON YUSEN KK, 22,400 SHRS$737,130$737,130
OBAYASHI CORP, 15,300 SHRS$202,991$202,991
ONO PHARMACEUTICAL CO LTD, 1,700 SHRS$18,218$18,218
ORIX CORP, 50,100 SHRS$1,033,225$1,033,225
T&D HOLDINGS INC, 25,000 SHRS$530,627$530,627
SUZUKI MOTOR CORP, 2,500 SHRS$30,259$30,259
TOKYO ELECTRON LTD, 2,600 SHRS$349,646$349,646
ASTELLAS PHARMA INC, 40,900 SHRS$395,626$395,626
DAIICHI SANKYO CO LTD, 14,100 SHRS$331,049$331,049
BANDAI NAMCO HOLDINGS INC, 15,500 SHRS$518,671$518,671
MS&AD INSURANCE GROUP HOLDINGS, 21,800 SHRS$470,142$470,142
ENEOS HOLDINGS INC, 139,600 SHRS$730,300$730,300
JAPAN AIRLINES CO LTD, 7,300 SHRS$124,799$124,799
CONCORDIA FINANCIAL GROUP LTD, 3,800 SHRS$24,934$24,934
ASR NEDERLAND NV, 1,730 SHRS$99,006$99,006
NN GROUP NV, 1,956 SHRS$108,348$108,348
TELENOR ASA, 4,749 SHRS$67,845$67,845
KONGSBERG GRUPPEN ASA, 994 SHRS$144,835$144,835
NORSK HYDRO ASA, 2,941 SHRS$16,840$16,840
DNB BANK ASA, 35,370 SHRS$924,989$924,989
CARNIVAL CORP, 25,323 SHRS$494,558$494,558
INPOST SA, 9,235 SHRS$134,671$134,671
SINGAPORE TECHNOLOGIES ENGINEE, 37,800 SHRS$190,955$190,955
DBS GROUP HOLDINGS LTD, 900 SHRS$31,116$31,116
SINGAPORE EXCHANGE LTD, 22,100 SHRS$219,833$219,833
UNITED OVERSEAS BANK LTD, 8,600 SHRS$243,713$243,713
OVERSEA-CHINESE BANKING CORP L, 2,100 SHRS$27,029$27,029
SINGAPORE TECHNOLOGIES ENGINEE, 41,400 SHRS$211,140$211,140
BANCO BILBAO VIZCAYA ARGENTARI, 76,025 SHRS$1,030,223$1,030,223
BANCO SANTANDER SA, 17,990 SHRS$120,406$120,406
CAIXABANK SA, 142,302 SHRS$1,102,749$1,102,749
TELEFONAKTIEBOLAGET LM ERICSSO, 80,203 SHRS$620,220$620,220
TELIA CO AB, 12,362 SHRS$44,660$44,660
SKANSKA AB, 17,265 SHRS$379,672$379,672
ALFA LAVAL AB, 1,801 SHRS$76,898$76,898
SWEDISH ORPHAN BIOVITRUM AB, 2,110 SHRS$60,369$60,369
VOLVO AB, 1,649 SHRS$48,132$48,132
ADDTECH AB, 1,192 SHRS$34,745$34,745
SVENSKA HANDELSBANKEN AB, 2,458 SHRS$27,687$27,687
ZURICH INSURANCE GROUP AG, 576 SHRS$400,384$400,384
NOVARTIS AG, 4,910 SHRS$542,972$542,972
ABB LTD, 2,738 SHRS$139,941$139,941
SWISS RE AG, 1,365 SHRS$231,421$231,421
UBS GROUP AG, 10,996 SHRS$333,950$333,950
GARMIN LTD, 2,544 SHRS$552,379$552,379
BAE SYSTEMS PLC, 61,871 SHRS$1,245,417$1,245,417
HSBC HOLDINGS PLC, 23,693 SHRS$267,254$267,254
MARKS & SPENCER GROUP PLC, 6,830 SHRS$31,340$31,340
ROLLS-ROYCE HOLDINGS PLC, 17,822 SHRS$172,298$172,298
ROYALTY PHARMA PLC, 19,160 SHRS$596,451$596,451
AT&T INC, 13,220 SHRS$373,862$373,862
ABBVIE INC, 13,736 SHRS$2,877,967$2,877,967
AECOM, 6,271 SHRS$581,510$581,510
ALLSTATE CORP/THE, 5,185 SHRS$1,073,658$1,073,658
ALNYLAM PHARMACEUTICALS INC, 966 SHRS$260,839$260,839
ALPHABET INC, 2,536 SHRS$396,199$396,199
ALPHABET INC, 2,865 SHRS$443,044$443,044
ALTRIA GROUP INC, 24,639 SHRS$1,478,833$1,478,833
AMAZON.COM INC, 5,724 SHRS$1,089,048$1,089,048
AMERICAN EXPRESS CO, 4,573 SHRS$1,230,366$1,230,366
AMPHENOL CORP, 23,232 SHRS$1,523,787$1,523,787
ANALOG DEVICES INC, 499 SHRS$100,633$100,633
APPLE INC, 10,715 SHRS$2,380,123$2,380,123
APPLOVIN CORP, 499 SHRS$132,220$132,220
ARISTA NETWORKS INC, 4,852 SHRS$375,933$375,933
ATLASSIAN CORP, 4,639 SHRS$984,442$984,442
BLACKSTONE INC, 3,414 SHRS$477,209$477,209
BOOZ ALLEN HAMILTON HOLDING CO, 5,994 SHRS$626,853$626,853
BRISTOL-MYERS SQUIBB CO, 4,448 SHRS$271,284$271,284
BROADCOM INC, 12,323 SHRS$2,063,240$2,063,240
BROWN & BROWN INC, 2,698 SHRS$335,631$335,631
CAPITAL ONE FINANCIAL CORP, 6,720 SHRS$1,204,896$1,204,896
CHARTER COMMUNICATIONS INC, 312 SHRS$114,981$114,981
CHENIERE ENERGY INC, 7,420 SHRS$1,716,988$1,716,988
CISCO SYSTEMS INC, 20,303 SHRS$1,252,898$1,252,898
CITIGROUP INC, 3,588 SHRS$254,712$254,712
COMCAST CORP, 22,716 SHRS$838,220$838,220
CORNING INC, 19,794 SHRS$906,169$906,169
DELTA AIR LINES INC, 8,235 SHRS$359,046$359,046
DOCUSIGN INC, 991 SHRS$80,667$80,667
DOORDASH INC, 2,967 SHRS$542,279$542,279
EDISON INTERNATIONAL, 11,710 SHRS$689,953$689,953
EMCOR GROUP INC, 1,356 SHRS$501,218$501,218
EQUITABLE HOLDINGS INC, 13,677 SHRS$712,435$712,435
EXPEDIA GROUP INC, 5,973 SHRS$1,004,061$1,004,061
META PLATFORMS INC, 942 SHRS$542,931$542,931
F5 INC, 2,709 SHRS$721,325$721,325
FORTINET INC, 14,669 SHRS$1,412,038$1,412,038
FREEPORT-MCMORAN INC, 40,617 SHRS$1,537,760$1,537,760
GE AEROSPACE, 1,294 SHRS$258,994$258,994
GILEAD SCIENCES INC, 22,495 SHRS$2,520,565$2,520,565
HCA HEALTHCARE INC, 200 SHRS$69,110$69,110
HOWMET AEROSPACE INC, 16,398 SHRS$2,127,313$2,127,313
INCYTE CORP, 4,902 SHRS$296,816$296,816
JOHNSON & JOHNSON, 16,144 SHRS$2,677,321$2,677,321
KLA CORP, 738 SHRS$501,692$501,692
LAM RESEARCH CORP, 6,198 SHRS$450,595$450,595
ELI LILLY & CO, 103 SHRS$85,069$85,069
LOCKHEED MARTIN CORP, 239 SHRS$106,764$106,764
LULULEMON ATHLETICA INC, 2,632 SHRS$745,014$745,014
MERCADOLIBRE INC, 11 SHRS$21,460$21,460
MERCK & CO INC, 2,899 SHRS$260,214$260,214
MICROSOFT CORP, 1,966 SHRS$738,017$738,017
MOLINA HEALTHCARE INC, 1,621 SHRS$533,941$533,941
MOODY'S CORP, 417 SHRS$194,193$194,193
MOTOROLA SOLUTIONS INC, 1,206 SHRS$527,999$527,999
NRG ENERGY INC, 9,467 SHRS$903,720$903,720
NETFLIX INC, 1,827 SHRS$1,703,732$1,703,732
NORTHROP GRUMMAN CORP, 55 SHRS$28,161$28,161
NVIDIA CORP, 42,681 SHRS$4,625,767$4,625,767
PALANTIR TECHNOLOGIES INC, 3,345 SHRS$282,318$282,318
PARKER-HANNIFIN CORP, 479 SHRS$291,160$291,160
PFIZER INC, 38,902 SHRS$985,777$985,777
PHILIP MORRIS INTERNATIONAL IN, 12,570 SHRS$1,995,236$1,995,236
PROGRESSIVE CORP/THE, 1,302 SHRS$368,479$368,479
RAYMOND JAMES FINANCIAL INC, 3,722 SHRS$517,023$517,023
RTX CORP, 2,778 SHRS$367,974$367,974
RESMED INC, 259 SHRS$57,977$57,977
CHARLES SCHWAB CORP/THE, 26,230 SHRS$2,053,284$2,053,284
SIMON PROPERTY GROUP INC, 12,119 SHRS$2,012,724$2,012,724
SNAP INC, 6,292 SHRS$54,803$54,803
SNOWFLAKE INC, 351 SHRS$51,302$51,302
SYNCHRONY FINANCIAL, 13,535 SHRS$716,543$716,543
TARGA RESOURCES CORP, 129 SHRS$25,861$25,861
TESLA INC, 3,741 SHRS$969,518$969,518
TRADEWEB MARKETS INC, 2,172 SHRS$322,455$322,455
TWILIO INC, 3,828 SHRS$374,799$374,799
US BANCORP, 44,345 SHRS$1,872,246$1,872,246
UNITED THERAPEUTICS CORP, 379 SHRS$116,834$116,834
UNIVERSAL HEALTH SERVICES INC, 2,730 SHRS$512,967$512,967
VENTAS INC, 1,744 SHRS$119,917$119,917
VERIZON COMMUNICATIONS INC, 14,687 SHRS$666,202$666,202
VISA INC, 2,611 SHRS$915,051$915,051
VISTRA CORP, 2,806 SHRS$329,537$329,537
WALMART INC, 1,643 SHRS$144,239$144,239
UNITED THERAPEUTICS CORP, 1,256 SHRS$387,187$387,187
NETFLIX INC, 895 SHRS$834,614$834,614
FORTINET INC, 2,839 SHRS$273,282$273,282
META PLATFORMS INC, 1,932 SHRS$1,113,528$1,113,528
ARISTA NETWORKS INC, 428 SHRS$33,161$33,161
MOTOROLA SOLUTIONS INC, 2,718 SHRS$1,189,968$1,189,968
NORTHROP GRUMMAN CORPORATION, 179 SHRS$91,650$91,650
LILLY (ELI) & CO COM STK NPV, 311 SHRS$256,858$256,858
PROGRESSIVE CORP OHIO COM, 4,151 SHRS$1,174,775$1,174,775
AMERICAN EXPRESS CO, 1,046 SHRS$281,426$281,426
AMAZON COM INC COM, 8,567 SHRS$1,629,957$1,629,957
MERCK & CO INC, 9,163 SHRS$822,471$822,471
BRISTOL MYERS SQUIBB CO, 20,387 SHRS$1,243,403$1,243,403
APPLE INC, 14,677 SHRS$3,260,202$3,260,202
CISCO SYSTEMS INC COM, 17,506 SHRS$1,080,295$1,080,295
ALPHABET INC, 8,411 SHRS$1,314,051$1,314,051
ALPHABET INC, 9,502 SHRS$1,469,389$1,469,389
RESMED INC COM, 857 SHRS$191,839$191,839
MICROSOFT CORP COM, 5,848 SHRS$2,195,281$2,195,281
WALMART INC, 12,334 SHRS$1,082,802$1,082,802
PDD HOLDINGS INC, 12,500 SHRS$1,479,375$1,479,375
NU HOLDINGS LTD/CAYMAN ISLANDS, 567,667 SHRS$5,812,910$5,812,910
WISE PLC, 168,200 SHRS$2,051,634$2,051,634
CONFLUENT INC, 22,315 SHRS$523,064$523,064
CROWDSTRIKE HOLDINGS INC, 12,800 SHRS$4,513,024$4,513,024
DOXIMITY INC, 6,974 SHRS$404,701$404,701
META PLATFORMS INC, 8,000 SHRS$4,610,880$4,610,880
FRESHWORKS INC, 18,841 SHRS$265,847$265,847
MAPLEBEAR INC, 80,000 SHRS$3,191,200$3,191,200
ROBINHOOD MARKETS INC, 50,000 SHRS$2,081,000$2,081,000
ROBLOX CORP, 54,000 SHRS$3,147,660$3,147,660
SAMSARA INC, 101,250 SHRS$3,880,913$3,880,913
SNOWFLAKE INC, 42,316 SHRS$6,184,907$6,184,907

Investments Other Schedule2 InvestmentsOtherSchedule2

Investments Other InvestmentsOtherGrp (196 entries)

Category Or ItemCategoryOrItemTxtListed At Cost Or FMVListedAtCostOrFMVCdBook ValueBookValueAmtEOYFMVEOYFMVAmt
JPM US LARGE CAPFMV$178,600,044$178,600,044
SPDR TRUST SERIES IFMV$184,715,613$184,715,613
JPM CORE BONDFMV$1,024,328,467$1,024,328,467
JPM SHORT DURATION BONDFMV$250,849,044$250,849,044
CHATHAMFMV$113,440,052$113,440,052
CHATHAM OFFSHOREFMV$111,292,568$111,292,568
CAMBERFMV$153,014,742$153,014,742
ORBIMED GENESIS FUNDFMV$37,527,977$37,527,977
SEQUOIA CAP GLOBALFMV$206,953,932$206,953,932
ACADIAN FRONTIERFMV$19$19
HIGHCLERE INTL SCFMV$134,563,864$134,563,864
LACM WORLD SMALL CAPFMV$119,401,516$119,401,516
MARATHON GLOBALFMV$211,603,977$211,603,977
SILCHESTER INTLFMV$147,151,131$147,151,131
BLACKROCK US DEBTFMV$96,977,617$96,977,617
EIG ENERGY FUND XVIFMV$30,133,391$30,133,391
EIG ENERGY XVFMV$1,002,113$1,002,113
EIG ENERGY XVIIFMV$6,505,004$6,505,004
FDAF DISLOCATED IIFMV$8,202,611$8,202,611
FDAF DISLOCATED IIIFMV$25,456,191$25,456,191
FDAF DISLOCATED IVFMV$30,329,915$30,329,915
GSO CAPITAL SOLS IIFMV$2,006,596$2,006,596
HIG BAYSIDE IIIFMV$3,232,157$3,232,157
MHR AXIOMFMV$265,837,155$265,837,155
MHR INST PARTNERS IVFMV$61,299,374$61,299,374
NEWMARKET IIFCFMV$6,973,612$6,973,612
ORBIMED ROYALTY IIFMV$334,374$334,374
ACCEL GROWTH FUND IVFMV$16,748,134$16,748,134
ACCEL GROWTH IIFMV$9,271,705$9,271,705
ACCEL GROWTH IIIFMV$11,675,661$11,675,661
ACCEL GROWTH VFMV$27,092,782$27,092,782
ACCEL GROWTH VIFMV$20,568,357$20,568,357
ACCEL GROWTH VIIFMV$1,500,000$1,500,000
ACCEL INDIA VFMV$12,493,701$12,493,701
ACCEL INDIA VIFMV$7,439,015$7,439,015
ACCEL INDIA VIIFMV$4,788,163$4,788,163
ACCEL INDIA VIIIFMV$480,000$480,000
ACCEL LEADERS 4FMV$22,921,263$22,921,263
ACCEL LEADERS FUNDFMV$13,524,240$13,524,240
ACCEL LEADERS IIFMV$7,276,777$7,276,777
ACCEL LEADERS IIIFMV$30,532,173$30,532,173
ACCEL XIFMV$5,410,664$5,410,664
ACCEL XIIFMV$28,342,318$28,342,318
ACCEL XIIIFMV$13,141,628$13,141,628
ACCEL XIVFMV$8,594,510$8,594,510
ACCEL XVFMV$6,585,862$6,585,862
ACCEL XVIFMV$735,234$735,234
AH 2024 MULTIPLEXERFMV$12,737,561$12,737,561
AH BIO FUND IFMV$5,176,647$5,176,647
AH BIO FUND IIFMV$14,929,368$14,929,368
AH BIO IIIFMV$16,462,239$16,462,239
AH BIO IVFMV$7,998,035$7,998,035
AH CNK IVFMV$8,208,321$8,208,321
AH CNK SEED IFMV$4,301,427$4,301,427
AH FUND VIIFMV$12,034,065$12,034,065
AH FUND VIIIFMV$11,590,228$11,590,228
AH IIIFMV$49,216,024$49,216,024
AH III PARALLELFMV$11,126,940$11,126,940
AH IVFMV$30,083,291$30,083,291
AH IV PARALLELFMV$11,316,856$11,316,856
AH LSV FUND IIFMV$19,257,909$19,257,909
AH LSV FUND IIIFMV$20,045,228$20,045,228
AH LSV IFMV$19,976,431$19,976,431
AH VFMV$44,769,088$44,769,088
AH V PARALLELFMV$33,862,315$33,862,315
AH VIFMV$24,736,043$24,736,043
ANGELENO INV IIIFMV$16,937,302$16,937,302
ARBORETUM IIIFMV$1,524,062$1,524,062
ARBORETUM IVFMV$9,387,239$9,387,239
ARBORETUM VFMV$18,895,979$18,895,979
ARBORETUM VIFMV$6,985,934$6,985,934
COLLER VIFMV$1,828,988$1,828,988
COLLER VIIFMV$16,996,428$16,996,428
COLLER VIIIFMV$30,024,784$30,024,784
CONGRUENT CONTINUITYFMV$9,287,107$9,287,107
CRESTVIEW ELOFMV$8,183,115$8,183,115
CRESTVIEW IIIFMV$26,093,392$26,093,392
CRESTVIEW IVFMV$33,243,027$33,243,027
EMERGENCE IIIFMV$46,017,551$46,017,551
EMERGENCE IVFMV$20,172,577$20,172,577
EMERGENCE OPP IFMV$9,089,321$9,089,321
EMERGENCE VFMV$23,199,567$23,199,567
EMERGENCE VIFMV$17,410,140$17,410,140
EPIRIS ELEC CO INVFMV$11,385,608$11,385,608
EPIRIS IIFMV$23,171,624$23,171,624
EPIRIS IIIFMV$16,328,049$16,328,049
FORTISSIMO IVFMV$19,196,561$19,196,561
FORTISSIMO VFMV$22,493,956$22,493,956
FORTISSIMO VIFMV$9,078,435$9,078,435
FRAZIER COINVEST 2FMV$5,326,646$5,326,646
FRAZIER GTH BUYOUT XFMV$21,632,010$21,632,010
FRAZIER IXFMV$9,082,650$9,082,650
FRAZIER OVERAGEFMV$15,831,875$15,831,875
FRAZIER PUBLIC FUNDFMV$22,412,499$22,412,499
FRAZIER SUNMD CO INVFMV$19,746,931$19,746,931
FRAZIER XFMV$12,252,780$12,252,780
FRAZIER XIFMV$11,103,867$11,103,867
GAVEA IVFMV$1,481,298$1,481,298
GAVEA VFMV$4,823,759$4,823,759
GENERL ATLANTIC 2013FMV$56,584,009$56,584,009
GENERL ATLANTIC 2018FMV$81,061,163$81,061,163
HIG BRAZILFMV$4,561,515$4,561,515
HIG BRAZIL LATAM BFMV$13,830,119$13,830,119
HIG BRAZIL LATAM CFMV$13,830,119$13,830,119
HIG CAPITAL VFMV$6,919,413$6,919,413
HIG GROWTH B&E F IIFMV$5,863,861$5,863,861
HIG GROWTH IIIFMV$9,010,867$9,010,867
HIG HEALTHBRIDGEFMV$12,324,531$12,324,531
HIG MID MARKET IIFMV$9,689,585$9,689,585
HIG MID MARKET IIIFMV$14,609,366$14,609,366
HONGSHAN EXP IFMV$3,085,468$3,085,468
HONGSHAN GROWTH IIIFMV$95,878,511$95,878,511
HONGSHAN GROWTH IVFMV$25,673,901$25,673,901
HONGSHAN GROWTH VFMV$27,640,078$27,640,078
HONGSHAN GROWTH VIFMV$20,523,846$20,523,846
HONGSHAN GROWTH VIIFMV$3,545,914$3,545,914
HONGSHAN VTR IVFMV$9,697,533$9,697,533
HONGSHAN VTR IXFMV$1,322,435$1,322,435
HONGSHAN VTR VFMV$5,824,079$5,824,079
HONGSHAN VTR VIFMV$8,559,963$8,559,963
HONGSHAN VTR VIIFMV$4,923,713$4,923,713
HONGSHAN VTR VIIIFMV$4,325,586$4,325,586
IDG BREYERFMV$8,885,912$8,885,912
IDG CHINA CAP IIIFMV$26,363,578$26,363,578
IDG CHINA VTR IVFMV$23,121,637$23,121,637
IDG CHINA VTR VFMV$26,625,184$26,625,184
IDG-ACCEL CHINA CAPFMV$10,968,798$10,968,798
IDG-ACCEL CHINA GWTHFMV$9,016,097$9,016,097
IRON POINT IVFMV$18,434,932$18,434,932
JPM PEG SECONDRY IIIFMV$4,230,920$4,230,920
ORBIMED ASIA IIIFMV$60,416,564$60,416,564
ORBIMED ASIA IVFMV$22,143,164$22,143,164
ORBIMED ISRAELFMV$1,901,085$1,901,085
ORBIMED ISRAEL IIFMV$18,373,039$18,373,039
ORBIMED PI IXFMV$12,366,730$12,366,730
ORBIMED PI VIFMV$8,266,524$8,266,524
ORBIMED PI VIIFMV$22,037,580$22,037,580
ORBIMED PI VIIIFMV$20,222,556$20,222,556
ORBMIED ASIA VFMV$9,096,219$9,096,219
PEAK XV GWTH IIIFMV$12,330,411$12,330,411
PEAK XV GWTH IVFMV$3,179,607$3,179,607
PEAK XV SEA IFMV$3,021,093$3,021,093
PEAK XV VFMV$11,804,254$11,804,254
PEAK XV VIFMV$12,978,906$12,978,906
PEAK XV VIIIFMV$1,240,660$1,240,660
PEAK XV VTR VIIFMV$3,398,972$3,398,972
PEP IV COREFMV$993,669$993,669
PEP IV SUPPLFMV$415,294$415,294
PEP VIFMV$24,448,554$24,448,554
PEP VIIFMV$771,788$771,788
PIATNGO VTR IXFMV$1,248,959$1,248,959
PITANGO GROWTHFMV$61,640,072$61,640,072
PITANGO GROWTH IIFMV$22,204,708$22,204,708
PITANGO HEALTH IIFMV$2,764,419$2,764,419
PITANGO HEALTHTECH IFMV$9,827,519$9,827,519
PITANGO SPVFMV$21,958,799$21,958,799
PITANGO VI, LPFMV$26,100,607$26,100,607
PITANGO VTR VIIFMV$26,088,396$26,088,396
PITANGO VTR VIIIFMV$16,931,226$16,931,226
RIDGEWOOD IIIFMV$32,098,781$32,098,781
RIDGEWOOD IVFMV$28,194,204$28,194,204
S CAPITALFMV$17,281,159$17,281,159
S CAPITAL IIFMV$11,018,147$11,018,147
S CAPITAL IIIFMV$4,253,438$4,253,438
SCF LIQUID PORTFOLIOFMV$48,081,485$48,081,485
SEQUOIA GBL GRTH IIIFMV$99,769,116$99,769,116
SEQUOIA GG 3 CH ANXFMV$16,460,729$16,460,729
SEQUOIA GLB GROWTHFMV$29,555,443$29,555,443
SEQUOIA GLB GRWTH IIFMV$39,595,153$39,595,153
SEQUOIA ISRAEL VFMV$7,530,636$7,530,636
SEQUOIA SCOUT IIIFMV$2,279,728$2,279,728
SEQUOIA SCOUT IVFMV$1,334,197$1,334,197
SEQUOIA US ECO IFMV$917,754$917,754
SEQUOIA US EXP IFMV$10,005,071$10,005,071
SEQUOIA US GROWTH VFMV$745,209$745,209
SEQUOIA US GRTH VIIIFMV$10,900,783$10,900,783
SEQUOIA US GRWTH VIIFMV$4,075,351$4,075,351
SEQUOIA US GWTH IXFMV$8,557,960$8,557,960
SEQUOIA US GWTH VIFMV$810,240$810,240
SEQUOIA US GWTH XFMV$5,831,950$5,831,950
SEQUOIA US SEED VFMV$892,249$892,249
SEQUOIA US VENT XVIFMV$12,559,632$12,559,632
SEQUOIA US VTR XIVFMV$2,869,150$2,869,150
SEQUOIA US VTR XVFMV$5,144,966$5,144,966
SEQUOIA US VTR XVIIFMV$5,923,830$5,923,830
SEQUOIA US VTR XVIIIFMV$1,822,252$1,822,252
SQUOIA GG 3 US IN AXFMV$15,234,847$15,234,847
STARWOOD XFMV$11,001,661$11,001,661
STARWOOD XIFMV$42,603,687$42,603,687
STARWOOD XIIFMV$39,678,065$39,678,065
QMETCOFMV$27,754,179$27,754,179
WTI VLL IXFMV$10,474,200$10,474,200
WTI VLL VIIFMV$6,649,000$6,649,000
WTI VLL VIIIFMV$10,939,495$10,939,495
WTI VLL XFMV$7,561,920$7,561,920
YORK CO INVEST 1FMV$996,336$996,336

Land Etc Schedule2 LandEtcSchedule2

Land Etc LandEtcGrp (3 entries)

Category Or ItemCategoryOrItemTxtCost Or Other BasisCostOrOtherBasisAmtAccumulated DepreciationAccumulatedDepreciationAmtBook ValueBookValueAmtEOYFMVEOYFMVAmt
FURNITURE, FIXTURES AND EQUIPMENT$3,154,445$2,231,333$923,112$923,112
LEASEHOLD IMPROVEMENTS$7,446,632$2,514,038$4,932,594$4,932,594
WORK IN PROGRESS$1,325$0$1,325$1,325

Legal Fees Schedule LegalFeesSchedule

Legal Fees LegalFeesGrp (3 entries)

CategoryCategoryTxtLegal FeesLegalFeesAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
LEGAL FEES - INVESTMENTS$184,836$184,836$0
LEGAL FEES - PROGRAMS$252,018$0$310,816
LEGAL FEES - GENERAL ADMINISTRATIVE$118,389$0$123,435

Other Assets Schedule OtherAssetsSchedule

Other Assets Schedule OtherAssetsScheduleGrp (7 entries)

DescDescBOY Book ValueBOYBookValueAmtEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
ACCRUED INCOME RECEIVABLE$1,416,200$1,680,919$1,680,919
DUE FROM BROKER$25,945,689$14,137,129$14,137,129
RETIREMENT PLAN ASSET$2,162,642$2,064,360$2,064,360
ADVANCES AND OTHER RECEIVABLES$6,037$7,040$7,040
PROGRAM RELATED INVESTMENTS$18,971,538$24,011,405$24,011,405
OPERATING LEASE RIGHT OF USE ASSET$7,359,283$6,372,839$6,372,839
PREPAID FEDERAL EXCISE TAX$786,796$786,796

Other Decreases Schedule OtherDecreasesSchedule

Other Decreases Detail OtherDecreasesDetail (3 entries)

DescDescAmtAmt
UNREALIZED LOSS ON INVESTMENTS$152,784,093
UNREALIZED LOSS ON PROGRAM RELATED INVESTMENTS$178,498
PROVISION FOR CREDIT LOSSES - RELATED TO PROGRAM RELATED INVESTMENTS$8,876,050

Other Expenses Schedule OtherExpensesSchedule

Other Expenses Schedule OtherExpensesScheduleGrp (8 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
AMERICAN DEPOSITARY RECEIPT FEE$10,820$10,820$0
CONSULTING REIMBURSEMENTS$34,621$126$42,173
CUSTODY, BANK, & PERFORMANCE REPORTING FEES$731,527$731,477$50
STATE FILING FEES AND PENALTIES$163$0$0
INFORMATION TECHNOLOGY/COMPUTERS$1,676,118$254,043$1,559,119
INSURANCE$415,037$39,955$374,123
OFFICE EXPENSES$1,000,781$466,522$513,810
PORTFOLIO DEDUCTIONS$12,723,578$54,775,206$0

Other Income Schedule2 OtherIncomeSchedule2

Other Income Detail OtherIncomeDetail (9 entries)

DescDescNet Investment IncomeNetInvestmentIncomeAmtRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtAdjusted Net IncomeAdjustedNetIncomeAmt
FX TRANSACTION NET LOSS - TAX-$429,874
CLASS ACTION PROCEEDS, NET$19,132$19,132$19,132
OTHER PARTNERSHIP INCOME$22,439,795$25,329,605$25,329,605
SECTION 951(A) INCOME INCLUSION$2,447,781
OTHER INVESTMENT INCOME$42$42$42
GRANT RECOVERIES$7,276,276$7,276,276
OTHER NON-TAXABLE INCOME$27,454$27,454
FEDERAL EXCISE TAX BENEFIT$3,842,567$3,842,567
FX TRANSACTION NET LOSS - BOOK-$496,216-$496,216

Other Increases Schedule OtherIncreasesSchedule

Other Increases Detail OtherIncreasesDetail

FieldValueIRS element (for citing)
DescDEFERRED FEDERAL EXCISE TAX BENEFITDesc
Amt$2,181,205Amt

Other Liabilities Schedule OtherLiabilitiesSchedule

Other Liabilities Detail OtherLiabilitiesDetail (8 entries)

DescDescBOY Book ValueBOYBookValueAmtEOY Book ValueEOYBookValueAmt
DEFERRED FEDERAL EXCISE TAX$24,836,165$22,654,960
RETIREMENT PLAN LIABILITY$2,432,030$2,948,693
ACCRUED VACATION$1,168,550$1,342,903
GRANT REFUNDS PENDING MODIFICATION$3,852,387$38,746
OPERATING LEASE LIABILITIES$8,365,590$7,261,172
FEDERAL EXCISE TAX PAYABLE$4,555,771$0
ALLOWANCE FOR CREDIT LOSSES$646,935$6,171,350
REFUNDABLE DEPOSITS$0$419

Other Professional Fees Schedule OtherProfessionalFeesSchedule

Other Professional Fees Detail OtherProfessionalFeesDetail (9 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
GRANTS MANAGEMENT CONSULTING$122,100$0$151,588
HUMAN RESOURCE CONSULTING$79,696$7,000$75,696
INFORMATION TECHNOLOGY CONSULTING$406,409$40,896$348,594
INVESTMENT ADVISORY$513,656$513,656$0
INVESTMENT MANAGEMENT$14,260,530$14,260,530$0
MANAGEMENT CONSULTING$70,936$0$110,936
PROGRAM CONSULTING$1,182,556$0$1,375,891
PUBLIC RELATIONS$321,574$0$385,730
RECRUITMENT$127,045$25,306$90,073

Taxes Schedule TaxesSchedule

Taxes Detail TaxesDetail (2 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
STATE UBI AND OTHER TAXES$823,811$0$0
FOREIGN TAXES WITHHELD$478,700$3,875,590$0

Transfers Frm Controlled Entities TransfersFrmControlledEntities

Transfers From Controlled Ent TransfersFromControlledEntGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINDescDescAmtAmt
MHR LONGEVITY PARTNERS
40 WEST 57TH ST FLOOR 24NEW YORKNY10019981471155DISTRIBUTION FROM PARTNERSHIP$54,725,000
NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP
1325 NORTH BEACH STREET SUITE 201PHILADELPHIAPA19125981142649DISTRIBUTION$8,659,313
FieldValueIRS element (for citing)
Total$66,292,906TotalAmt

Transfers To Controlled Entities TransfersToControlledEntities

Transfers To Controlled Ent TransfersToControlledEntGrp (4 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINDescDescAmtAmtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
LACM WORLD SMALL CAP EQUITY FUND LP
11150 SANTA MONICA BLVD STE 200LOS ANGELESCA90025832888004CONTRIBUTION OF CAPITAL$20,000,000
MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST
611915057CONTRIBUTION OF CAPITAL$30,000,000ORION HOUSE 5 UPPER ST MARTINS LANELONDONUKWC2H 9EA
MHR LONGEVITY PARTNERS
40 WEST 57TH ST FLOOR 24NEW YORKNY10019981471155CONTRIBUTION OF CAPITAL$54,725,000
NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP
1325 NORTH BEACH STREET SUITE 201PHILADELPHIAPA19125981142649MANAGEMENT FEES$8,659,313
FieldValueIRS element (for citing)
Total$113,384,313TotalAmt